id	sid	tid	token	lemma	pos
cuesj-184	1	1	52	52	NUM
cuesj-184	1	2	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-184	1	3	cuesj	cuesj	NOUN
cuesj-184	1	4	2020	2020	NUM
cuesj-184	1	5	,	,	PUNCT
cuesj-184	1	6	4	4	NUM
cuesj-184	1	7	(	(	PUNCT
cuesj-184	1	8	1	1	NUM
cuesj-184	1	9	):	):	PUNCT
cuesj-184	1	10	52	52	NUM
cuesj-184	1	11	-	-	SYM
cuesj-184	1	12	56	56	NUM
cuesj-184	1	13	research	research	NOUN
cuesj-184	1	14	article	article	NOUN
cuesj-184	1	15	significance	significance	NOUN
cuesj-184	1	16	of	of	ADP
cuesj-184	1	17	hepatitis	hepatitis	PROPN
cuesj-184	1	18	b	b	PROPN
cuesj-184	1	19	virus	virus	NOUN
cuesj-184	1	20	diagnosis	diagnosis	NOUN
cuesj-184	1	21	by	by	ADP
cuesj-184	1	22	real	real	ADJ
cuesj-184	1	23	-	-	PUNCT
cuesj-184	1	24	time	time	NOUN
cuesj-184	1	25	polymerase	polymerase	NOUN
cuesj-184	1	26	chain	chain	NOUN
cuesj-184	1	27	reaction	reaction	NOUN
cuesj-184	1	28	over	over	ADP
cuesj-184	1	29	serological	serological	ADJ
cuesj-184	1	30	markers	marker	NOUN
cuesj-184	1	31	in	in	ADP
cuesj-184	1	32	hepatitis	hepatitis	PROPN
cuesj-184	1	33	b	b	PROPN
cuesj-184	1	34	virus	virus	NOUN
cuesj-184	1	35	patients	patient	VERB
cuesj-184	1	36	amer	amer	PROPN
cuesj-184	1	37	a.	a.	PROPN
cuesj-184	1	38	khaleell	khaleell	PROPN
cuesj-184	1	39	*	*	PROPN
cuesj-184	1	40	,	,	PUNCT
cuesj-184	1	41	salah	salah	PROPN
cuesj-184	1	42	t.	t.	PROPN
cuesj-184	1	43	jalall	jalall	PROPN
cuesj-184	1	44	,	,	PUNCT
cuesj-184	1	45	saeed	saeed	PROPN
cuesj-184	1	46	g.	g.	PROPN
cuesj-184	1	47	hussain2	hussain2	PROPN
cuesj-184	2	1	1department	1department	NUM
cuesj-184	2	2	of	of	ADP
cuesj-184	2	3	medical	medical	ADJ
cuesj-184	2	4	microbiology	microbiology	NOUN
cuesj-184	2	5	,	,	PUNCT
cuesj-184	2	6	college	college	NOUN
cuesj-184	2	7	of	of	ADP
cuesj-184	2	8	health	health	PROPN
cuesj-184	2	9	sciences	sciences	PROPN
cuesj-184	2	10	-	-	PUNCT
cuesj-184	2	11	hawler	hawler	NOUN
cuesj-184	2	12	medical	medical	PROPN
cuesj-184	2	13	university	university	PROPN
cuesj-184	2	14	,	,	PUNCT
cuesj-184	2	15	erbil	erbil	PROPN
cuesj-184	2	16	,	,	PUNCT
cuesj-184	2	17	iraq	iraq	PROPN
cuesj-184	2	18	,	,	PUNCT
cuesj-184	2	19	2department	2department	NUM
cuesj-184	2	20	of	of	ADP
cuesj-184	2	21	medical	medical	ADJ
cuesj-184	2	22	microbiology	microbiology	NOUN
cuesj-184	2	23	,	,	PUNCT
cuesj-184	2	24	college	college	NOUN
cuesj-184	2	25	of	of	ADP
cuesj-184	2	26	medicine	medicine	NOUN
cuesj-184	2	27	-	-	PUNCT
cuesj-184	2	28	hawler	hawler	NOUN
cuesj-184	2	29	medical	medical	PROPN
cuesj-184	2	30	university	university	PROPN
cuesj-184	2	31	,	,	PUNCT
cuesj-184	2	32	erbil	erbil	PROPN
cuesj-184	2	33	,	,	PUNCT
cuesj-184	2	34	iraq	iraq	PROPN
cuesj-184	2	35	abstract	abstract	ADJ
cuesj-184	2	36	hepatitis	hepatitis	PROPN
cuesj-184	2	37	b	b	PROPN
cuesj-184	2	38	virus	virus	NOUN
cuesj-184	2	39	(	(	PUNCT
cuesj-184	2	40	hbv	hbv	NOUN
cuesj-184	2	41	)	)	PUNCT
cuesj-184	2	42	is	be	AUX
cuesj-184	2	43	the	the	DET
cuesj-184	2	44	leading	lead	VERB
cuesj-184	2	45	cause	cause	NOUN
cuesj-184	2	46	of	of	ADP
cuesj-184	2	47	viral	viral	ADJ
cuesj-184	2	48	hepatitis	hepatitis	NOUN
cuesj-184	2	49	,	,	PUNCT
cuesj-184	2	50	as	as	ADV
cuesj-184	2	51	currently	currently	ADV
cuesj-184	2	52	over	over	ADP
cuesj-184	2	53	2	2	NUM
cuesj-184	2	54	billion	billion	NUM
cuesj-184	2	55	people	people	NOUN
cuesj-184	2	56	have	have	VERB
cuesj-184	2	57	hbv	hbv	NOUN
cuesj-184	2	58	infection	infection	NOUN
cuesj-184	2	59	worldwide	worldwide	ADV
cuesj-184	2	60	.	.	PUNCT
cuesj-184	3	1	nucleic	nucleic	ADJ
cuesj-184	3	2	acid	acid	NOUN
cuesj-184	3	3	assay	assay	PROPN
cuesj-184	3	4	and	and	CCONJ
cuesj-184	3	5	quantitative	quantitative	ADJ
cuesj-184	3	6	hepatitis	hepatitis	PROPN
cuesj-184	3	7	b	b	PROPN
cuesj-184	3	8	surface	surface	NOUN
cuesj-184	3	9	antigen	antigen	NOUN
cuesj-184	3	10	(	(	PUNCT
cuesj-184	3	11	hbsag	hbsag	NOUN
cuesj-184	3	12	)	)	PUNCT
cuesj-184	3	13	have	have	AUX
cuesj-184	3	14	been	be	AUX
cuesj-184	3	15	developed	develop	VERB
cuesj-184	3	16	for	for	ADP
cuesj-184	3	17	diagnostic	diagnostic	ADJ
cuesj-184	3	18	and	and	CCONJ
cuesj-184	3	19	therapeutic	therapeutic	ADJ
cuesj-184	3	20	monitoring	monitoring	NOUN
cuesj-184	3	21	of	of	ADP
cuesj-184	3	22	patients	patient	NOUN
cuesj-184	3	23	with	with	ADP
cuesj-184	3	24	hbv	hbv	NOUN
cuesj-184	3	25	infection	infection	NOUN
cuesj-184	3	26	.	.	PUNCT
cuesj-184	4	1	these	these	DET
cuesj-184	4	2	tests	test	NOUN
cuesj-184	4	3	might	might	AUX
cuesj-184	4	4	also	also	ADV
cuesj-184	4	5	show	show	VERB
cuesj-184	4	6	correlation	correlation	NOUN
cuesj-184	4	7	between	between	ADP
cuesj-184	4	8	hbv	hbv	NOUN
cuesj-184	4	9	dna	dna	PROPN
cuesj-184	4	10	and	and	CCONJ
cuesj-184	4	11	hbs	hbs	PROPN
cuesj-184	4	12	serostatus	serostatus	NOUN
cuesj-184	4	13	.	.	PUNCT
cuesj-184	5	1	the	the	DET
cuesj-184	5	2	study	study	NOUN
cuesj-184	5	3	aimed	aim	VERB
cuesj-184	5	4	to	to	PART
cuesj-184	5	5	find	find	VERB
cuesj-184	5	6	and	and	CCONJ
cuesj-184	5	7	analyze	analyze	VERB
cuesj-184	5	8	the	the	DET
cuesj-184	5	9	frequency	frequency	NOUN
cuesj-184	5	10	and	and	CCONJ
cuesj-184	5	11	impact	impact	NOUN
cuesj-184	5	12	of	of	ADP
cuesj-184	5	13	hbsag	hbsag	ADJ
cuesj-184	5	14	seropositivity	seropositivity	NOUN
cuesj-184	5	15	among	among	ADP
cuesj-184	5	16	patients	patient	NOUN
cuesj-184	5	17	revealed	reveal	VERB
cuesj-184	5	18	hbv	hbv	PROPN
cuesj-184	5	19	dna	dna	PROPN
cuesj-184	5	20	negative	negative	ADJ
cuesj-184	5	21	level	level	NOUN
cuesj-184	5	22	through	through	ADP
cuesj-184	5	23	quantitative	quantitative	ADJ
cuesj-184	5	24	estimation	estimation	NOUN
cuesj-184	5	25	of	of	ADP
cuesj-184	5	26	both	both	DET
cuesj-184	5	27	seromarkers	seromarker	NOUN
cuesj-184	5	28	.	.	PUNCT
cuesj-184	6	1	real	real	ADJ
cuesj-184	6	2	-	-	PUNCT
cuesj-184	6	3	time	time	NOUN
cuesj-184	6	4	polymerase	polymerase	NOUN
cuesj-184	6	5	chain	chain	NOUN
cuesj-184	6	6	reaction	reaction	NOUN
cuesj-184	6	7	(	(	PUNCT
cuesj-184	6	8	rt	rt	NOUN
cuesj-184	6	9	-	-	PUNCT
cuesj-184	6	10	pcr	pcr	NOUN
cuesj-184	6	11	)	)	PUNCT
cuesj-184	6	12	and	and	CCONJ
cuesj-184	6	13	elecsys	elecsys	ADJ
cuesj-184	6	14	assays	assay	NOUN
cuesj-184	6	15	were	be	AUX
cuesj-184	6	16	used	use	VERB
cuesj-184	6	17	for	for	ADP
cuesj-184	6	18	quantitative	quantitative	ADJ
cuesj-184	6	19	estimation	estimation	NOUN
cuesj-184	6	20	of	of	ADP
cuesj-184	6	21	hbv	hbv	PROPN
cuesj-184	6	22	dna	dna	PROPN
cuesj-184	6	23	and	and	CCONJ
cuesj-184	6	24	hbs	hbs	PROPN
cuesj-184	6	25	antigen	antigen	PROPN
cuesj-184	6	26	,	,	PUNCT
cuesj-184	6	27	respectively	respectively	ADV
cuesj-184	6	28	.	.	PUNCT
cuesj-184	7	1	a	a	DET
cuesj-184	7	2	total	total	NOUN
cuesj-184	7	3	of	of	ADP
cuesj-184	7	4	256	256	NUM
cuesj-184	7	5	blood	blood	NOUN
cuesj-184	7	6	samples	sample	NOUN
cuesj-184	7	7	were	be	AUX
cuesj-184	7	8	used	use	VERB
cuesj-184	7	9	from	from	ADP
cuesj-184	7	10	patients	patient	NOUN
cuesj-184	7	11	referred	refer	VERB
cuesj-184	7	12	for	for	ADP
cuesj-184	7	13	either	either	CCONJ
cuesj-184	7	14	diagnostic	diagnostic	ADJ
cuesj-184	7	15	purpose	purpose	NOUN
cuesj-184	7	16	and/or	and/or	CCONJ
cuesj-184	7	17	hbv	hbv	NOUN
cuesj-184	7	18	viral	viral	ADJ
cuesj-184	7	19	load	load	NOUN
cuesj-184	7	20	monitoring	monitoring	NOUN
cuesj-184	7	21	after	after	ADP
cuesj-184	7	22	antiviral	antiviral	ADJ
cuesj-184	7	23	therapy	therapy	NOUN
cuesj-184	7	24	.	.	PUNCT
cuesj-184	8	1	blood	blood	NOUN
cuesj-184	8	2	profile	profile	NOUN
cuesj-184	8	3	analysis	analysis	NOUN
cuesj-184	8	4	showed	show	VERB
cuesj-184	8	5	12.26	12.26	NUM
cuesj-184	8	6	%	%	NOUN
cuesj-184	8	7	hbs	hbs	PROPN
cuesj-184	8	8	antigen	antigen	PROPN
cuesj-184	8	9	seropositivity	seropositivity	NOUN
cuesj-184	8	10	among	among	ADP
cuesj-184	8	11	patients	patient	NOUN
cuesj-184	8	12	revealed	reveal	VERB
cuesj-184	8	13	negative	negative	ADJ
cuesj-184	8	14	for	for	ADP
cuesj-184	8	15	nucleic	nucleic	ADJ
cuesj-184	8	16	acid	acid	NOUN
cuesj-184	8	17	assay	assay	NOUN
cuesj-184	8	18	for	for	ADP
cuesj-184	8	19	hbv	hbv	NOUN
cuesj-184	8	20	dna	dna	PROPN
cuesj-184	8	21	.	.	PUNCT
cuesj-184	9	1	positive	positive	ADJ
cuesj-184	9	2	hbs	hbs	PROPN
cuesj-184	9	3	antigen	antigen	NOUN
cuesj-184	9	4	titers	titer	NOUN
cuesj-184	9	5	ranged	range	VERB
cuesj-184	9	6	from	from	ADP
cuesj-184	9	7	1000–50,000	1000–50,000	NUM
cuesj-184	9	8	coi	coi	NOUN
cuesj-184	9	9	,	,	PUNCT
cuesj-184	9	10	with	with	ADP
cuesj-184	9	11	seronegative	seronegative	ADJ
cuesj-184	9	12	anti	anti	ADJ
cuesj-184	9	13	-	-	ADJ
cuesj-184	9	14	hbs	hbs	ADJ
cuesj-184	9	15	antibody	antibody	NOUN
cuesj-184	9	16	test	test	NOUN
cuesj-184	9	17	for	for	ADP
cuesj-184	9	18	all	all	DET
cuesj-184	9	19	samples	sample	NOUN
cuesj-184	9	20	tested	test	VERB
cuesj-184	9	21	positive	positive	ADJ
cuesj-184	9	22	for	for	ADP
cuesj-184	9	23	hbs	hbs	PROPN
cuesj-184	9	24	antigen	antigen	PROPN
cuesj-184	9	25	.	.	PUNCT
cuesj-184	10	1	this	this	DET
cuesj-184	10	2	study	study	NOUN
cuesj-184	10	3	delineated	delineate	VERB
cuesj-184	10	4	that	that	SCONJ
cuesj-184	10	5	negative	negative	ADJ
cuesj-184	10	6	or	or	CCONJ
cuesj-184	10	7	undetectable	undetectable	ADJ
cuesj-184	10	8	quantitation	quantitation	NOUN
cuesj-184	10	9	of	of	ADP
cuesj-184	10	10	hbv	hbv	NOUN
cuesj-184	10	11	dna	dna	PROPN
cuesj-184	10	12	level	level	NOUN
cuesj-184	10	13	does	do	AUX
cuesj-184	10	14	not	not	PART
cuesj-184	10	15	exclude	exclude	VERB
cuesj-184	10	16	hbv	hbv	NOUN
cuesj-184	10	17	infection	infection	NOUN
cuesj-184	10	18	;	;	PUNCT
cuesj-184	10	19	as	as	SCONJ
cuesj-184	10	20	the	the	DET
cuesj-184	10	21	level	level	NOUN
cuesj-184	10	22	might	might	AUX
cuesj-184	10	23	fluctuate	fluctuate	VERB
cuesj-184	10	24	in	in	ADP
cuesj-184	10	25	different	different	ADJ
cuesj-184	10	26	phases	phase	NOUN
cuesj-184	10	27	of	of	ADP
cuesj-184	10	28	hbv	hbv	NOUN
cuesj-184	10	29	replication	replication	NOUN
cuesj-184	10	30	.	.	PUNCT
cuesj-184	11	1	this	this	PRON
cuesj-184	11	2	gives	give	VERB
cuesj-184	11	3	an	an	DET
cuesj-184	11	4	impression	impression	NOUN
cuesj-184	11	5	and	and	CCONJ
cuesj-184	11	6	raising	raise	VERB
cuesj-184	11	7	a	a	DET
cuesj-184	11	8	question	question	NOUN
cuesj-184	11	9	about	about	ADP
cuesj-184	11	10	significance	significance	NOUN
cuesj-184	11	11	of	of	ADP
cuesj-184	11	12	replacing	replace	VERB
cuesj-184	11	13	test	test	NOUN
cuesj-184	11	14	for	for	ADP
cuesj-184	11	15	hbsag	hbsag	NOUN
cuesj-184	11	16	with	with	ADP
cuesj-184	11	17	quantitation	quantitation	NOUN
cuesj-184	11	18	of	of	ADP
cuesj-184	11	19	hbv	hbv	PROPN
cuesj-184	11	20	dna	dna	PROPN
cuesj-184	11	21	pcr	pcr	PROPN
cuesj-184	11	22	assay	assay	VERB
cuesj-184	11	23	.	.	PUNCT
cuesj-184	12	1	thus	thus	ADV
cuesj-184	12	2	,	,	PUNCT
cuesj-184	12	3	the	the	DET
cuesj-184	12	4	study	study	NOUN
cuesj-184	12	5	refers	refer	VERB
cuesj-184	12	6	to	to	ADP
cuesj-184	12	7	a	a	DET
cuesj-184	12	8	special	special	ADJ
cuesj-184	12	9	hbv	hbv	NOUN
cuesj-184	12	10	profile	profile	NOUN
cuesj-184	12	11	outside	outside	ADP
cuesj-184	12	12	the	the	DET
cuesj-184	12	13	classical	classical	ADJ
cuesj-184	12	14	pattern	pattern	NOUN
cuesj-184	12	15	.	.	PUNCT
cuesj-184	13	1	keywords	keyword	NOUN
cuesj-184	13	2	:	:	PUNCT
cuesj-184	13	3	component	component	NOUN
cuesj-184	13	4	,	,	PUNCT
cuesj-184	13	5	hepatitis	hepatitis	PROPN
cuesj-184	13	6	b	b	PROPN
cuesj-184	13	7	surface	surface	NOUN
cuesj-184	13	8	antigen	antigen	ADV
cuesj-184	13	9	,	,	PUNCT
cuesj-184	13	10	hepatitis	hepatitis	PROPN
cuesj-184	13	11	b	b	PROPN
cuesj-184	13	12	virus	virus	NOUN
cuesj-184	13	13	,	,	PUNCT
cuesj-184	13	14	hepatitis	hepatitis	NOUN
cuesj-184	13	15	,	,	PUNCT
cuesj-184	13	16	quantitative	quantitative	ADJ
cuesj-184	13	17	hepatitis	hepatitis	PROPN
cuesj-184	13	18	b	b	PROPN
cuesj-184	13	19	virus	virus	NOUN
cuesj-184	13	20	dna	dna	PROPN
cuesj-184	13	21	introduction	introduction	NOUN
cuesj-184	13	22	hepatitis	hepatitis	PROPN
cuesj-184	13	23	b	b	PROPN
cuesj-184	13	24	virus	virus	NOUN
cuesj-184	13	25	(	(	PUNCT
cuesj-184	13	26	hbv	hbv	NOUN
cuesj-184	13	27	)	)	PUNCT
cuesj-184	13	28	is	be	AUX
cuesj-184	13	29	the	the	DET
cuesj-184	13	30	leading	lead	VERB
cuesj-184	13	31	cause	cause	NOUN
cuesj-184	13	32	of	of	ADP
cuesj-184	13	33	viral	viral	ADJ
cuesj-184	13	34	hepatitis	hepatitis	NOUN
cuesj-184	13	35	,	,	PUNCT
cuesj-184	13	36	as	as	ADV
cuesj-184	13	37	currently	currently	ADV
cuesj-184	13	38	over	over	ADP
cuesj-184	13	39	2	2	NUM
cuesj-184	13	40	billion	billion	NUM
cuesj-184	13	41	people	people	NOUN
cuesj-184	13	42	have	have	VERB
cuesj-184	13	43	hbv	hbv	NOUN
cuesj-184	13	44	infection	infection	NOUN
cuesj-184	13	45	worldwide	worldwide	ADV
cuesj-184	13	46	.	.	PUNCT
cuesj-184	14	1	approximately	approximately	ADV
cuesj-184	14	2	600,000	600,000	NUM
cuesj-184	14	3	deaths	death	NOUN
cuesj-184	14	4	occur	occur	VERB
cuesj-184	14	5	every	every	DET
cuesj-184	14	6	year	year	NOUN
cuesj-184	14	7	as	as	ADP
cuesj-184	14	8	a	a	DET
cuesj-184	14	9	result	result	NOUN
cuesj-184	14	10	of	of	ADP
cuesj-184	14	11	the	the	DET
cuesj-184	14	12	acute	acute	ADJ
cuesj-184	14	13	and	and	CCONJ
cuesj-184	14	14	chronic	chronic	ADJ
cuesj-184	14	15	consequences	consequence	NOUN
cuesj-184	14	16	of	of	ADP
cuesj-184	14	17	hbv	hbv	NOUN
cuesj-184	14	18	infection.[1	infection.[1	NOUN
cuesj-184	14	19	]	]	PUNCT
cuesj-184	14	20	chronic	chronic	ADJ
cuesj-184	14	21	hbv	hbv	NOUN
cuesj-184	14	22	affects	affect	VERB
cuesj-184	14	23	nearly	nearly	ADV
cuesj-184	14	24	350	350	NUM
cuesj-184	14	25	million	million	NUM
cuesj-184	14	26	patients	patient	NOUN
cuesj-184	14	27	worldwide	worldwide	ADV
cuesj-184	14	28	and	and	CCONJ
cuesj-184	14	29	may	may	AUX
cuesj-184	14	30	further	far	ADV
cuesj-184	14	31	progress	progress	VERB
cuesj-184	14	32	to	to	ADP
cuesj-184	14	33	cirrhosis	cirrhosis	NOUN
cuesj-184	14	34	and/or	and/or	CCONJ
cuesj-184	14	35	hepatocellular	hepatocellular	ADJ
cuesj-184	14	36	carcinoma	carcinoma	NOUN
cuesj-184	14	37	(	(	PUNCT
cuesj-184	14	38	hcc	hcc	PROPN
cuesj-184	14	39	)	)	PUNCT
cuesj-184	14	40	in	in	ADP
cuesj-184	14	41	15–40	15–40	NUM
cuesj-184	14	42	%	%	NOUN
cuesj-184	14	43	of	of	ADP
cuesj-184	14	44	cases.[2	cases.[2	PROPN
cuesj-184	14	45	]	]	PUNCT
cuesj-184	14	46	hbv	hbv	NOUN
cuesj-184	14	47	infection	infection	NOUN
cuesj-184	14	48	is	be	AUX
cuesj-184	14	49	a	a	DET
cuesj-184	14	50	dynamic	dynamic	ADJ
cuesj-184	14	51	process	process	NOUN
cuesj-184	14	52	characterized	characterize	VERB
cuesj-184	14	53	by	by	ADP
cuesj-184	14	54	replicative	replicative	ADJ
cuesj-184	14	55	and	and	CCONJ
cuesj-184	14	56	non	non	ADJ
cuesj-184	14	57	-	-	ADJ
cuesj-184	14	58	replicative	replicative	ADJ
cuesj-184	14	59	phases	phase	NOUN
cuesj-184	14	60	based	base	VERB
cuesj-184	14	61	on	on	ADP
cuesj-184	14	62	virus	virus	NOUN
cuesj-184	14	63	-	-	PUNCT
cuesj-184	14	64	host	host	NOUN
cuesj-184	14	65	interaction	interaction	NOUN
cuesj-184	14	66	,	,	PUNCT
cuesj-184	14	67	which	which	PRON
cuesj-184	14	68	are	be	AUX
cuesj-184	14	69	present	present	ADJ
cuesj-184	14	70	in	in	ADP
cuesj-184	14	71	some	some	DET
cuesj-184	14	72	form	form	NOUN
cuesj-184	14	73	of	of	ADP
cuesj-184	14	74	all	all	DET
cuesj-184	14	75	infected	infected	ADJ
cuesj-184	14	76	patients.[3	patients.[3	NOUN
cuesj-184	14	77	]	]	PUNCT
cuesj-184	14	78	to	to	PART
cuesj-184	14	79	measure	measure	VERB
cuesj-184	14	80	hbv	hbv	PROPN
cuesj-184	14	81	dna	dna	PROPN
cuesj-184	14	82	(	(	PUNCT
cuesj-184	14	83	viral	viral	ADJ
cuesj-184	14	84	load	load	NOUN
cuesj-184	14	85	)	)	PUNCT
cuesj-184	14	86	,	,	PUNCT
cuesj-184	14	87	a	a	DET
cuesj-184	14	88	laboratory	laboratory	NOUN
cuesj-184	14	89	measures	measure	NOUN
cuesj-184	14	90	how	how	SCONJ
cuesj-184	14	91	many	many	ADJ
cuesj-184	14	92	hbv	hbv	NOUN
cuesj-184	14	93	dna	dna	PROPN
cuesj-184	14	94	units	unit	NOUN
cuesj-184	14	95	are	be	AUX
cuesj-184	14	96	found	find	VERB
cuesj-184	14	97	in	in	ADP
cuesj-184	14	98	1	1	NUM
cuesj-184	14	99	ml	ml	NOUN
cuesj-184	14	100	of	of	ADP
cuesj-184	14	101	blood	blood	NOUN
cuesj-184	14	102	.	.	PUNCT
cuesj-184	15	1	the	the	DET
cuesj-184	15	2	result	result	NOUN
cuesj-184	15	3	is	be	AUX
cuesj-184	15	4	written	write	VERB
cuesj-184	15	5	in	in	ADP
cuesj-184	15	6	international	international	ADJ
cuesj-184	15	7	units	unit	NOUN
cuesj-184	15	8	per	per	ADP
cuesj-184	15	9	ml	ml	X
cuesj-184	15	10	(	(	PUNCT
cuesj-184	15	11	iu	iu	NOUN
cuesj-184	15	12	/	/	SYM
cuesj-184	15	13	ml	ml	NOUN
cuesj-184	15	14	)	)	PUNCT
cuesj-184	15	15	.	.	PUNCT
cuesj-184	16	1	high	high	ADJ
cuesj-184	16	2	levels	level	NOUN
cuesj-184	16	3	of	of	ADP
cuesj-184	16	4	hbv	hbv	PROPN
cuesj-184	16	5	dna	dna	PROPN
cuesj-184	16	6	indicate	indicate	VERB
cuesj-184	16	7	a	a	DET
cuesj-184	16	8	high	high	ADJ
cuesj-184	16	9	rate	rate	NOUN
cuesj-184	16	10	of	of	ADP
cuesj-184	16	11	hbv	hbv	NOUN
cuesj-184	16	12	replication	replication	NOUN
cuesj-184	16	13	;	;	PUNCT
cuesj-184	16	14	however	however	ADV
cuesj-184	16	15	,	,	PUNCT
cuesj-184	16	16	low	low	ADJ
cuesj-184	16	17	or	or	CCONJ
cuesj-184	16	18	undetectable	undetectable	ADJ
cuesj-184	16	19	levels–<2000	levels–<2000	NOUN
cuesj-184	16	20	iu	iu	ADV
cuesj-184	16	21	/	/	SYM
cuesj-184	16	22	ml	ml	AUX
cuesj-184	16	23	indicate	indicate	VERB
cuesj-184	16	24	an	an	DET
cuesj-184	16	25	“	"	PUNCT
cuesj-184	16	26	inactive	inactive	ADJ
cuesj-184	16	27	”	"	PUNCT
cuesj-184	16	28	infection.[4	infection.[4	PUNCT
cuesj-184	16	29	]	]	PUNCT
cuesj-184	16	30	during	during	ADP
cuesj-184	16	31	hbv	hbv	NOUN
cuesj-184	16	32	infection	infection	NOUN
cuesj-184	16	33	,	,	PUNCT
cuesj-184	16	34	markers	marker	NOUN
cuesj-184	16	35	can	can	AUX
cuesj-184	16	36	be	be	AUX
cuesj-184	16	37	detected	detect	VERB
cuesj-184	16	38	in	in	ADP
cuesj-184	16	39	sera	sera	NOUN
cuesj-184	16	40	samples	sample	NOUN
cuesj-184	16	41	using	use	VERB
cuesj-184	16	42	immunoassays	immunoassay	NOUN
cuesj-184	16	43	.	.	PUNCT
cuesj-184	17	1	for	for	ADP
cuesj-184	17	2	example	example	NOUN
cuesj-184	17	3	,	,	PUNCT
cuesj-184	17	4	patient	patient	ADJ
cuesj-184	17	5	sera	sera	NOUN
cuesj-184	17	6	that	that	PRON
cuesj-184	17	7	contain	contain	VERB
cuesj-184	17	8	anti	anti	ADJ
cuesj-184	17	9	-	-	ADJ
cuesj-184	17	10	hbs	hbs	PROPN
cuesj-184	17	11	indicates	indicate	VERB
cuesj-184	17	12	immunity	immunity	NOUN
cuesj-184	17	13	from	from	ADP
cuesj-184	17	14	past	past	ADJ
cuesj-184	17	15	infections	infection	NOUN
cuesj-184	17	16	or	or	CCONJ
cuesj-184	17	17	vaccinations	vaccination	NOUN
cuesj-184	17	18	,	,	PUNCT
cuesj-184	17	19	and	and	CCONJ
cuesj-184	17	20	a	a	DET
cuesj-184	17	21	patient	patient	NOUN
cuesj-184	17	22	with	with	ADP
cuesj-184	17	23	anti	anti	ADJ
cuesj-184	17	24	-	-	ADJ
cuesj-184	17	25	hbe	hbe	ADJ
cuesj-184	17	26	antibodies	antibody	NOUN
cuesj-184	17	27	in	in	ADP
cuesj-184	17	28	their	their	PRON
cuesj-184	17	29	sera	sera	NOUN
cuesj-184	17	30	is	be	AUX
cuesj-184	17	31	considered	consider	VERB
cuesj-184	17	32	as	as	ADP
cuesj-184	17	33	spontaneous	spontaneous	ADJ
cuesj-184	17	34	resolution	resolution	NOUN
cuesj-184	17	35	of	of	ADP
cuesj-184	17	36	infection	infection	NOUN
cuesj-184	17	37	or	or	CCONJ
cuesj-184	17	38	therapy	therapy	NOUN
cuesj-184	17	39	-	-	PUNCT
cuesj-184	17	40	induced	induce	VERB
cuesj-184	17	41	improvement.[5,6	improvement.[5,6	NOUN
cuesj-184	17	42	]	]	X
cuesj-184	17	43	one	one	NUM
cuesj-184	17	44	of	of	ADP
cuesj-184	17	45	the	the	DET
cuesj-184	17	46	serological	serological	ADJ
cuesj-184	17	47	methods	method	NOUN
cuesj-184	17	48	using	use	VERB
cuesj-184	17	49	for	for	ADP
cuesj-184	17	50	the	the	DET
cuesj-184	17	51	diagnosis	diagnosis	NOUN
cuesj-184	17	52	of	of	ADP
cuesj-184	17	53	hbv	hbv	NOUN
cuesj-184	17	54	is	be	AUX
cuesj-184	17	55	enzyme	enzyme	NOUN
cuesj-184	17	56	immune	immune	ADJ
cuesj-184	17	57	assays	assay	NOUN
cuesj-184	17	58	.	.	PUNCT
cuesj-184	18	1	the	the	DET
cuesj-184	18	2	hepatitis	hepatitis	PROPN
cuesj-184	18	3	b	b	PROPN
cuesj-184	18	4	surface	surface	NOUN
cuesj-184	18	5	antigen	antigen	NOUN
cuesj-184	18	6	(	(	PUNCT
cuesj-184	18	7	hbsag	hbsag	NOUN
cuesj-184	18	8	)	)	PUNCT
cuesj-184	18	9	and	and	CCONJ
cuesj-184	18	10	hbv	hbv	PROPN
cuesj-184	18	11	dna	dna	PROPN
cuesj-184	18	12	levels	level	NOUN
cuesj-184	18	13	were	be	AUX
cuesj-184	18	14	considered	consider	VERB
cuesj-184	18	15	to	to	PART
cuesj-184	18	16	be	be	AUX
cuesj-184	18	17	a	a	DET
cuesj-184	18	18	risk	risk	NOUN
cuesj-184	18	19	factor	factor	NOUN
cuesj-184	18	20	of	of	ADP
cuesj-184	18	21	hepatocarcinogenesis	hepatocarcinogenesis	NOUN
cuesj-184	18	22	in	in	ADP
cuesj-184	18	23	untreated	untreated	ADJ
cuesj-184	18	24	hb	hb	NOUN
cuesj-184	18	25	patients.[7	patients.[7	NOUN
cuesj-184	18	26	]	]	PUNCT
cuesj-184	18	27	the	the	DET
cuesj-184	18	28	levels	level	NOUN
cuesj-184	18	29	of	of	ADP
cuesj-184	18	30	quantified	quantified	ADJ
cuesj-184	18	31	hbsag	hbsag	NOUN
cuesj-184	18	32	are	be	AUX
cuesj-184	18	33	considered	consider	VERB
cuesj-184	18	34	as	as	ADP
cuesj-184	18	35	a	a	DET
cuesj-184	18	36	marker	marker	NOUN
cuesj-184	18	37	with	with	ADP
cuesj-184	18	38	which	which	PRON
cuesj-184	18	39	to	to	PART
cuesj-184	18	40	evaluate	evaluate	VERB
cuesj-184	18	41	the	the	DET
cuesj-184	18	42	host	host	NOUN
cuesj-184	18	43	immunological	immunological	ADJ
cuesj-184	18	44	control	control	NOUN
cuesj-184	18	45	of	of	ADP
cuesj-184	18	46	infection	infection	NOUN
cuesj-184	18	47	and	and	CCONJ
cuesj-184	18	48	hbv	hbv	NOUN
cuesj-184	18	49	replication.[8	replication.[8	PROPN
cuesj-184	18	50	]	]	PUNCT
cuesj-184	18	51	low	low	ADJ
cuesj-184	18	52	hbsag	hbsag	ADJ
cuesj-184	18	53	levels	level	NOUN
cuesj-184	18	54	in	in	ADP
cuesj-184	18	55	some	some	DET
cuesj-184	18	56	hbv	hbv	NOUN
cuesj-184	18	57	patients	patient	NOUN
cuesj-184	18	58	are	be	AUX
cuesj-184	18	59	considered	consider	VERB
cuesj-184	18	60	to	to	PART
cuesj-184	18	61	indicate	indicate	VERB
cuesj-184	18	62	a	a	DET
cuesj-184	18	63	high	high	ADJ
cuesj-184	18	64	likelihood	likelihood	NOUN
cuesj-184	18	65	of	of	ADP
cuesj-184	18	66	hbv	hbv	NOUN
cuesj-184	18	67	clearance	clearance	NOUN
cuesj-184	18	68	and	and	CCONJ
cuesj-184	18	69	lower	low	ADJ
cuesj-184	18	70	hepatitis	hepatitis	NOUN
cuesj-184	18	71	activity.[7,9	activity.[7,9	NOUN
cuesj-184	18	72	]	]	PUNCT
cuesj-184	18	73	the	the	DET
cuesj-184	18	74	aim	aim	NOUN
cuesj-184	18	75	of	of	ADP
cuesj-184	18	76	this	this	DET
cuesj-184	18	77	study	study	NOUN
cuesj-184	18	78	was	be	AUX
cuesj-184	18	79	to	to	PART
cuesj-184	18	80	estimate	estimate	VERB
cuesj-184	18	81	hbv	hbv	NOUN
cuesj-184	18	82	-	-	PUNCT
cuesj-184	18	83	dna	dna	PROPN
cuesj-184	18	84	positivity	positivity	NOUN
cuesj-184	18	85	states	state	NOUN
cuesj-184	18	86	among	among	ADP
cuesj-184	18	87	serologically	serologically	ADV
cuesj-184	18	88	screened	screen	VERB
cuesj-184	18	89	patients	patient	NOUN
cuesj-184	18	90	and	and	CCONJ
cuesj-184	18	91	to	to	PART
cuesj-184	18	92	compare	compare	VERB
cuesj-184	18	93	the	the	DET
cuesj-184	18	94	sensitivity	sensitivity	NOUN
cuesj-184	18	95	of	of	ADP
cuesj-184	18	96	molecular	molecular	ADJ
cuesj-184	18	97	and	and	CCONJ
cuesj-184	18	98	serological	serological	ADJ
cuesj-184	18	99	methods	method	NOUN
cuesj-184	18	100	for	for	ADP
cuesj-184	18	101	the	the	DET
cuesj-184	18	102	diagnosis	diagnosis	NOUN
cuesj-184	18	103	of	of	ADP
cuesj-184	18	104	hbv	hbv	NOUN
cuesj-184	18	105	infections	infection	NOUN
cuesj-184	18	106	.	.	PUNCT
cuesj-184	19	1	cihan	cihan	VERB
cuesj-184	19	2	university	university	NOUN
cuesj-184	19	3	-	-	PUNCT
cuesj-184	19	4	erbil	erbil	PROPN
cuesj-184	19	5	scientific	scientific	ADJ
cuesj-184	19	6	journal	journal	NOUN
cuesj-184	19	7	(	(	PUNCT
cuesj-184	19	8	cuesj	cuesj	PROPN
cuesj-184	19	9	)	)	PUNCT
cuesj-184	19	10	corresponding	correspond	VERB
cuesj-184	19	11	author	author	NOUN
cuesj-184	19	12	:	:	PUNCT
cuesj-184	19	13	amer	amer	PROPN
cuesj-184	19	14	a.	a.	PROPN
cuesj-184	19	15	khaleel	khaleel	PROPN
cuesj-184	19	16	,	,	PUNCT
cuesj-184	19	17	college	college	NOUN
cuesj-184	19	18	of	of	ADP
cuesj-184	19	19	health	health	PROPN
cuesj-184	19	20	sciences	sciences	PROPN
cuesj-184	19	21	-	-	PUNCT
cuesj-184	19	22	hawler	hawler	NOUN
cuesj-184	19	23	medical	medical	PROPN
cuesj-184	19	24	university	university	PROPN
cuesj-184	19	25	,	,	PUNCT
cuesj-184	19	26	erbil	erbil	PROPN
cuesj-184	19	27	,	,	PUNCT
cuesj-184	19	28	iraq	iraq	PROPN
cuesj-184	19	29	.	.	PUNCT
cuesj-184	20	1	e	e	X
cuesj-184	20	2	-	-	NOUN
cuesj-184	20	3	mail	mail	NOUN
cuesj-184	20	4	:	:	PUNCT
cuesj-184	20	5	ameralikhaleel@yahoo.com	ameralikhaleel@yahoo.com	PROPN
cuesj-184	20	6	received	receive	VERB
cuesj-184	20	7	:	:	PUNCT
cuesj-184	20	8	mar	mar	PROPN
cuesj-184	20	9	31	31	NUM
cuesj-184	20	10	,	,	PUNCT
cuesj-184	20	11	2019	2019	NUM
cuesj-184	20	12	accepted	accept	VERB
cuesj-184	20	13	:	:	PUNCT
cuesj-184	20	14	apr	apr	NOUN
cuesj-184	20	15	17	17	NUM
cuesj-184	20	16	,	,	PUNCT
cuesj-184	20	17	2019	2019	NUM
cuesj-184	20	18	published	publish	VERB
cuesj-184	20	19	:	:	PUNCT
cuesj-184	20	20	jan	jan	PROPN
cuesj-184	20	21	20	20	NUM
cuesj-184	20	22	,	,	PUNCT
cuesj-184	20	23	2020	2020	NUM
cuesj-184	20	24	doi	doi	NOUN
cuesj-184	20	25	:	:	PUNCT
cuesj-184	20	26	10.24086	10.24086	NUM
cuesj-184	20	27	/	/	SYM
cuesj-184	20	28	cuesj.v4n1y2020.pp52	cuesj.v4n1y2020.pp52	PROPN
cuesj-184	20	29	-	-	SYM
cuesj-184	20	30	56	56	NUM
cuesj-184	20	31	copyright	copyright	NOUN
cuesj-184	20	32	©	©	PROPN
cuesj-184	20	33	2020	2020	NUM
cuesj-184	20	34	amer	amer	PROPN
cuesj-184	20	35	amer	amer	PROPN
cuesj-184	20	36	a.	a.	PROPN
cuesj-184	20	37	khaleel	khaleel	PROPN
cuesj-184	20	38	,	,	PUNCT
cuesj-184	20	39	salah	salah	PROPN
cuesj-184	20	40	t.	t.	PROPN
cuesj-184	20	41	jalal	jalal	PROPN
cuesj-184	20	42	,	,	PUNCT
cuesj-184	20	43	saeed	saeed	PROPN
cuesj-184	20	44	g.	g.	PROPN
cuesj-184	20	45	hussain	hussain	PROPN
cuesj-184	20	46	.	.	PUNCT
cuesj-184	21	1	this	this	PRON
cuesj-184	21	2	is	be	AUX
cuesj-184	21	3	an	an	DET
cuesj-184	21	4	open	open	ADJ
cuesj-184	21	5	-	-	PUNCT
cuesj-184	21	6	access	access	NOUN
cuesj-184	21	7	article	article	NOUN
cuesj-184	21	8	distributed	distribute	VERB
cuesj-184	21	9	under	under	ADP
cuesj-184	21	10	the	the	DET
cuesj-184	21	11	creative	creative	ADJ
cuesj-184	21	12	commons	common	NOUN
cuesj-184	21	13	attribution	attribution	NOUN
cuesj-184	21	14	license	license	NOUN
cuesj-184	21	15	.	.	PUNCT
cuesj-184	22	1	https://creativecommons.org/licenses/by-nc-nd/4.0/	https://creativecommons.org/licenses/by-nc-nd/4.0/	PROPN
cuesj-184	22	2	https://creativecommons.org/licenses/by-nc-nd/4.0/	https://creativecommons.org/licenses/by-nc-nd/4.0/	PROPN
cuesj-184	22	3	khaleel	khaleel	PROPN
cuesj-184	22	4	,	,	PUNCT
cuesj-184	22	5	et	et	PROPN
cuesj-184	22	6	al	al	PROPN
cuesj-184	22	7	.	.	PUNCT
cuesj-184	22	8	:	:	PUNCT
cuesj-184	23	1	significance	significance	NOUN
cuesj-184	23	2	of	of	ADP
cuesj-184	23	3	hbv	hbv	NOUN
cuesj-184	23	4	diagnosis	diagnosis	NOUN
cuesj-184	23	5	by	by	ADP
cuesj-184	23	6	rt	rt	PROPN
cuesj-184	23	7	-	-	PUNCT
cuesj-184	23	8	pcr	pcr	ADJ
cuesj-184	23	9	53	53	NUM
cuesj-184	23	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-184	23	11	cuesj	cuesj	NOUN
cuesj-184	23	12	2020	2020	NUM
cuesj-184	23	13	,	,	PUNCT
cuesj-184	23	14	4	4	NUM
cuesj-184	23	15	(	(	PUNCT
cuesj-184	23	16	1	1	NUM
cuesj-184	23	17	):	):	PUNCT
cuesj-184	23	18	52	52	NUM
cuesj-184	23	19	-	-	SYM
cuesj-184	23	20	56	56	NUM
cuesj-184	23	21	materials	material	NOUN
cuesj-184	23	22	and	and	CCONJ
cuesj-184	23	23	methods	method	NOUN
cuesj-184	23	24	for	for	ADP
cuesj-184	23	25	this	this	DET
cuesj-184	23	26	cross	cross	ADJ
cuesj-184	23	27	-	-	ADJ
cuesj-184	23	28	sectional	sectional	ADJ
cuesj-184	23	29	study	study	NOUN
cuesj-184	23	30	,	,	PUNCT
cuesj-184	23	31	a	a	DET
cuesj-184	23	32	total	total	NOUN
cuesj-184	23	33	of	of	ADP
cuesj-184	23	34	256	256	NUM
cuesj-184	23	35	blood	blood	NOUN
cuesj-184	23	36	samples	sample	NOUN
cuesj-184	23	37	were	be	AUX
cuesj-184	23	38	collected	collect	VERB
cuesj-184	23	39	from	from	ADP
cuesj-184	23	40	hbv	hbv	NOUN
cuesj-184	23	41	patients	patient	NOUN
cuesj-184	23	42	referred	refer	VERB
cuesj-184	23	43	to	to	ADP
cuesj-184	23	44	erbil	erbil	PROPN
cuesj-184	23	45	central	central	PROPN
cuesj-184	23	46	laboratory	laboratory	NOUN
cuesj-184	23	47	,	,	PUNCT
cuesj-184	23	48	from	from	ADP
cuesj-184	23	49	june	june	PROPN
cuesj-184	23	50	2017	2017	NUM
cuesj-184	23	51	to	to	ADP
cuesj-184	23	52	september	september	PROPN
cuesj-184	23	53	2017	2017	NUM
cuesj-184	23	54	.	.	PUNCT
cuesj-184	24	1	both	both	DET
cuesj-184	24	2	sexes	sex	NOUN
cuesj-184	24	3	were	be	AUX
cuesj-184	24	4	included	include	VERB
cuesj-184	24	5	(	(	PUNCT
cuesj-184	24	6	154	154	NUM
cuesj-184	24	7	males	male	NOUN
cuesj-184	24	8	and	and	CCONJ
cuesj-184	24	9	102	102	NUM
cuesj-184	24	10	females	female	NOUN
cuesj-184	24	11	)	)	PUNCT
cuesj-184	24	12	,	,	PUNCT
cuesj-184	24	13	with	with	ADP
cuesj-184	24	14	age	age	NOUN
cuesj-184	24	15	range	range	NOUN
cuesj-184	24	16	between	between	ADP
cuesj-184	24	17	20	20	NUM
cuesj-184	24	18	and	and	CCONJ
cuesj-184	24	19	60	60	NUM
cuesj-184	24	20	years	year	NOUN
cuesj-184	24	21	.	.	PUNCT
cuesj-184	25	1	real	real	ADJ
cuesj-184	25	2	-	-	PUNCT
cuesj-184	25	3	time	time	NOUN
cuesj-184	25	4	polymerase	polymerase	NOUN
cuesj-184	25	5	chain	chain	NOUN
cuesj-184	25	6	reaction	reaction	NOUN
cuesj-184	25	7	(	(	PUNCT
cuesj-184	25	8	rt	rt	NOUN
cuesj-184	25	9	-	-	PUNCT
cuesj-184	25	10	pcr	pcr	NOUN
cuesj-184	25	11	)	)	PUNCT
cuesj-184	25	12	as	as	ADP
cuesj-184	25	13	a	a	DET
cuesj-184	25	14	molecular	molecular	NOUN
cuesj-184	25	15	and	and	CCONJ
cuesj-184	25	16	elecsys	elecsy	VERB
cuesj-184	25	17	assay	assay	VERB
cuesj-184	25	18	as	as	SCONJ
cuesj-184	25	19	a	a	DET
cuesj-184	25	20	serological	serological	ADJ
cuesj-184	25	21	method	method	NOUN
cuesj-184	25	22	were	be	AUX
cuesj-184	25	23	used	use	VERB
cuesj-184	25	24	for	for	ADP
cuesj-184	25	25	the	the	DET
cuesj-184	25	26	diagnosis	diagnosis	NOUN
cuesj-184	25	27	and	and	CCONJ
cuesj-184	25	28	comparing	compare	VERB
cuesj-184	25	29	their	their	PRON
cuesj-184	25	30	sensitivity	sensitivity	NOUN
cuesj-184	25	31	purposes	purpose	NOUN
cuesj-184	25	32	.	.	PUNCT
cuesj-184	26	1	for	for	ADP
cuesj-184	26	2	rt	rt	ADJ
cuesj-184	26	3	-	-	PUNCT
cuesj-184	26	4	pcr	pcr	NOUN
cuesj-184	26	5	technique	technique	NOUN
cuesj-184	26	6	,	,	PUNCT
cuesj-184	26	7	5	5	NUM
cuesj-184	26	8	ml	ml	NOUN
cuesj-184	26	9	of	of	ADP
cuesj-184	26	10	venous	venous	ADJ
cuesj-184	26	11	blood	blood	NOUN
cuesj-184	26	12	were	be	AUX
cuesj-184	26	13	collected	collect	VERB
cuesj-184	26	14	using	use	VERB
cuesj-184	26	15	edta	edta	NOUN
cuesj-184	26	16	tubes	tube	NOUN
cuesj-184	26	17	and	and	CCONJ
cuesj-184	26	18	centrifuged	centrifuge	VERB
cuesj-184	26	19	at	at	ADP
cuesj-184	26	20	1000	1000	NUM
cuesj-184	26	21	rpm	rpm	NOUN
cuesj-184	26	22	for	for	SCONJ
cuesj-184	26	23	5	5	NUM
cuesj-184	26	24	min	min	NOUN
cuesj-184	26	25	and	and	CCONJ
cuesj-184	26	26	patients	patient	NOUN
cuesj-184	26	27	’	'	PUNCT
cuesj-184	26	28	plasma	plasma	NOUN
cuesj-184	26	29	was	be	AUX
cuesj-184	26	30	separated	separate	VERB
cuesj-184	26	31	.	.	PUNCT
cuesj-184	27	1	viral	viral	ADJ
cuesj-184	27	2	dna	dna	PROPN
cuesj-184	27	3	was	be	AUX
cuesj-184	27	4	extracted	extract	VERB
cuesj-184	27	5	from	from	ADP
cuesj-184	27	6	a	a	DET
cuesj-184	27	7	200	200	NUM
cuesj-184	27	8	µl	µl	ADP
cuesj-184	27	9	aliquot	aliquot	NOUN
cuesj-184	27	10	of	of	ADP
cuesj-184	27	11	serum	serum	NOUN
cuesj-184	27	12	using	use	VERB
cuesj-184	27	13	a	a	DET
cuesj-184	27	14	qiagen	qiagen	NOUN
cuesj-184	27	15	mini	mini	NOUN
cuesj-184	27	16	blood	blood	NOUN
cuesj-184	27	17	kit	kit	NOUN
cuesj-184	27	18	(	(	PUNCT
cuesj-184	27	19	qiagen	qiagen	PROPN
cuesj-184	27	20	,	,	PUNCT
cuesj-184	27	21	hilden	hilden	PROPN
cuesj-184	27	22	,	,	PUNCT
cuesj-184	27	23	germany	germany	PROPN
cuesj-184	27	24	)	)	PUNCT
cuesj-184	27	25	according	accord	VERB
cuesj-184	27	26	to	to	ADP
cuesj-184	27	27	the	the	DET
cuesj-184	27	28	manufacture	manufacture	NOUN
cuesj-184	27	29	instructions	instruction	NOUN
cuesj-184	27	30	.	.	PUNCT
cuesj-184	28	1	viral	viral	ADJ
cuesj-184	28	2	loads	load	NOUN
cuesj-184	28	3	of	of	ADP
cuesj-184	28	4	hbv	hbv	NOUN
cuesj-184	28	5	dna	dna	PROPN
cuesj-184	28	6	were	be	AUX
cuesj-184	28	7	estimated	estimate	VERB
cuesj-184	28	8	by	by	ADP
cuesj-184	28	9	rt	rt	PROPN
cuesj-184	28	10	-	-	PUNCT
cuesj-184	28	11	pcr	pcr	PROPN
cuesj-184	28	12	(	(	PUNCT
cuesj-184	28	13	hbv	hbv	NOUN
cuesj-184	28	14	rg	rg	PROPN
cuesj-184	28	15	pcr	pcr	PROPN
cuesj-184	28	16	artus	artus	PROPN
cuesj-184	28	17	,	,	PUNCT
cuesj-184	28	18	germany	germany	PROPN
cuesj-184	28	19	)	)	PUNCT
cuesj-184	28	20	.	.	PUNCT
cuesj-184	29	1	the	the	DET
cuesj-184	29	2	amplification	amplification	NOUN
cuesj-184	29	3	was	be	AUX
cuesj-184	29	4	performed	perform	VERB
cuesj-184	29	5	in	in	ADP
cuesj-184	29	6	a	a	DET
cuesj-184	29	7	50	50	NUM
cuesj-184	29	8	µl	µl	ADP
cuesj-184	29	9	reaction	reaction	NOUN
cuesj-184	29	10	mixture	mixture	NOUN
cuesj-184	29	11	containing	contain	VERB
cuesj-184	29	12	30	30	NUM
cuesj-184	29	13	µl	µl	NOUN
cuesj-184	29	14	of	of	ADP
cuesj-184	29	15	mixture	mixture	NOUN
cuesj-184	29	16	of	of	ADP
cuesj-184	29	17	hbv	hbv	NOUN
cuesj-184	29	18	rg	rg	PROPN
cuesj-184	29	19	master	master	NOUN
cuesj-184	29	20	mix	mix	NOUN
cuesj-184	29	21	(	(	PUNCT
cuesj-184	29	22	buffer	buffer	NOUN
cuesj-184	29	23	,	,	PUNCT
cuesj-184	29	24	dntp	dntp	NOUN
cuesj-184	29	25	,	,	PUNCT
cuesj-184	29	26	primer	primer	NOUN
cuesj-184	29	27	,	,	PUNCT
cuesj-184	29	28	probe	probe	NOUN
cuesj-184	29	29	,	,	PUNCT
cuesj-184	29	30	and	and	CCONJ
cuesj-184	29	31	enzymes	enzyme	NOUN
cuesj-184	29	32	)	)	PUNCT
cuesj-184	29	33	and	and	CCONJ
cuesj-184	29	34	hbv	hbv	NOUN
cuesj-184	29	35	rg	rg	PROPN
cuesj-184	29	36	inhibition	inhibition	NOUN
cuesj-184	29	37	control	control	NOUN
cuesj-184	29	38	mixed	mix	VERB
cuesj-184	29	39	with	with	ADP
cuesj-184	29	40	20	20	NUM
cuesj-184	29	41	µl	µl	NOUN
cuesj-184	29	42	of	of	ADP
cuesj-184	29	43	dna	dna	PROPN
cuesj-184	29	44	template	template	NOUN
cuesj-184	29	45	to	to	ADP
cuesj-184	29	46	each	each	DET
cuesj-184	29	47	reaction	reaction	NOUN
cuesj-184	29	48	.	.	PUNCT
cuesj-184	30	1	the	the	DET
cuesj-184	30	2	primers	primer	NOUN
cuesj-184	30	3	hbv	hbv	NOUN
cuesj-184	30	4	-	-	PUNCT
cuesj-184	30	5	taq	taq	NOUN
cuesj-184	30	6	i	i	PRON
cuesj-184	30	7	(	(	PUNCT
cuesj-184	30	8	forward	forward	NOUN
cuesj-184	30	9	primer	primer	NOUN
cuesj-184	30	10	):	):	PUNCT
cuesj-184	30	11	caa	caa	PROPN
cuesj-184	30	12	cct	cct	PROPN
cuesj-184	30	13	cca	cca	PROPN
cuesj-184	30	14	atc	atc	PROPN
cuesj-184	30	15	act	act	PROPN
cuesj-184	30	16	cac	cac	PROPN
cuesj-184	30	17	caac	caac	PROPN
cuesj-184	30	18	and	and	CCONJ
cuesj-184	30	19	hbv	hbv	NOUN
cuesj-184	30	20	-	-	PUNCT
cuesj-184	30	21	taq	taq	NOUN
cuesj-184	30	22	2	2	NUM
cuesj-184	30	23	(	(	PUNCT
cuesj-184	30	24	reverse	reverse	NOUN
cuesj-184	30	25	primer	primer	NOUN
cuesj-184	30	26	):	):	PUNCT
cuesj-184	30	27	ata	ata	PROPN
cuesj-184	30	28	tga	tga	PROPN
cuesj-184	30	29	taa	taa	PROPN
cuesj-184	30	30	aac	aac	PROPN
cuesj-184	30	31	gcc	gcc	NOUN
cuesj-184	30	32	gca	gca	PROPN
cuesj-184	30	33	gac	gac	PROPN
cuesj-184	30	34	ac	ac	PROPN
cuesj-184	30	35	were	be	AUX
cuesj-184	30	36	used	use	VERB
cuesj-184	30	37	from	from	ADP
cuesj-184	30	38	the	the	DET
cuesj-184	30	39	sequences	sequence	NOUN
cuesj-184	30	40	of	of	ADP
cuesj-184	30	41	the	the	DET
cuesj-184	30	42	conserved	conserve	VERB
cuesj-184	30	43	regions	region	NOUN
cuesj-184	30	44	of	of	ADP
cuesj-184	30	45	the	the	DET
cuesj-184	30	46	hbv	hbv	NOUN
cuesj-184	30	47	surface	surface	NOUN
cuesj-184	30	48	gene	gene	NOUN
cuesj-184	30	49	used	use	VERB
cuesj-184	30	50	previously	previously	ADV
cuesj-184	30	51	by	by	ADP
cuesj-184	30	52	weinberger	weinberger	PROPN
cuesj-184	30	53	et	et	PROPN
cuesj-184	30	54	al.[10	al.[10	PROPN
cuesj-184	30	55	]	]	PUNCT
cuesj-184	30	56	for	for	ADP
cuesj-184	30	57	performing	perform	VERB
cuesj-184	30	58	rt	rt	NOUN
cuesj-184	30	59	-	-	PUNCT
cuesj-184	30	60	pcr	pcr	ADJ
cuesj-184	30	61	,	,	PUNCT
cuesj-184	30	62	rotorgene	rotorgene	NOUN
cuesj-184	30	63	3000	3000	NUM
cuesj-184	30	64	(	(	PUNCT
cuesj-184	30	65	a	a	DET
cuesj-184	30	66	machine	machine	NOUN
cuesj-184	30	67	used	use	VERB
cuesj-184	30	68	routinely	routinely	ADV
cuesj-184	30	69	in	in	ADP
cuesj-184	30	70	erbil	erbil	PROPN
cuesj-184	30	71	central	central	PROPN
cuesj-184	30	72	laboratory	laboratory	NOUN
cuesj-184	30	73	for	for	ADP
cuesj-184	30	74	detection	detection	NOUN
cuesj-184	30	75	of	of	ADP
cuesj-184	30	76	variety	variety	NOUN
cuesj-184	30	77	of	of	ADP
cuesj-184	30	78	dnas	dna	NOUN
cuesj-184	30	79	and	and	CCONJ
cuesj-184	30	80	rnas	rna	NOUN
cuesj-184	30	81	)	)	PUNCT
cuesj-184	30	82	was	be	AUX
cuesj-184	30	83	used	use	VERB
cuesj-184	30	84	following	follow	VERB
cuesj-184	30	85	manufacture	manufacture	NOUN
cuesj-184	30	86	’s	’s	PART
cuesj-184	30	87	instructions	instruction	NOUN
cuesj-184	30	88	.	.	PUNCT
cuesj-184	31	1	the	the	DET
cuesj-184	31	2	rt	rt	ADJ
cuesj-184	31	3	-	-	PUNCT
cuesj-184	31	4	pcr	pcr	ADJ
cuesj-184	31	5	cycling	cycling	NOUN
cuesj-184	31	6	parameters	parameter	NOUN
cuesj-184	31	7	consisted	consist	VERB
cuesj-184	31	8	of	of	ADP
cuesj-184	31	9	denaturation	denaturation	NOUN
cuesj-184	31	10	at	at	ADP
cuesj-184	31	11	95	95	NUM
cuesj-184	31	12	°	°	ADP
cuesj-184	31	13	c	c	NOUN
cuesj-184	31	14	for	for	ADP
cuesj-184	31	15	15	15	NUM
cuesj-184	31	16	s	s	NOUN
cuesj-184	31	17	,	,	PUNCT
cuesj-184	31	18	55	55	NUM
cuesj-184	31	19	°	°	ADP
cuesj-184	31	20	c	c	NOUN
cuesj-184	31	21	for	for	ADP
cuesj-184	31	22	30	30	NUM
cuesj-184	31	23	s	s	NOUN
cuesj-184	31	24	,	,	PUNCT
cuesj-184	31	25	and	and	CCONJ
cuesj-184	31	26	72	72	NUM
cuesj-184	31	27	°	°	NUM
cuesj-184	31	28	c	c	NOUN
cuesj-184	31	29	for	for	ADP
cuesj-184	31	30	15	15	NUM
cuesj-184	31	31	s.	s.	NOUN
cuesj-184	31	32	the	the	DET
cuesj-184	31	33	results	result	NOUN
cuesj-184	31	34	were	be	AUX
cuesj-184	31	35	considered	consider	VERB
cuesj-184	31	36	positive	positive	ADJ
cuesj-184	31	37	if	if	SCONJ
cuesj-184	31	38	a	a	DET
cuesj-184	31	39	signal	signal	NOUN
cuesj-184	31	40	was	be	AUX
cuesj-184	31	41	detected	detect	VERB
cuesj-184	31	42	in	in	ADP
cuesj-184	31	43	cycling	cycle	VERB
cuesj-184	31	44	a	a	DET
cuesj-184	31	45	fam	fam	NOUN
cuesj-184	31	46	,	,	PUNCT
cuesj-184	31	47	whereas	whereas	SCONJ
cuesj-184	31	48	no	no	DET
cuesj-184	31	49	signal	signal	ADJ
cuesj-184	31	50	detection	detection	NOUN
cuesj-184	31	51	indicated	indicate	VERB
cuesj-184	31	52	as	as	ADP
cuesj-184	31	53	negative	negative	ADJ
cuesj-184	31	54	results	result	NOUN
cuesj-184	31	55	.	.	PUNCT
cuesj-184	32	1	the	the	DET
cuesj-184	32	2	quantitation	quantitation	NOUN
cuesj-184	32	3	of	of	ADP
cuesj-184	32	4	hbv	hbv	PROPN
cuesj-184	32	5	dna	dna	PROPN
cuesj-184	32	6	was	be	AUX
cuesj-184	32	7	performed	perform	VERB
cuesj-184	32	8	for	for	ADP
cuesj-184	32	9	all	all	DET
cuesj-184	32	10	blood	blood	NOUN
cuesj-184	32	11	samples	sample	NOUN
cuesj-184	32	12	and	and	CCONJ
cuesj-184	32	13	the	the	DET
cuesj-184	32	14	results	result	NOUN
cuesj-184	32	15	were	be	AUX
cuesj-184	32	16	considered	consider	VERB
cuesj-184	32	17	positive	positive	ADJ
cuesj-184	32	18	and	and	CCONJ
cuesj-184	32	19	significant	significant	ADJ
cuesj-184	32	20	if	if	SCONJ
cuesj-184	32	21	viral	viral	ADJ
cuesj-184	32	22	load	load	NOUN
cuesj-184	32	23	was	be	AUX
cuesj-184	32	24	more	more	ADJ
cuesj-184	32	25	than	than	ADP
cuesj-184	32	26	1×105	1×105	NUM
cuesj-184	32	27	viral	viral	ADJ
cuesj-184	32	28	copies/	copies/	NUM
cuesj-184	32	29	ml	ml	NOUN
cuesj-184	32	30	.	.	PUNCT
cuesj-184	33	1	titers	titer	NOUN
cuesj-184	33	2	<	<	X
cuesj-184	33	3	50	50	NUM
cuesj-184	33	4	iu	iu	ADP
cuesj-184	33	5	were	be	AUX
cuesj-184	33	6	considered	consider	VERB
cuesj-184	33	7	as	as	ADP
cuesj-184	33	8	negative	negative	ADJ
cuesj-184	33	9	for	for	ADP
cuesj-184	33	10	hbv	hbv	NOUN
cuesj-184	33	11	dna	dna	PROPN
cuesj-184	33	12	.	.	PUNCT
cuesj-184	34	1	the	the	DET
cuesj-184	34	2	screened	screen	VERB
cuesj-184	34	3	results	result	NOUN
cuesj-184	34	4	were	be	AUX
cuesj-184	34	5	categorized	categorize	VERB
cuesj-184	34	6	according	accord	VERB
cuesj-184	34	7	to	to	ADP
cuesj-184	34	8	positive	positive	ADJ
cuesj-184	34	9	hbv	hbv	NOUN
cuesj-184	34	10	dna	dna	PROPN
cuesj-184	34	11	titers	titer	NOUN
cuesj-184	34	12	into	into	ADP
cuesj-184	34	13	inactive	inactive	ADJ
cuesj-184	34	14	,	,	PUNCT
cuesj-184	34	15	gray	gray	ADJ
cuesj-184	34	16	zone	zone	NOUN
cuesj-184	34	17	,	,	PUNCT
cuesj-184	34	18	and	and	CCONJ
cuesj-184	34	19	active	active	ADJ
cuesj-184	34	20	carriers	carrier	NOUN
cuesj-184	34	21	.	.	PUNCT
cuesj-184	35	1	quantitation	quantitation	NOUN
cuesj-184	35	2	of	of	ADP
cuesj-184	35	3	hbsag	hbsag	NOUN
cuesj-184	35	4	was	be	AUX
cuesj-184	35	5	measured	measure	VERB
cuesj-184	35	6	using	use	VERB
cuesj-184	35	7	the	the	DET
cuesj-184	35	8	elecsys	elecsys	PROPN
cuesj-184	35	9	hbsag	hbsag	PROPN
cuesj-184	35	10	quantitative	quantitative	ADJ
cuesj-184	35	11	assay	assay	NOUN
cuesj-184	35	12	.	.	PUNCT
cuesj-184	36	1	detection	detection	NOUN
cuesj-184	36	2	of	of	ADP
cuesj-184	36	3	hbsag	hbsag	NOUN
cuesj-184	36	4	by	by	ADP
cuesj-184	36	5	elecsys	elecsys	PROPN
cuesj-184	36	6	utilizes	utilize	VERB
cuesj-184	36	7	a	a	DET
cuesj-184	36	8	sandwich	sandwich	NOUN
cuesj-184	36	9	principle	principle	NOUN
cuesj-184	36	10	and	and	CCONJ
cuesj-184	36	11	this	this	DET
cuesj-184	36	12	assay	assay	NOUN
cuesj-184	36	13	has	have	VERB
cuesj-184	36	14	two	two	NUM
cuesj-184	36	15	stages	stage	NOUN
cuesj-184	36	16	:	:	PUNCT
cuesj-184	36	17	first	first	ADV
cuesj-184	36	18	,	,	PUNCT
cuesj-184	36	19	a	a	DET
cuesj-184	36	20	complex	complex	NOUN
cuesj-184	36	21	is	be	AUX
cuesj-184	36	22	formed	form	VERB
cuesj-184	36	23	with	with	ADP
cuesj-184	36	24	two	two	NUM
cuesj-184	36	25	monoclonal	monoclonal	NOUN
cuesj-184	36	26	hbsagspecific	hbsagspecific	ADJ
cuesj-184	36	27	antibodies	antibody	NOUN
cuesj-184	36	28	,	,	PUNCT
cuesj-184	36	29	one	one	NUM
cuesj-184	36	30	of	of	ADP
cuesj-184	36	31	which	which	PRON
cuesj-184	36	32	is	be	AUX
cuesj-184	36	33	biotinylated	biotinylate	VERB
cuesj-184	36	34	and	and	CCONJ
cuesj-184	36	35	the	the	DET
cuesj-184	36	36	other	other	ADJ
cuesj-184	36	37	labeled	label	VERB
cuesj-184	36	38	with	with	ADP
cuesj-184	36	39	a	a	DET
cuesj-184	36	40	ruthenium	ruthenium	NOUN
cuesj-184	36	41	complex	complex	NOUN
cuesj-184	36	42	.	.	PUNCT
cuesj-184	37	1	this	this	DET
cuesj-184	37	2	complex	complex	NOUN
cuesj-184	37	3	joins	join	VERB
cuesj-184	37	4	to	to	ADP
cuesj-184	37	5	the	the	DET
cuesj-184	37	6	solid	solid	ADJ
cuesj-184	37	7	phase	phase	NOUN
cuesj-184	37	8	through	through	ADP
cuesj-184	37	9	the	the	DET
cuesj-184	37	10	interaction	interaction	NOUN
cuesj-184	37	11	of	of	ADP
cuesj-184	37	12	biotin	biotin	NOUN
cuesj-184	37	13	and	and	CCONJ
cuesj-184	37	14	streptavidin	streptavidin	VERB
cuesj-184	37	15	after	after	ADP
cuesj-184	37	16	the	the	DET
cuesj-184	37	17	attachment	attachment	NOUN
cuesj-184	37	18	of	of	ADP
cuesj-184	37	19	streptavidin	streptavidin	VERB
cuesj-184	37	20	-	-	PUNCT
cuesj-184	37	21	coated	coat	VERB
cuesj-184	37	22	microparticles.[11	microparticles.[11	PROPN
cuesj-184	37	23	]	]	X
cuesj-184	37	24	the	the	DET
cuesj-184	37	25	mixture	mixture	NOUN
cuesj-184	37	26	is	be	AUX
cuesj-184	37	27	subsequently	subsequently	ADV
cuesj-184	37	28	aspirated	aspirate	VERB
cuesj-184	37	29	into	into	ADP
cuesj-184	37	30	a	a	DET
cuesj-184	37	31	measuring	measure	VERB
cuesj-184	37	32	cell	cell	NOUN
cuesj-184	37	33	,	,	PUNCT
cuesj-184	37	34	where	where	SCONJ
cuesj-184	37	35	application	application	NOUN
cuesj-184	37	36	of	of	ADP
cuesj-184	37	37	a	a	DET
cuesj-184	37	38	voltage	voltage	NOUN
cuesj-184	37	39	induces	induce	VERB
cuesj-184	37	40	chemiluminescent	chemiluminescent	NOUN
cuesj-184	37	41	emission	emission	NOUN
cuesj-184	37	42	,	,	PUNCT
cuesj-184	37	43	which	which	PRON
cuesj-184	37	44	is	be	AUX
cuesj-184	37	45	measured	measure	VERB
cuesj-184	37	46	by	by	ADP
cuesj-184	37	47	a	a	DET
cuesj-184	37	48	photomultiplier	photomultiplier	NOUN
cuesj-184	37	49	.	.	PUNCT
cuesj-184	38	1	all	all	DET
cuesj-184	38	2	serum	serum	NOUN
cuesj-184	38	3	samples	sample	NOUN
cuesj-184	38	4	were	be	AUX
cuesj-184	38	5	tested	test	VERB
cuesj-184	38	6	at	at	ADP
cuesj-184	38	7	a	a	DET
cuesj-184	38	8	dilution	dilution	NOUN
cuesj-184	38	9	of	of	ADP
cuesj-184	38	10	1:400	1:400	NUM
cuesj-184	38	11	.	.	PUNCT
cuesj-184	39	1	the	the	DET
cuesj-184	39	2	elecsys	elecsys	PROPN
cuesj-184	39	3	hbsag	hbsag	PROPN
cuesj-184	39	4	quantitative	quantitative	ADJ
cuesj-184	39	5	assay	assay	NOUN
cuesj-184	39	6	is	be	AUX
cuesj-184	39	7	calibrated	calibrate	VERB
cuesj-184	39	8	to	to	PART
cuesj-184	39	9	give	give	VERB
cuesj-184	39	10	results	result	NOUN
cuesj-184	39	11	in	in	ADP
cuesj-184	39	12	iu	iu	ADP
cuesj-184	39	13	/	/	SYM
cuesj-184	39	14	ml.[11	ml.[11	NOUN
cuesj-184	39	15	]	]	PUNCT
cuesj-184	39	16	statistical	statistical	ADJ
cuesj-184	39	17	analysis	analysis	NOUN
cuesj-184	39	18	statistical	statistical	ADJ
cuesj-184	39	19	analysis	analysis	NOUN
cuesj-184	39	20	was	be	AUX
cuesj-184	39	21	done	do	VERB
cuesj-184	39	22	using	use	VERB
cuesj-184	39	23	spss	spss	PROPN
cuesj-184	39	24	23.0	23.0	NUM
cuesj-184	39	25	.	.	PUNCT
cuesj-184	40	1	hbv	hbv	NOUN
cuesj-184	40	2	titers	titer	NOUN
cuesj-184	40	3	expressed	express	VERB
cuesj-184	40	4	as	as	SCONJ
cuesj-184	40	5	means	mean	VERB
cuesj-184	40	6	±	±	NUM
cuesj-184	40	7	standard	standard	PROPN
cuesj-184	40	8	error	error	NOUN
cuesj-184	40	9	.	.	PUNCT
cuesj-184	41	1	comparisons	comparison	NOUN
cuesj-184	41	2	between	between	ADP
cuesj-184	41	3	active	active	ADJ
cuesj-184	41	4	and	and	CCONJ
cuesj-184	41	5	inactive	inactive	ADJ
cuesj-184	41	6	carriers	carrier	NOUN
cuesj-184	41	7	use	use	VERB
cuesj-184	41	8	t	t	NOUN
cuesj-184	41	9	-	-	PUNCT
cuesj-184	41	10	tests	test	NOUN
cuesj-184	41	11	.	.	PUNCT
cuesj-184	42	1	comparisons	comparison	NOUN
cuesj-184	42	2	between	between	ADP
cuesj-184	42	3	multiple	multiple	ADJ
cuesj-184	42	4	groups	group	NOUN
cuesj-184	42	5	were	be	AUX
cuesj-184	42	6	performed	perform	VERB
cuesj-184	42	7	by	by	ADP
cuesj-184	42	8	anova	anova	PROPN
cuesj-184	42	9	.	.	PUNCT
cuesj-184	43	1	p	p	NOUN
cuesj-184	43	2	≤	≤	NUM
cuesj-184	43	3	0.05	0.05	NUM
cuesj-184	43	4	was	be	AUX
cuesj-184	43	5	considered	consider	VERB
cuesj-184	43	6	as	as	ADP
cuesj-184	43	7	statistically	statistically	ADV
cuesj-184	43	8	significant	significant	ADJ
cuesj-184	43	9	.	.	PUNCT
cuesj-184	44	1	results	result	NOUN
cuesj-184	44	2	and	and	CCONJ
cuesj-184	44	3	discussion	discussion	NOUN
cuesj-184	44	4	of	of	ADP
cuesj-184	44	5	the	the	DET
cuesj-184	44	6	256	256	NUM
cuesj-184	44	7	cases	case	NOUN
cuesj-184	44	8	,	,	PUNCT
cuesj-184	44	9	154	154	NUM
cuesj-184	44	10	(	(	PUNCT
cuesj-184	44	11	60	60	NUM
cuesj-184	44	12	%	%	NOUN
cuesj-184	44	13	)	)	PUNCT
cuesj-184	44	14	were	be	AUX
cuesj-184	44	15	male	male	ADJ
cuesj-184	44	16	and	and	CCONJ
cuesj-184	44	17	102	102	NUM
cuesj-184	44	18	(	(	PUNCT
cuesj-184	44	19	40	40	NUM
cuesj-184	44	20	%	%	NOUN
cuesj-184	44	21	)	)	PUNCT
cuesj-184	44	22	were	be	AUX
cuesj-184	44	23	female	female	ADJ
cuesj-184	44	24	,	,	PUNCT
cuesj-184	44	25	with	with	ADP
cuesj-184	44	26	age	age	NOUN
cuesj-184	44	27	range	range	NOUN
cuesj-184	44	28	between	between	ADP
cuesj-184	44	29	20	20	NUM
cuesj-184	44	30	and	and	CCONJ
cuesj-184	44	31	60	60	NUM
cuesj-184	44	32	years	year	NOUN
cuesj-184	44	33	.	.	PUNCT
cuesj-184	45	1	rt	rt	ADJ
cuesj-184	45	2	-	-	PUNCT
cuesj-184	45	3	pcr	pcr	ADJ
cuesj-184	45	4	results	result	NOUN
cuesj-184	45	5	showed	show	VERB
cuesj-184	45	6	that	that	SCONJ
cuesj-184	45	7	163	163	NUM
cuesj-184	45	8	of	of	ADP
cuesj-184	45	9	256	256	NUM
cuesj-184	45	10	samples	sample	NOUN
cuesj-184	45	11	were	be	AUX
cuesj-184	45	12	hbv	hbv	NOUN
cuesj-184	45	13	dna	dna	PROPN
cuesj-184	45	14	negative	negative	ADJ
cuesj-184	45	15	,	,	PUNCT
cuesj-184	45	16	from	from	ADP
cuesj-184	45	17	them	they	PRON
cuesj-184	45	18	,	,	PUNCT
cuesj-184	45	19	20	20	NUM
cuesj-184	45	20	samples	sample	NOUN
cuesj-184	45	21	showed	show	VERB
cuesj-184	45	22	positive	positive	ADJ
cuesj-184	45	23	results	result	NOUN
cuesj-184	45	24	for	for	ADP
cuesj-184	45	25	hbsag	hbsag	ADJ
cuesj-184	45	26	quantitation	quantitation	NOUN
cuesj-184	46	1	[	[	X
cuesj-184	46	2	table	table	NOUN
cuesj-184	46	3	1	1	NUM
cuesj-184	46	4	]	]	PUNCT
cuesj-184	46	5	.	.	PUNCT
cuesj-184	47	1	the	the	DET
cuesj-184	47	2	asian	asian	PROPN
cuesj-184	47	3	pacific	pacific	PROPN
cuesj-184	47	4	association	association	PROPN
cuesj-184	47	5	for	for	ADP
cuesj-184	47	6	the	the	DET
cuesj-184	47	7	study	study	NOUN
cuesj-184	47	8	of	of	ADP
cuesj-184	47	9	the	the	DET
cuesj-184	47	10	liver	liver	NOUN
cuesj-184	47	11	,	,	PUNCT
cuesj-184	47	12	european	european	PROPN
cuesj-184	47	13	association	association	PROPN
cuesj-184	47	14	for	for	ADP
cuesj-184	47	15	the	the	DET
cuesj-184	47	16	study	study	NOUN
cuesj-184	47	17	of	of	ADP
cuesj-184	47	18	the	the	DET
cuesj-184	47	19	liver	liver	NOUN
cuesj-184	47	20	,	,	PUNCT
cuesj-184	47	21	and	and	CCONJ
cuesj-184	47	22	the	the	DET
cuesj-184	47	23	guidelines	guideline	NOUN
cuesj-184	47	24	of	of	ADP
cuesj-184	47	25	the	the	DET
cuesj-184	47	26	american	american	PROPN
cuesj-184	47	27	association	association	PROPN
cuesj-184	47	28	for	for	ADP
cuesj-184	47	29	the	the	DET
cuesj-184	47	30	study	study	NOUN
cuesj-184	47	31	of	of	ADP
cuesj-184	47	32	liver	liver	NOUN
cuesj-184	47	33	diseases	disease	NOUN
cuesj-184	47	34	refer	refer	VERB
cuesj-184	47	35	that	that	SCONJ
cuesj-184	47	36	the	the	DET
cuesj-184	47	37	disappearance	disappearance	NOUN
cuesj-184	47	38	of	of	ADP
cuesj-184	47	39	hbsag	hbsag	NOUN
cuesj-184	47	40	is	be	AUX
cuesj-184	47	41	the	the	DET
cuesj-184	47	42	ideal	ideal	ADJ
cuesj-184	47	43	and	and	CCONJ
cuesj-184	47	44	cornerstone	cornerstone	NOUN
cuesj-184	47	45	during	during	ADP
cuesj-184	47	46	natural	natural	ADJ
cuesj-184	47	47	course	course	NOUN
cuesj-184	47	48	of	of	ADP
cuesj-184	47	49	hbv	hbv	NOUN
cuesj-184	47	50	infection.[12	infection.[12	PROPN
cuesj-184	47	51	-	-	PUNCT
cuesj-184	47	52	14	14	NUM
cuesj-184	47	53	]	]	PUNCT
cuesj-184	47	54	from	from	ADP
cuesj-184	47	55	the	the	DET
cuesj-184	47	56	clinical	clinical	ADJ
cuesj-184	47	57	standpoint	standpoint	NOUN
cuesj-184	47	58	of	of	ADP
cuesj-184	47	59	view	view	NOUN
cuesj-184	47	60	,	,	PUNCT
cuesj-184	47	61	the	the	DET
cuesj-184	47	62	progression	progression	NOUN
cuesj-184	47	63	from	from	ADP
cuesj-184	47	64	chronic	chronic	ADJ
cuesj-184	47	65	hepatitis	hepatitis	PROPN
cuesj-184	47	66	b	b	NOUN
cuesj-184	47	67	to	to	ADP
cuesj-184	47	68	cirrhosis	cirrhosis	NOUN
cuesj-184	47	69	is	be	AUX
cuesj-184	47	70	increasingly	increasingly	ADV
cuesj-184	47	71	signified	signify	VERB
cuesj-184	47	72	through	through	ADP
cuesj-184	47	73	the	the	DET
cuesj-184	47	74	hbv	hbv	NOUN
cuesj-184	47	75	viral	viral	ADJ
cuesj-184	47	76	load.[8	load.[8	NOUN
cuesj-184	47	77	]	]	PUNCT
cuesj-184	47	78	meanwhile	meanwhile	ADV
cuesj-184	47	79	,	,	PUNCT
cuesj-184	47	80	quantitative	quantitative	ADJ
cuesj-184	47	81	hbsag	hbsag	ADJ
cuesj-184	47	82	level	level	NOUN
cuesj-184	47	83	was	be	AUX
cuesj-184	47	84	regarded	regard	VERB
cuesj-184	47	85	as	as	ADP
cuesj-184	47	86	marker	marker	NOUN
cuesj-184	47	87	for	for	ADP
cuesj-184	47	88	clearance	clearance	NOUN
cuesj-184	47	89	,	,	PUNCT
cuesj-184	47	90	hepatitis	hepatitis	NOUN
cuesj-184	47	91	activity	activity	NOUN
cuesj-184	47	92	,	,	PUNCT
cuesj-184	47	93	and	and	CCONJ
cuesj-184	47	94	immunological	immunological	ADJ
cuesj-184	47	95	host	host	NOUN
cuesj-184	47	96	response	response	NOUN
cuesj-184	47	97	to	to	PART
cuesj-184	47	98	control	control	VERB
cuesj-184	47	99	hbv	hbv	NOUN
cuesj-184	47	100	replication	replication	NOUN
cuesj-184	47	101	and	and	CCONJ
cuesj-184	47	102	the	the	DET
cuesj-184	47	103	likelihood	likelihood	NOUN
cuesj-184	47	104	of	of	ADP
cuesj-184	47	105	inactive	inactive	ADJ
cuesj-184	47	106	virus	virus	NOUN
cuesj-184	47	107	carrier.[9,7,15	carrier.[9,7,15	PROPN
cuesj-184	47	108	]	]	PUNCT
cuesj-184	47	109	however	however	ADV
cuesj-184	47	110	,	,	PUNCT
cuesj-184	47	111	little	little	ADJ
cuesj-184	47	112	is	be	AUX
cuesj-184	47	113	known	know	VERB
cuesj-184	47	114	about	about	ADP
cuesj-184	47	115	correlation	correlation	NOUN
cuesj-184	47	116	between	between	ADP
cuesj-184	47	117	hbv	hbv	NOUN
cuesj-184	47	118	replication	replication	NOUN
cuesj-184	47	119	and	and	CCONJ
cuesj-184	47	120	low	low	ADJ
cuesj-184	47	121	levels	level	NOUN
cuesj-184	47	122	of	of	ADP
cuesj-184	47	123	hbsag	hbsag	NOUN
cuesj-184	47	124	,	,	PUNCT
cuesj-184	47	125	as	as	SCONJ
cuesj-184	47	126	reported	report	VERB
cuesj-184	47	127	in	in	ADP
cuesj-184	47	128	some	some	DET
cuesj-184	47	129	patients	patient	NOUN
cuesj-184	47	130	with	with	ADP
cuesj-184	47	131	chronic	chronic	ADJ
cuesj-184	47	132	hbv	hbv	NOUN
cuesj-184	47	133	infection.[16	infection.[16	PROPN
cuesj-184	47	134	-	-	SYM
cuesj-184	47	135	18	18	NUM
cuesj-184	47	136	]	]	PUNCT
cuesj-184	47	137	the	the	DET
cuesj-184	47	138	results	result	NOUN
cuesj-184	47	139	of	of	ADP
cuesj-184	47	140	the	the	DET
cuesj-184	47	141	present	present	ADJ
cuesj-184	47	142	study	study	NOUN
cuesj-184	47	143	showed	show	VERB
cuesj-184	47	144	12.26	12.26	NUM
cuesj-184	47	145	%	%	NOUN
cuesj-184	47	146	hbs	hbs	PROPN
cuesj-184	47	147	seropositivity	seropositivity	NOUN
cuesj-184	47	148	(	(	PUNCT
cuesj-184	47	149	range	range	NOUN
cuesj-184	47	150	1000–5000	1000–5000	NUM
cuesj-184	47	151	coi	coi	NOUN
cuesj-184	47	152	)	)	PUNCT
cuesj-184	47	153	among	among	ADP
cuesj-184	47	154	patients	patient	NOUN
cuesj-184	47	155	seronegative	seronegative	ADJ
cuesj-184	47	156	for	for	ADP
cuesj-184	47	157	hbv	hbv	NOUN
cuesj-184	47	158	dna	dna	PROPN
cuesj-184	48	1	[	[	X
cuesj-184	48	2	table	table	NOUN
cuesj-184	48	3	2	2	NUM
cuesj-184	48	4	]	]	PUNCT
cuesj-184	48	5	,	,	PUNCT
cuesj-184	48	6	with	with	ADP
cuesj-184	48	7	highly	highly	ADV
cuesj-184	48	8	significant	significant	ADJ
cuesj-184	48	9	difference	difference	NOUN
cuesj-184	48	10	(	(	PUNCT
cuesj-184	48	11	p	p	NOUN
cuesj-184	48	12	≤	≤	NUM
cuesj-184	48	13	0.001	0.001	NUM
cuesj-184	48	14	)	)	PUNCT
cuesj-184	48	15	between	between	ADP
cuesj-184	48	16	mean	mean	NOUN
cuesj-184	48	17	of	of	ADP
cuesj-184	48	18	hbv	hbv	NOUN
cuesj-184	48	19	dna	dna	PROPN
cuesj-184	48	20	seropositive	seropositive	ADJ
cuesj-184	48	21	table	table	NOUN
cuesj-184	48	22	1	1	NUM
cuesj-184	48	23	:	:	PUNCT
cuesj-184	48	24	baseline	baseline	PROPN
cuesj-184	48	25	patient	patient	NOUN
cuesj-184	48	26	’s	’s	PART
cuesj-184	48	27	characteristics	characteristic	NOUN
cuesj-184	48	28	variables	variable	VERB
cuesj-184	48	29	all	all	DET
cuesj-184	48	30	patients	patient	NOUN
cuesj-184	48	31	(	(	PUNCT
cuesj-184	48	32	n=256	n=256	NOUN
cuesj-184	48	33	)	)	PUNCT
cuesj-184	48	34	gender	gender	NOUN
cuesj-184	48	35	male	male	NOUN
cuesj-184	48	36	154	154	NUM
cuesj-184	48	37	(	(	PUNCT
cuesj-184	48	38	60	60	NUM
cuesj-184	48	39	%	%	NOUN
cuesj-184	48	40	)	)	PUNCT
cuesj-184	48	41	female	female	NOUN
cuesj-184	48	42	102	102	NUM
cuesj-184	48	43	(	(	PUNCT
cuesj-184	48	44	40	40	NUM
cuesj-184	48	45	%	%	NOUN
cuesj-184	48	46	)	)	PUNCT
cuesj-184	48	47	hbv	hbv	PROPN
cuesj-184	48	48	dna	dna	PROPN
cuesj-184	48	49	iu	iu	PROPN
cuesj-184	48	50	/	/	SYM
cuesj-184	48	51	ml	ml	PROPN
cuesj-184	48	52	256	256	NUM
cuesj-184	48	53	<	<	NOUN
cuesj-184	48	54	50	50	NUM
cuesj-184	48	55	(	(	PUNCT
cuesj-184	48	56	negative	negative	ADJ
cuesj-184	48	57	)	)	PUNCT
cuesj-184	48	58	163	163	NUM
cuesj-184	48	59	(	(	PUNCT
cuesj-184	48	60	63.67	63.67	NUM
cuesj-184	48	61	%	%	NOUN
cuesj-184	48	62	)	)	PUNCT
cuesj-184	48	63	101–500	101–500	NUM
cuesj-184	48	64	22	22	NUM
cuesj-184	48	65	(	(	PUNCT
cuesj-184	48	66	24.44	24.44	NUM
cuesj-184	48	67	%	%	NOUN
cuesj-184	48	68	)	)	PUNCT
cuesj-184	48	69	501–1000	501–1000	NUM
cuesj-184	48	70	10	10	NUM
cuesj-184	48	71	(	(	PUNCT
cuesj-184	48	72	11.11	11.11	NUM
cuesj-184	48	73	%	%	NOUN
cuesj-184	48	74	)	)	PUNCT
cuesj-184	48	75	1001–2000	1001–2000	NUM
cuesj-184	48	76	10	10	NUM
cuesj-184	48	77	(	(	PUNCT
cuesj-184	48	78	11.11	11.11	NUM
cuesj-184	48	79	%	%	NOUN
cuesj-184	48	80	)	)	PUNCT
cuesj-184	48	81	2001–20,000	2001–20,000	NUM
cuesj-184	48	82	20	20	NUM
cuesj-184	48	83	(	(	PUNCT
cuesj-184	48	84	22.22	22.22	NUM
cuesj-184	48	85	%	%	NOUN
cuesj-184	48	86	)	)	PUNCT
cuesj-184	48	87	>	>	PUNCT
cuesj-184	48	88	20,000	20,000	NUM
cuesj-184	48	89	31	31	NUM
cuesj-184	48	90	(	(	PUNCT
cuesj-184	48	91	34.44	34.44	NUM
cuesj-184	48	92	%	%	NOUN
cuesj-184	48	93	)	)	PUNCT
cuesj-184	48	94	qhbsag	qhbsag	NOUN
cuesj-184	48	95	tested	test	VERB
cuesj-184	48	96	163/256	163/256	PROPN
cuesj-184	48	97	(	(	PUNCT
cuesj-184	48	98	63.67	63.67	NUM
cuesj-184	48	99	%	%	NOUN
cuesj-184	48	100	)	)	PUNCT
cuesj-184	49	1	<	<	X
cuesj-184	49	2	10	10	NUM
cuesj-184	49	3	coi	coi	NOUN
cuesj-184	49	4	143	143	NUM
cuesj-184	49	5	(	(	PUNCT
cuesj-184	49	6	55.85	55.85	NUM
cuesj-184	49	7	%	%	NOUN
cuesj-184	49	8	)	)	PUNCT
cuesj-184	49	9	1000–2000	1000–2000	NUM
cuesj-184	49	10	coi	coi	NOUN
cuesj-184	49	11	3	3	NUM
cuesj-184	49	12	(	(	PUNCT
cuesj-184	49	13	15	15	NUM
cuesj-184	49	14	%	%	NOUN
cuesj-184	49	15	)	)	PUNCT
cuesj-184	49	16	2001–3000	2001–3000	NUM
cuesj-184	49	17	coi	coi	NOUN
cuesj-184	49	18	4	4	NUM
cuesj-184	49	19	(	(	PUNCT
cuesj-184	49	20	20	20	NUM
cuesj-184	49	21	%	%	NOUN
cuesj-184	49	22	)	)	PUNCT
cuesj-184	49	23	3001–4000	3001–4000	NUM
cuesj-184	49	24	coi	coi	NOUN
cuesj-184	49	25	8	8	NUM
cuesj-184	49	26	(	(	PUNCT
cuesj-184	49	27	40	40	NUM
cuesj-184	49	28	%	%	NOUN
cuesj-184	49	29	)	)	PUNCT
cuesj-184	49	30	4001–5000	4001–5000	NUM
cuesj-184	49	31	coi	coi	NOUN
cuesj-184	49	32	5	5	NUM
cuesj-184	49	33	(	(	PUNCT
cuesj-184	49	34	25	25	NUM
cuesj-184	49	35	%	%	NOUN
cuesj-184	49	36	)	)	PUNCT
cuesj-184	49	37	anti	anti	ADJ
cuesj-184	49	38	-	-	ADJ
cuesj-184	49	39	hbsab	hbsab	ADJ
cuesj-184	49	40	tested	test	VERB
cuesj-184	49	41	20	20	NUM
cuesj-184	49	42	positive	positive	ADJ
cuesj-184	49	43	0.00	0.00	NUM
cuesj-184	49	44	negative	negative	ADJ
cuesj-184	49	45	20	20	NUM
cuesj-184	49	46	(	(	PUNCT
cuesj-184	49	47	100	100	NUM
cuesj-184	49	48	%	%	NOUN
cuesj-184	49	49	)	)	PUNCT
cuesj-184	50	1	hbs	hbs	PROPN
cuesj-184	50	2	positive	positive	ADJ
cuesj-184	50	3	,	,	PUNCT
cuesj-184	50	4	hbv	hbv	PROPN
cuesj-184	50	5	dna	dna	PROPN
cuesj-184	50	6	negative	negative	ADJ
cuesj-184	50	7	20/163	20/163	NUM
cuesj-184	50	8	qhbsag	qhbsag	NOUN
cuesj-184	50	9	:	:	PUNCT
cuesj-184	50	10	quantitative	quantitative	ADJ
cuesj-184	50	11	hepatitis	hepatitis	PROPN
cuesj-184	50	12	b	b	PROPN
cuesj-184	50	13	surface	surface	NOUN
cuesj-184	50	14	antigen	antigen	ADV
cuesj-184	50	15	,	,	PUNCT
cuesj-184	50	16	hbv	hbv	NOUN
cuesj-184	50	17	:	:	PUNCT
cuesj-184	50	18	hepatitis	hepatitis	PROPN
cuesj-184	50	19	b	b	PROPN
cuesj-184	50	20	virus	virus	NOUN
cuesj-184	50	21	table	table	NOUN
cuesj-184	50	22	2	2	NUM
cuesj-184	50	23	:	:	PUNCT
cuesj-184	50	24	frequencies	frequency	NOUN
cuesj-184	50	25	of	of	ADP
cuesj-184	50	26	hbv	hbv	NOUN
cuesj-184	50	27	dna	dna	PROPN
cuesj-184	50	28	seropositivity	seropositivity	NOUN
cuesj-184	50	29	among	among	ADP
cuesj-184	50	30	patients	patient	NOUN
cuesj-184	50	31	negative	negative	ADJ
cuesj-184	50	32	for	for	ADP
cuesj-184	50	33	hbv	hbv	NOUN
cuesj-184	50	34	dna	dna	PROPN
cuesj-184	50	35	assay	assay	NOUN
cuesj-184	50	36	number	number	NOUN
cuesj-184	50	37	screened	screen	VERB
cuesj-184	50	38	hbv	hbv	PROPN
cuesj-184	50	39	dna	dna	PROPN
cuesj-184	50	40	pcr	pcr	PROPN
cuesj-184	51	1	+	+	PROPN
cuesj-184	51	2	ve	ve	PROPN
cuesj-184	51	3	hbv	hbv	NOUN
cuesj-184	51	4	dna	dna	PROPN
cuesj-184	51	5	pcr−ve	pcr−ve	PROPN
cuesj-184	51	6	(	(	PUNCT
cuesj-184	51	7	n=163	n=163	NOUN
cuesj-184	51	8	)	)	PUNCT
cuesj-184	51	9	hbs	hbs	PROPN
cuesj-184	52	1	+	+	PROPN
cuesj-184	52	2	ve	ve	AUX
cuesj-184	52	3	hbs	hbs	PROPN
cuesj-184	52	4	−ve	−ve	PROPN
cuesj-184	52	5	n=256	n=256	PROPN
cuesj-184	52	6	93	93	NUM
cuesj-184	52	7	(	(	PUNCT
cuesj-184	52	8	36.32	36.32	NUM
cuesj-184	52	9	%	%	NOUN
cuesj-184	52	10	)	)	PUNCT
cuesj-184	52	11	20	20	NUM
cuesj-184	52	12	(	(	PUNCT
cuesj-184	52	13	12.26	12.26	NUM
cuesj-184	52	14	%	%	NOUN
cuesj-184	52	15	)	)	PUNCT
cuesj-184	52	16	143	143	NUM
cuesj-184	52	17	(	(	PUNCT
cuesj-184	52	18	87.73	87.73	NUM
cuesj-184	52	19	%	%	NOUN
cuesj-184	52	20	)	)	PUNCT
cuesj-184	52	21	hbv	hbv	NOUN
cuesj-184	52	22	:	:	PUNCT
cuesj-184	52	23	hepatitis	hepatitis	PROPN
cuesj-184	52	24	b	b	PROPN
cuesj-184	52	25	virus	virus	PROPN
cuesj-184	52	26	,	,	PUNCT
cuesj-184	52	27	pcr	pcr	PROPN
cuesj-184	52	28	:	:	PUNCT
cuesj-184	52	29	polymerase	polymerase	NOUN
cuesj-184	52	30	chain	chain	NOUN
cuesj-184	52	31	reaction	reaction	NOUN
cuesj-184	52	32	khaleel	khaleel	PROPN
cuesj-184	52	33	,	,	PUNCT
cuesj-184	52	34	et	et	PROPN
cuesj-184	52	35	al	al	PROPN
cuesj-184	52	36	.	.	PUNCT
cuesj-184	52	37	:	:	PUNCT
cuesj-184	53	1	significance	significance	NOUN
cuesj-184	53	2	of	of	ADP
cuesj-184	53	3	hbv	hbv	NOUN
cuesj-184	53	4	diagnosis	diagnosis	NOUN
cuesj-184	53	5	by	by	ADP
cuesj-184	53	6	rt	rt	PROPN
cuesj-184	53	7	-	-	PUNCT
cuesj-184	53	8	pcr	pcr	ADJ
cuesj-184	53	9	54	54	NUM
cuesj-184	53	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-184	53	11	cuesj	cuesj	NOUN
cuesj-184	53	12	2020	2020	NUM
cuesj-184	53	13	,	,	PUNCT
cuesj-184	53	14	4	4	NUM
cuesj-184	53	15	(	(	PUNCT
cuesj-184	53	16	1	1	NUM
cuesj-184	53	17	):	):	PUNCT
cuesj-184	53	18	52	52	NUM
cuesj-184	53	19	-	-	SYM
cuesj-184	53	20	56	56	NUM
cuesj-184	53	21	and	and	CCONJ
cuesj-184	53	22	negative	negative	ADJ
cuesj-184	53	23	titers	titer	NOUN
cuesj-184	53	24	[	[	X
cuesj-184	53	25	table	table	NOUN
cuesj-184	53	26	3	3	NUM
cuesj-184	53	27	]	]	PUNCT
cuesj-184	53	28	.	.	PUNCT
cuesj-184	54	1	regarding	regard	VERB
cuesj-184	54	2	to	to	ADP
cuesj-184	54	3	the	the	DET
cuesj-184	54	4	gender	gender	NOUN
cuesj-184	54	5	positivity	positivity	NOUN
cuesj-184	54	6	for	for	ADP
cuesj-184	54	7	pcr	pcr	ADJ
cuesj-184	54	8	test	test	NOUN
cuesj-184	54	9	,	,	PUNCT
cuesj-184	54	10	in	in	ADP
cuesj-184	54	11	total	total	NOUN
cuesj-184	54	12	of	of	ADP
cuesj-184	54	13	154	154	NUM
cuesj-184	54	14	male	male	ADJ
cuesj-184	54	15	patients	patient	NOUN
cuesj-184	54	16	65	65	NUM
cuesj-184	54	17	(	(	PUNCT
cuesj-184	54	18	42	42	NUM
cuesj-184	54	19	%	%	NOUN
cuesj-184	54	20	)	)	PUNCT
cuesj-184	54	21	were	be	AUX
cuesj-184	54	22	positive	positive	ADJ
cuesj-184	54	23	and	and	CCONJ
cuesj-184	54	24	of	of	ADP
cuesj-184	54	25	102	102	NUM
cuesj-184	54	26	female	female	ADJ
cuesj-184	54	27	patients	patient	NOUN
cuesj-184	54	28	only	only	ADV
cuesj-184	54	29	28	28	NUM
cuesj-184	54	30	(	(	PUNCT
cuesj-184	54	31	27	27	NUM
cuesj-184	54	32	%	%	NOUN
cuesj-184	54	33	)	)	PUNCT
cuesj-184	54	34	were	be	AUX
cuesj-184	54	35	positive	positive	ADJ
cuesj-184	55	1	[	[	X
cuesj-184	55	2	table	table	NOUN
cuesj-184	55	3	4	4	NUM
cuesj-184	55	4	]	]	PUNCT
cuesj-184	55	5	.	.	PUNCT
cuesj-184	56	1	the	the	DET
cuesj-184	56	2	seromarkers	seromarker	NOUN
cuesj-184	56	3	profile	profile	VERB
cuesj-184	56	4	among	among	ADP
cuesj-184	56	5	patients	patient	NOUN
cuesj-184	56	6	negative	negative	ADJ
cuesj-184	56	7	for	for	ADP
cuesj-184	56	8	hbv	hbv	NOUN
cuesj-184	56	9	dna	dna	PROPN
cuesj-184	56	10	revealed	reveal	VERB
cuesj-184	56	11	anti	anti	ADJ
cuesj-184	56	12	-	-	ADJ
cuesj-184	56	13	hbs	hbs	ADJ
cuesj-184	56	14	antibody	antibody	NOUN
cuesj-184	56	15	seronegative	seronegative	ADJ
cuesj-184	56	16	among	among	ADP
cuesj-184	56	17	the	the	DET
cuesj-184	56	18	total	total	ADJ
cuesj-184	56	19	20	20	NUM
cuesj-184	56	20	patients	patient	NOUN
cuesj-184	56	21	positive	positive	ADJ
cuesj-184	56	22	for	for	ADP
cuesj-184	56	23	hbsag	hbsag	NOUN
cuesj-184	56	24	[	[	X
cuesj-184	56	25	table	table	NOUN
cuesj-184	56	26	5	5	NUM
cuesj-184	56	27	]	]	PUNCT
cuesj-184	56	28	.	.	PUNCT
cuesj-184	57	1	however	however	ADV
cuesj-184	57	2	,	,	PUNCT
cuesj-184	57	3	results	result	NOUN
cuesj-184	57	4	of	of	ADP
cuesj-184	57	5	anti	anti	ADJ
cuesj-184	57	6	-	-	ADJ
cuesj-184	57	7	hbs	hbs	ADJ
cuesj-184	57	8	titers	titer	NOUN
cuesj-184	57	9	among	among	ADP
cuesj-184	57	10	patients	patient	NOUN
cuesj-184	57	11	negative	negative	ADJ
cuesj-184	57	12	for	for	ADP
cuesj-184	57	13	hbv	hbv	NOUN
cuesj-184	57	14	dna	dna	PROPN
cuesj-184	57	15	showed	show	VERB
cuesj-184	57	16	20	20	NUM
cuesj-184	57	17	samples	sample	NOUN
cuesj-184	57	18	were	be	AUX
cuesj-184	57	19	positive	positive	ADJ
cuesj-184	57	20	showing	show	VERB
cuesj-184	57	21	different	different	ADJ
cuesj-184	57	22	titers	titer	NOUN
cuesj-184	58	1	[	[	X
cuesj-184	58	2	table	table	NOUN
cuesj-184	58	3	6	6	NUM
cuesj-184	58	4	]	]	PUNCT
cuesj-184	58	5	.	.	PUNCT
cuesj-184	59	1	during	during	ADP
cuesj-184	59	2	the	the	DET
cuesj-184	59	3	immune	immune	ADJ
cuesj-184	59	4	-	-	PUNCT
cuesj-184	59	5	tolerant	tolerant	ADJ
cuesj-184	59	6	phase	phase	NOUN
cuesj-184	59	7	,	,	PUNCT
cuesj-184	59	8	hbsag	hbsag	ADJ
cuesj-184	59	9	level	level	NOUN
cuesj-184	59	10	is	be	AUX
cuesj-184	59	11	the	the	DET
cuesj-184	59	12	highest	high	ADJ
cuesj-184	59	13	one	one	NUM
cuesj-184	59	14	,	,	PUNCT
cuesj-184	59	15	and	and	CCONJ
cuesj-184	59	16	the	the	DET
cuesj-184	59	17	level	level	NOUN
cuesj-184	59	18	decreases	decrease	VERB
cuesj-184	59	19	progressively	progressively	ADV
cuesj-184	59	20	from	from	ADP
cuesj-184	59	21	immune	immune	ADJ
cuesj-184	59	22	tolerance	tolerance	NOUN
cuesj-184	59	23	to	to	ADP
cuesj-184	59	24	inactive	inactive	ADJ
cuesj-184	59	25	phase	phase	NOUN
cuesj-184	59	26	that	that	PRON
cuesj-184	59	27	reflects	reflect	VERB
cuesj-184	59	28	a	a	DET
cuesj-184	59	29	low	low	ADJ
cuesj-184	59	30	replicative	replicative	ADJ
cuesj-184	59	31	phase	phase	NOUN
cuesj-184	59	32	of	of	ADP
cuesj-184	59	33	immune	immune	ADJ
cuesj-184	59	34	control.[19	control.[19	NOUN
cuesj-184	59	35	]	]	X
cuesj-184	59	36	the	the	DET
cuesj-184	59	37	detection	detection	NOUN
cuesj-184	59	38	of	of	ADP
cuesj-184	59	39	hbv	hbv	NOUN
cuesj-184	59	40	infection	infection	NOUN
cuesj-184	59	41	is	be	AUX
cuesj-184	59	42	vital	vital	ADJ
cuesj-184	59	43	for	for	ADP
cuesj-184	59	44	diagnosis	diagnosis	NOUN
cuesj-184	59	45	our	our	PRON
cuesj-184	59	46	group	group	NOUN
cuesj-184	59	47	published	publish	VERB
cuesj-184	59	48	a	a	DET
cuesj-184	59	49	paper	paper	NOUN
cuesj-184	59	50	that	that	PRON
cuesj-184	59	51	delineated	delineate	VERB
cuesj-184	59	52	the	the	DET
cuesj-184	59	53	impact	impact	NOUN
cuesj-184	59	54	of	of	ADP
cuesj-184	59	55	pcr	pcr	ADJ
cuesj-184	59	56	dna	dna	PROPN
cuesj-184	59	57	assay	assay	VERB
cuesj-184	59	58	for	for	ADP
cuesj-184	59	59	the	the	DET
cuesj-184	59	60	diagnosis	diagnosis	NOUN
cuesj-184	59	61	of	of	ADP
cuesj-184	59	62	hbv	hbv	PROPN
cuesj-184	59	63	infection.[20	infection.[20	PROPN
cuesj-184	59	64	]	]	X
cuesj-184	59	65	the	the	DET
cuesj-184	59	66	data	datum	NOUN
cuesj-184	59	67	of	of	ADP
cuesj-184	59	68	this	this	DET
cuesj-184	59	69	study	study	NOUN
cuesj-184	59	70	are	be	AUX
cuesj-184	59	71	agree	agree	VERB
cuesj-184	59	72	with	with	ADP
cuesj-184	59	73	other	other	ADJ
cuesj-184	59	74	studies[21	studies[21	NOUN
cuesj-184	59	75	]	]	PUNCT
cuesj-184	59	76	for	for	ADP
cuesj-184	59	77	the	the	DET
cuesj-184	59	78	serologic	serologic	ADJ
cuesj-184	59	79	profile	profile	NOUN
cuesj-184	59	80	of	of	ADP
cuesj-184	59	81	hbsag	hbsag	ADJ
cuesj-184	59	82	seropositivity	seropositivity	NOUN
cuesj-184	59	83	among	among	ADP
cuesj-184	59	84	patients	patient	NOUN
cuesj-184	59	85	screened	screen	VERB
cuesj-184	59	86	negative	negative	ADJ
cuesj-184	59	87	for	for	ADP
cuesj-184	59	88	hbv	hbv	NOUN
cuesj-184	59	89	dna	dna	PROPN
cuesj-184	59	90	.	.	PUNCT
cuesj-184	60	1	they	they	PRON
cuesj-184	60	2	reported	report	VERB
cuesj-184	60	3	6	6	NUM
cuesj-184	60	4	%	%	NOUN
cuesj-184	60	5	of	of	ADP
cuesj-184	60	6	their	their	PRON
cuesj-184	60	7	samples	sample	NOUN
cuesj-184	60	8	gave	give	VERB
cuesj-184	60	9	hbsag	hbsag	NOUN
cuesj-184	60	10	positive	positive	ADJ
cuesj-184	60	11	among	among	ADP
cuesj-184	60	12	donations	donation	NOUN
cuesj-184	60	13	negative	negative	ADJ
cuesj-184	60	14	for	for	ADP
cuesj-184	60	15	hbv	hbv	NOUN
cuesj-184	60	16	dna	dna	PROPN
cuesj-184	60	17	level	level	NOUN
cuesj-184	60	18	,	,	PUNCT
cuesj-184	60	19	others[8	others[8	PROPN
cuesj-184	60	20	]	]	PUNCT
cuesj-184	60	21	referred	refer	VERB
cuesj-184	60	22	that	that	SCONJ
cuesj-184	60	23	in	in	ADP
cuesj-184	60	24	nine	nine	NUM
cuesj-184	60	25	patients	patient	NOUN
cuesj-184	60	26	with	with	ADP
cuesj-184	60	27	hcc	hcc	PROPN
cuesj-184	60	28	;	;	PUNCT
cuesj-184	60	29	hbv	hbv	PROPN
cuesj-184	60	30	dna	dna	PROPN
cuesj-184	60	31	was	be	AUX
cuesj-184	60	32	undetectable	undetectable	ADJ
cuesj-184	60	33	but	but	CCONJ
cuesj-184	60	34	the	the	DET
cuesj-184	60	35	level	level	NOUN
cuesj-184	60	36	of	of	ADP
cuesj-184	60	37	hbsag	hbsag	NOUN
cuesj-184	60	38	was	be	AUX
cuesj-184	60	39	≥2000	≥2000	X
cuesj-184	60	40	coi	coi	X
cuesj-184	60	41	.	.	PUNCT
cuesj-184	61	1	others	other	NOUN
cuesj-184	61	2	reported	report	VERB
cuesj-184	61	3	31.4	31.4	NUM
cuesj-184	61	4	%	%	NOUN
cuesj-184	61	5	hbsag	hbsag	NOUN
cuesj-184	61	6	positive	positive	ADJ
cuesj-184	61	7	among	among	ADP
cuesj-184	61	8	patients	patient	NOUN
cuesj-184	61	9	negative	negative	ADJ
cuesj-184	61	10	for	for	ADP
cuesj-184	61	11	hbv	hbv	NOUN
cuesj-184	61	12	dna.[22	dna.[22	NOUN
cuesj-184	61	13	]	]	X
cuesj-184	61	14	however	however	ADV
cuesj-184	61	15	,	,	PUNCT
cuesj-184	61	16	data	datum	NOUN
cuesj-184	61	17	from	from	ADP
cuesj-184	61	18	another	another	DET
cuesj-184	61	19	study	study	NOUN
cuesj-184	61	20	showed	show	VERB
cuesj-184	61	21	that	that	SCONJ
cuesj-184	61	22	100	100	NUM
cuesj-184	61	23	of	of	ADP
cuesj-184	61	24	140	140	NUM
cuesj-184	61	25	patients	patient	NOUN
cuesj-184	61	26	were	be	AUX
cuesj-184	61	27	seronegative	seronegative	ADJ
cuesj-184	61	28	for	for	ADP
cuesj-184	61	29	hbv	hbv	NOUN
cuesj-184	61	30	dna.[23	dna.[23	NOUN
cuesj-184	61	31	]	]	PUNCT
cuesj-184	61	32	another	another	DET
cuesj-184	61	33	study[24	study[24	NOUN
cuesj-184	61	34	]	]	PUNCT
cuesj-184	61	35	reported	report	VERB
cuesj-184	61	36	that	that	SCONJ
cuesj-184	61	37	69	69	NUM
cuesj-184	61	38	%	%	NOUN
cuesj-184	61	39	of	of	ADP
cuesj-184	61	40	confirmed	confirm	VERB
cuesj-184	61	41	hbsag	hbsag	ADJ
cuesj-184	61	42	-	-	PUNCT
cuesj-184	61	43	positive	positive	ADJ
cuesj-184	61	44	donations	donation	NOUN
cuesj-184	61	45	had	have	VERB
cuesj-184	61	46	undetectable	undetectable	ADJ
cuesj-184	61	47	hbv	hbv	NOUN
cuesj-184	61	48	dna	dna	PROPN
cuesj-184	61	49	levels	level	NOUN
cuesj-184	61	50	.	.	PUNCT
cuesj-184	62	1	however	however	ADV
cuesj-184	62	2	,	,	PUNCT
cuesj-184	62	3	others[25,26	others[25,26	PROPN
cuesj-184	62	4	]	]	PUNCT
cuesj-184	62	5	found	find	VERB
cuesj-184	62	6	that	that	SCONJ
cuesj-184	62	7	none	none	NOUN
cuesj-184	62	8	of	of	ADP
cuesj-184	62	9	the	the	DET
cuesj-184	62	10	hbsag	hbsag	ADJ
cuesj-184	62	11	-	-	PUNCT
cuesj-184	62	12	positive	positive	ADJ
cuesj-184	62	13	donors	donor	NOUN
cuesj-184	62	14	with	with	ADP
cuesj-184	62	15	very	very	ADV
cuesj-184	62	16	low	low	ADJ
cuesj-184	62	17	or	or	CCONJ
cuesj-184	62	18	negative	negative	ADJ
cuesj-184	62	19	for	for	ADP
cuesj-184	62	20	hbv	hbv	NOUN
cuesj-184	62	21	dna	dna	PROPN
cuesj-184	62	22	were	be	AUX
cuesj-184	62	23	anti	anti	ADJ
cuesj-184	62	24	-	-	ADJ
cuesj-184	62	25	hbs	hbs	ADJ
cuesj-184	62	26	antibody	antibody	NOUN
cuesj-184	62	27	positive.[24,27	positive.[24,27	VERB
cuesj-184	62	28	]	]	PUNCT
cuesj-184	62	29	among	among	ADP
cuesj-184	62	30	explanation	explanation	NOUN
cuesj-184	62	31	for	for	ADP
cuesj-184	62	32	such	such	ADJ
cuesj-184	62	33	unusual	unusual	ADJ
cuesj-184	62	34	hbv	hbv	NOUN
cuesj-184	62	35	serologic	serologic	NOUN
cuesj-184	62	36	profile	profile	NOUN
cuesj-184	62	37	,	,	PUNCT
cuesj-184	62	38	the	the	DET
cuesj-184	62	39	patients	patient	NOUN
cuesj-184	62	40	may	may	AUX
cuesj-184	62	41	be	be	AUX
cuesj-184	62	42	chronically	chronically	ADV
cuesj-184	62	43	infected	infect	VERB
cuesj-184	62	44	with	with	ADP
cuesj-184	62	45	hbv	hbv	NOUN
cuesj-184	62	46	particularly	particularly	ADV
cuesj-184	62	47	;	;	PUNCT
cuesj-184	62	48	they	they	PRON
cuesj-184	62	49	are	be	AUX
cuesj-184	62	50	in	in	ADP
cuesj-184	62	51	the	the	DET
cuesj-184	62	52	non	non	ADJ
cuesj-184	62	53	-	-	ADJ
cuesj-184	62	54	replicative	replicative	ADJ
cuesj-184	62	55	phase	phase	NOUN
cuesj-184	62	56	as	as	ADP
cuesj-184	62	57	part	part	NOUN
cuesj-184	62	58	of	of	ADP
cuesj-184	62	59	the	the	DET
cuesj-184	62	60	natural	natural	ADJ
cuesj-184	62	61	course	course	NOUN
cuesj-184	62	62	of	of	ADP
cuesj-184	62	63	infection.[22	infection.[22	PROPN
cuesj-184	62	64	]	]	X
cuesj-184	62	65	the	the	DET
cuesj-184	62	66	question	question	NOUN
cuesj-184	62	67	might	might	AUX
cuesj-184	62	68	be	be	AUX
cuesj-184	62	69	raised	raise	VERB
cuesj-184	62	70	here	here	ADV
cuesj-184	62	71	is	be	AUX
cuesj-184	62	72	about	about	ADP
cuesj-184	62	73	such	such	ADJ
cuesj-184	62	74	serologic	serologic	ADJ
cuesj-184	62	75	profile	profile	NOUN
cuesj-184	62	76	of	of	ADP
cuesj-184	62	77	hbsag	hbsag	NOUN
cuesj-184	62	78	positive	positive	ADJ
cuesj-184	62	79	among	among	ADP
cuesj-184	62	80	patients	patient	NOUN
cuesj-184	62	81	negative	negative	ADJ
cuesj-184	62	82	for	for	ADP
cuesj-184	62	83	hbv	hbv	NOUN
cuesj-184	62	84	dna	dna	PROPN
cuesj-184	62	85	,	,	PUNCT
cuesj-184	62	86	are	be	AUX
cuesj-184	62	87	these	these	DET
cuesj-184	62	88	patients	patient	NOUN
cuesj-184	62	89	infectious	infectious	ADJ
cuesj-184	62	90	and	and	CCONJ
cuesj-184	62	91	transmissible	transmissible	ADJ
cuesj-184	62	92	for	for	ADP
cuesj-184	62	93	community,[21	community,[21	PROPN
cuesj-184	62	94	]	]	PUNCT
cuesj-184	62	95	referred	refer	VERB
cuesj-184	62	96	for	for	ADP
cuesj-184	62	97	the	the	DET
cuesj-184	62	98	need	need	NOUN
cuesj-184	62	99	of	of	ADP
cuesj-184	62	100	larger	large	ADJ
cuesj-184	62	101	sample	sample	NOUN
cuesj-184	62	102	volume	volume	NOUN
cuesj-184	62	103	(	(	PUNCT
cuesj-184	62	104	5–10	5–10	PROPN
cuesj-184	62	105	ml	ml	VERB
cuesj-184	62	106	)	)	PUNCT
cuesj-184	62	107	necessary	necessary	ADJ
cuesj-184	62	108	for	for	ADP
cuesj-184	62	109	extraction	extraction	NOUN
cuesj-184	62	110	and	and	CCONJ
cuesj-184	62	111	concentration	concentration	NOUN
cuesj-184	62	112	to	to	PART
cuesj-184	62	113	determine	determine	VERB
cuesj-184	62	114	the	the	DET
cuesj-184	62	115	real	real	ADJ
cuesj-184	62	116	hbv	hbv	NOUN
cuesj-184	62	117	dna	dna	PROPN
cuesj-184	62	118	status	status	NOUN
cuesj-184	62	119	among	among	ADP
cuesj-184	62	120	samples	sample	NOUN
cuesj-184	62	121	negative	negative	ADJ
cuesj-184	62	122	for	for	ADP
cuesj-184	62	123	dna	dna	NOUN
cuesj-184	62	124	.	.	PUNCT
cuesj-184	63	1	in	in	ADP
cuesj-184	63	2	this	this	DET
cuesj-184	63	3	study	study	NOUN
cuesj-184	63	4	,	,	PUNCT
cuesj-184	63	5	pearson	pearson	PROPN
cuesj-184	63	6	’s	’s	PART
cuesj-184	63	7	correlation	correlation	NOUN
cuesj-184	63	8	analysis	analysis	NOUN
cuesj-184	63	9	revealed	reveal	VERB
cuesj-184	63	10	no	no	DET
cuesj-184	63	11	significant	significant	ADJ
cuesj-184	63	12	correlation	correlation	NOUN
cuesj-184	63	13	between	between	ADP
cuesj-184	63	14	serum	serum	NOUN
cuesj-184	63	15	hbv	hbv	NOUN
cuesj-184	63	16	dna	dna	PROPN
cuesj-184	63	17	and	and	CCONJ
cuesj-184	63	18	hbsag	hbsag	NOUN
cuesj-184	63	19	levels	level	NOUN
cuesj-184	63	20	(	(	PUNCT
cuesj-184	63	21	r	r	NOUN
cuesj-184	63	22	=	=	SYM
cuesj-184	63	23	0.331	0.331	NUM
cuesj-184	63	24	;	;	PUNCT
cuesj-184	63	25	p	p	X
cuesj-184	63	26	>	>	X
cuesj-184	63	27	0.3	0.3	NUM
cuesj-184	63	28	)	)	PUNCT
cuesj-184	64	1	[	[	X
cuesj-184	64	2	figure	figure	NOUN
cuesj-184	64	3	1	1	NUM
cuesj-184	64	4	]	]	PUNCT
cuesj-184	64	5	.	.	PUNCT
cuesj-184	65	1	different	different	ADJ
cuesj-184	65	2	studies	study	NOUN
cuesj-184	65	3	reported	report	VERB
cuesj-184	65	4	discrepant	discrepant	ADJ
cuesj-184	65	5	results	result	NOUN
cuesj-184	65	6	regarding	regard	VERB
cuesj-184	65	7	correlation	correlation	NOUN
cuesj-184	65	8	between	between	ADP
cuesj-184	65	9	hbv	hbv	NOUN
cuesj-184	65	10	dna	dna	PROPN
cuesj-184	65	11	and	and	CCONJ
cuesj-184	65	12	hbsag	hbsag	NOUN
cuesj-184	65	13	levels	level	NOUN
cuesj-184	65	14	,	,	PUNCT
cuesj-184	65	15	our	our	PRON
cuesj-184	65	16	data	datum	NOUN
cuesj-184	65	17	were	be	AUX
cuesj-184	65	18	disagree	disagree	VERB
cuesj-184	65	19	with	with	ADP
cuesj-184	65	20	other	other	ADJ
cuesj-184	65	21	studies	study	NOUN
cuesj-184	65	22	who	who	PRON
cuesj-184	65	23	reported	report	VERB
cuesj-184	65	24	positive	positive	ADJ
cuesj-184	65	25	correlation.[28	correlation.[28	NOUN
cuesj-184	65	26	-	-	PUNCT
cuesj-184	65	27	34	34	NUM
cuesj-184	65	28	]	]	PUNCT
cuesj-184	65	29	meanwhile	meanwhile	ADV
cuesj-184	65	30	,	,	PUNCT
cuesj-184	65	31	our	our	PRON
cuesj-184	65	32	results	result	NOUN
cuesj-184	65	33	agree	agree	VERB
cuesj-184	65	34	with	with	ADP
cuesj-184	65	35	others	other	NOUN
cuesj-184	65	36	for	for	ADP
cuesj-184	65	37	no	no	DET
cuesj-184	65	38	correlation	correlation	NOUN
cuesj-184	65	39	between	between	ADP
cuesj-184	65	40	hbv	hbv	NOUN
cuesj-184	65	41	dna	dna	PROPN
cuesj-184	65	42	and	and	CCONJ
cuesj-184	65	43	hbsag	hbsag	PROPN
cuesj-184	65	44	levels.[35,36	levels.[35,36	VERB
cuesj-184	65	45	]	]	PUNCT
cuesj-184	65	46	such	such	ADJ
cuesj-184	65	47	correlation	correlation	NOUN
cuesj-184	65	48	is	be	AUX
cuesj-184	65	49	only	only	ADV
cuesj-184	65	50	weak	weak	ADJ
cuesj-184	65	51	in	in	ADP
cuesj-184	65	52	patients	patient	NOUN
cuesj-184	65	53	negative	negative	ADJ
cuesj-184	65	54	for	for	ADP
cuesj-184	65	55	hbsag.[19,30,37,38	hbsag.[19,30,37,38	NOUN
cuesj-184	65	56	]	]	X
cuesj-184	65	57	this	this	PRON
cuesj-184	65	58	is	be	AUX
cuesj-184	65	59	because	because	SCONJ
cuesj-184	65	60	the	the	DET
cuesj-184	65	61	level	level	NOUN
cuesj-184	65	62	of	of	ADP
cuesj-184	65	63	hbv	hbv	NOUN
cuesj-184	65	64	dna	dna	PROPN
cuesj-184	65	65	fluctuates	fluctuate	VERB
cuesj-184	65	66	from	from	ADP
cuesj-184	65	67	undetectable	undetectable	ADJ
cuesj-184	65	68	to	to	ADP
cuesj-184	65	69	>	>	X
cuesj-184	65	70	2,000,000	2,000,000	NUM
cuesj-184	65	71	iu	iu	NOUN
cuesj-184	65	72	/	/	SYM
cuesj-184	65	73	ml.[12	ml.[12	NOUN
cuesj-184	65	74	]	]	PUNCT
cuesj-184	65	75	this	this	PRON
cuesj-184	65	76	is	be	AUX
cuesj-184	65	77	why	why	SCONJ
cuesj-184	65	78	the	the	DET
cuesj-184	65	79	level	level	NOUN
cuesj-184	65	80	of	of	ADP
cuesj-184	65	81	hbsag	hbsag	NOUN
cuesj-184	65	82	does	do	AUX
cuesj-184	65	83	not	not	PART
cuesj-184	65	84	fall	fall	VERB
cuesj-184	65	85	in	in	ADP
cuesj-184	65	86	the	the	DET
cuesj-184	65	87	same	same	ADJ
cuesj-184	65	88	proportion	proportion	NOUN
cuesj-184	65	89	or	or	CCONJ
cuesj-184	65	90	level	level	NOUN
cuesj-184	65	91	when	when	SCONJ
cuesj-184	65	92	correlated	correlate	VERB
cuesj-184	65	93	with	with	ADP
cuesj-184	65	94	hbv	hbv	NOUN
cuesj-184	65	95	dna	dna	PROPN
cuesj-184	65	96	level	level	NOUN
cuesj-184	65	97	as	as	ADP
cuesj-184	65	98	a	a	DET
cuesj-184	65	99	marker	marker	NOUN
cuesj-184	65	100	for	for	ADP
cuesj-184	65	101	table	table	NOUN
cuesj-184	65	102	3	3	NUM
cuesj-184	65	103	:	:	PUNCT
cuesj-184	65	104	mean	mean	VERB
cuesj-184	65	105	titers	titer	NOUN
cuesj-184	65	106	of	of	ADP
cuesj-184	65	107	hbv	hbv	PROPN
cuesj-184	65	108	dna	dna	PROPN
cuesj-184	65	109	among	among	ADP
cuesj-184	65	110	patients	patient	NOUN
cuesj-184	65	111	screened	screen	VERB
cuesj-184	65	112	number	number	NOUN
cuesj-184	65	113	screened	screen	VERB
cuesj-184	65	114	hbv	hbv	NOUN
cuesj-184	65	115	dna	dna	PROPN
cuesj-184	65	116	pcr	pcr	PROPN
cuesj-184	66	1	+	+	PROPN
cuesj-184	66	2	ve	ve	PROPN
cuesj-184	66	3	(	(	PUNCT
cuesj-184	66	4	n=93	n=93	PROPN
cuesj-184	66	5	)	)	PUNCT
cuesj-184	66	6	hbv	hbv	PROPN
cuesj-184	66	7	dna	dna	PROPN
cuesj-184	66	8	pcr	pcr	PROPN
cuesj-184	66	9	−ve	−ve	PROPN
cuesj-184	66	10	(	(	PUNCT
cuesj-184	66	11	n=163	n=163	NOUN
cuesj-184	66	12	)	)	PUNCT
cuesj-184	66	13	p	p	NOUN
cuesj-184	66	14	-	-	PUNCT
cuesj-184	66	15	value	value	NOUN
cuesj-184	66	16	n=256	n=256	NUM
cuesj-184	66	17	18,582,661.24±5,934,488.97	18,582,661.24±5,934,488.97	NUM
cuesj-184	66	18	31.12±4.45	31.12±4.45	NUM
cuesj-184	66	19	0.000	0.000	NUM
cuesj-184	66	20	hbv	hbv	NOUN
cuesj-184	66	21	:	:	PUNCT
cuesj-184	66	22	hepatitis	hepatitis	PROPN
cuesj-184	66	23	b	b	PROPN
cuesj-184	66	24	virus	virus	PROPN
cuesj-184	66	25	,	,	PUNCT
cuesj-184	66	26	pcr	pcr	PROPN
cuesj-184	66	27	:	:	PUNCT
cuesj-184	66	28	polymerase	polymerase	NOUN
cuesj-184	66	29	chain	chain	NOUN
cuesj-184	66	30	reaction	reaction	NOUN
cuesj-184	66	31	figure	figure	NOUN
cuesj-184	66	32	1	1	NUM
cuesj-184	66	33	:	:	PUNCT
cuesj-184	66	34	pearson	pearson	NOUN
cuesj-184	66	35	correlation	correlation	NOUN
cuesj-184	66	36	between	between	ADP
cuesj-184	66	37	quantitative	quantitative	ADJ
cuesj-184	66	38	hepatitis	hepatitis	PROPN
cuesj-184	66	39	b	b	PROPN
cuesj-184	66	40	virus	virus	NOUN
cuesj-184	66	41	dna	dna	NOUN
cuesj-184	66	42	level	level	NOUN
cuesj-184	66	43	and	and	CCONJ
cuesj-184	66	44	hepatitis	hepatitis	PROPN
cuesj-184	66	45	b	b	PROPN
cuesj-184	66	46	surface	surface	NOUN
cuesj-184	66	47	antigen	antigen	ADV
cuesj-184	66	48	.	.	PUNCT
cuesj-184	67	1	r	r	NOUN
cuesj-184	67	2	=	=	PUNCT
cuesj-184	67	3	0.229	0.229	NUM
cuesj-184	67	4	,	,	PUNCT
cuesj-184	67	5	p	p	NOUN
cuesj-184	67	6	=	=	NOUN
cuesj-184	67	7	0.331	0.331	NUM
cuesj-184	67	8	table	table	NOUN
cuesj-184	67	9	5	5	NUM
cuesj-184	67	10	:	:	PUNCT
cuesj-184	67	11	hbsag	hbsag	NOUN
cuesj-184	67	12	and	and	CCONJ
cuesj-184	67	13	anti	anti	ADJ
cuesj-184	67	14	-	-	ADJ
cuesj-184	67	15	hbs	hbs	ADJ
cuesj-184	67	16	seromarkers	seromarker	NOUN
cuesj-184	67	17	profile	profile	VERB
cuesj-184	67	18	among	among	ADP
cuesj-184	67	19	patients	patient	NOUN
cuesj-184	67	20	negative	negative	ADJ
cuesj-184	67	21	for	for	ADP
cuesj-184	67	22	hbv	hbv	NOUN
cuesj-184	67	23	dna	dna	PROPN
cuesj-184	67	24	serological	serological	ADJ
cuesj-184	67	25	profile	profile	NOUN
cuesj-184	67	26	hbs	hbs	PROPN
cuesj-184	67	27	anti	anti	PROPN
cuesj-184	67	28	-	-	ADJ
cuesj-184	67	29	hbs	hbs	ADJ
cuesj-184	67	30	(	(	PUNCT
cuesj-184	67	31	n=20	n=20	PROPN
cuesj-184	67	32	)	)	PUNCT
cuesj-184	67	33	>	>	PUNCT
cuesj-184	67	34	10	10	NUM
cuesj-184	67	35	coi	coi	NOUN
cuesj-184	67	36	+	+	NOUN
cuesj-184	67	37	ve	ve	PROPN
cuesj-184	67	38	<	<	X
cuesj-184	67	39	0.9	0.9	NUM
cuesj-184	67	40	coi	coi	NOUN
cuesj-184	67	41	−ve	−ve	PROPN
cuesj-184	67	42	<	<	X
cuesj-184	67	43	10	10	NUM
cuesj-184	67	44	iu	iu	NOUN
cuesj-184	67	45	/	/	SYM
cuesj-184	67	46	ml	ml	NOUN
cuesj-184	67	47	−ve	−ve	PROPN
cuesj-184	67	48	>	>	X
cuesj-184	67	49	10	10	NUM
cuesj-184	67	50	iu	iu	ADV
cuesj-184	67	51	/	/	SYM
cuesj-184	67	52	ml	ml	NOUN
cuesj-184	68	1	+	+	ADJ
cuesj-184	68	2	ve	ve	VERB
cuesj-184	68	3	hbv	hbv	NOUN
cuesj-184	68	4	dna	dna	PROPN
cuesj-184	68	5	pcr	pcr	PROPN
cuesj-184	68	6	negative	negative	ADJ
cuesj-184	68	7	(	(	PUNCT
cuesj-184	68	8	n=163	n=163	NUM
cuesj-184	68	9	)	)	PUNCT
cuesj-184	68	10	20	20	NUM
cuesj-184	68	11	(	(	PUNCT
cuesj-184	68	12	12.27	12.27	NUM
cuesj-184	68	13	%	%	NOUN
cuesj-184	68	14	)	)	PUNCT
cuesj-184	68	15	143	143	NUM
cuesj-184	68	16	(	(	PUNCT
cuesj-184	68	17	87.73	87.73	NUM
cuesj-184	68	18	%	%	NOUN
cuesj-184	68	19	)	)	PUNCT
cuesj-184	68	20	20	20	NUM
cuesj-184	68	21	(	(	PUNCT
cuesj-184	68	22	100	100	NUM
cuesj-184	68	23	%	%	NOUN
cuesj-184	68	24	)	)	PUNCT
cuesj-184	68	25	0.00	0.00	NUM
cuesj-184	68	26	hbv	hbv	NOUN
cuesj-184	68	27	:	:	PUNCT
cuesj-184	68	28	hepatitis	hepatitis	PROPN
cuesj-184	68	29	b	b	PROPN
cuesj-184	68	30	virus	virus	PROPN
cuesj-184	68	31	,	,	PUNCT
cuesj-184	68	32	pcr	pcr	PROPN
cuesj-184	68	33	:	:	PUNCT
cuesj-184	68	34	polymerase	polymerase	NOUN
cuesj-184	68	35	chain	chain	NOUN
cuesj-184	68	36	reaction	reaction	NOUN
cuesj-184	68	37	,	,	PUNCT
cuesj-184	68	38	hbsag	hbsag	NOUN
cuesj-184	68	39	:	:	PUNCT
cuesj-184	68	40	hepatitis	hepatitis	PROPN
cuesj-184	68	41	b	b	PROPN
cuesj-184	68	42	surface	surface	NOUN
cuesj-184	68	43	antigen	antigen	NOUN
cuesj-184	68	44	table	table	NOUN
cuesj-184	68	45	4	4	NUM
cuesj-184	68	46	:	:	PUNCT
cuesj-184	68	47	frequencies	frequency	NOUN
cuesj-184	68	48	of	of	ADP
cuesj-184	68	49	hbv	hbv	NOUN
cuesj-184	68	50	dna	dna	PROPN
cuesj-184	68	51	positivity	positivity	NOUN
cuesj-184	68	52	according	accord	VERB
cuesj-184	68	53	to	to	ADP
cuesj-184	68	54	the	the	DET
cuesj-184	68	55	gender	gender	NOUN
cuesj-184	68	56	gender	gender	NOUN
cuesj-184	68	57	positive	positive	ADJ
cuesj-184	68	58	pcr	pcr	ADJ
cuesj-184	68	59	negative	negative	ADJ
cuesj-184	68	60	pcr	pcr	ADJ
cuesj-184	68	61	total	total	NOUN
cuesj-184	68	62	p	p	ADJ
cuesj-184	68	63	-	-	PUNCT
cuesj-184	68	64	value	value	NOUN
cuesj-184	68	65	male	male	NOUN
cuesj-184	68	66	65	65	NUM
cuesj-184	68	67	(	(	PUNCT
cuesj-184	68	68	42.20	42.20	NUM
cuesj-184	68	69	%	%	NOUN
cuesj-184	68	70	)	)	PUNCT
cuesj-184	68	71	89	89	NUM
cuesj-184	68	72	(	(	PUNCT
cuesj-184	68	73	57.79	57.79	NUM
cuesj-184	68	74	%	%	NOUN
cuesj-184	68	75	)	)	PUNCT
cuesj-184	68	76	154	154	NUM
cuesj-184	68	77	≤0.001	≤0.001	NUM
cuesj-184	68	78	female	female	ADJ
cuesj-184	68	79	28	28	NUM
cuesj-184	68	80	(	(	PUNCT
cuesj-184	68	81	27.45	27.45	NUM
cuesj-184	68	82	%	%	NOUN
cuesj-184	68	83	)	)	PUNCT
cuesj-184	68	84	74	74	NUM
cuesj-184	68	85	(	(	PUNCT
cuesj-184	68	86	72.54	72.54	NUM
cuesj-184	68	87	%	%	NOUN
cuesj-184	68	88	)	)	PUNCT
cuesj-184	68	89	102	102	NUM
cuesj-184	68	90	total	total	NOUN
cuesj-184	68	91	93	93	NUM
cuesj-184	68	92	(	(	PUNCT
cuesj-184	68	93	36.3232	36.3232	NUM
cuesj-184	68	94	%	%	NOUN
cuesj-184	68	95	)	)	PUNCT
cuesj-184	68	96	163	163	NUM
cuesj-184	68	97	(	(	PUNCT
cuesj-184	68	98	63.67	63.67	NUM
cuesj-184	68	99	%	%	NOUN
cuesj-184	68	100	)	)	PUNCT
cuesj-184	68	101	256	256	NUM
cuesj-184	68	102	hbv	hbv	NOUN
cuesj-184	68	103	:	:	PUNCT
cuesj-184	68	104	hepatitis	hepatitis	PROPN
cuesj-184	68	105	b	b	PROPN
cuesj-184	68	106	virus	virus	PROPN
cuesj-184	68	107	,	,	PUNCT
cuesj-184	68	108	pcr	pcr	PROPN
cuesj-184	68	109	:	:	PUNCT
cuesj-184	68	110	polymerase	polymerase	NOUN
cuesj-184	68	111	chain	chain	NOUN
cuesj-184	68	112	reaction	reaction	NOUN
cuesj-184	68	113	table	table	NOUN
cuesj-184	68	114	6	6	NUM
cuesj-184	68	115	:	:	PUNCT
cuesj-184	68	116	distribution	distribution	NOUN
cuesj-184	68	117	of	of	ADP
cuesj-184	68	118	hbsag	hbsag	NOUN
cuesj-184	68	119	and	and	CCONJ
cuesj-184	68	120	anti	anti	ADJ
cuesj-184	68	121	-	-	ADJ
cuesj-184	68	122	hbs	hbs	ADJ
cuesj-184	68	123	titers	titer	NOUN
cuesj-184	68	124	among	among	ADP
cuesj-184	68	125	patients	patient	NOUN
cuesj-184	68	126	negative	negative	ADJ
cuesj-184	68	127	for	for	ADP
cuesj-184	68	128	hbv	hbv	PROPN
cuesj-184	68	129	dna	dna	PROPN
cuesj-184	68	130	hbs	hbs	PROPN
cuesj-184	68	131	titers	titer	NOUN
cuesj-184	68	132	coi	coi	VERB
cuesj-184	68	133	anti	anti	ADJ
cuesj-184	68	134	-	-	ADJ
cuesj-184	68	135	hbsab	hbsab	ADJ
cuesj-184	68	136	iu	iu	NOUN
cuesj-184	68	137	/	/	SYM
cuesj-184	68	138	ml	ml	NOUN
cuesj-184	68	139	non	non	ADJ
cuesj-184	68	140	-	-	ADJ
cuesj-184	68	141	reactive	reactive	ADJ
cuesj-184	68	142	<	<	X
cuesj-184	68	143	0.9	0.9	NUM
cuesj-184	68	144	coi	coi	NOUN
cuesj-184	68	145	1000–2000	1000–2000	NUM
cuesj-184	68	146	2001–3000	2001–3000	NUM
cuesj-184	68	147	3001–4000	3001–4000	NUM
cuesj-184	68	148	4001–>5000	4001–>5000	NUM
cuesj-184	68	149	non	non	ADJ
cuesj-184	68	150	-	-	ADJ
cuesj-184	68	151	reactive	reactive	ADJ
cuesj-184	68	152	<	<	NOUN
cuesj-184	68	153	10	10	NUM
cuesj-184	68	154	reactive	reactive	NOUN
cuesj-184	68	155	>	>	X
cuesj-184	68	156	10	10	NUM
cuesj-184	68	157	0.00	0.00	NUM
cuesj-184	68	158	3	3	NUM
cuesj-184	68	159	(	(	PUNCT
cuesj-184	68	160	15	15	NUM
cuesj-184	68	161	%	%	NOUN
cuesj-184	68	162	)	)	PUNCT
cuesj-184	68	163	4	4	NUM
cuesj-184	68	164	(	(	PUNCT
cuesj-184	68	165	20	20	NUM
cuesj-184	68	166	%	%	NOUN
cuesj-184	68	167	)	)	PUNCT
cuesj-184	68	168	8	8	NUM
cuesj-184	68	169	(	(	PUNCT
cuesj-184	68	170	40	40	NUM
cuesj-184	68	171	%	%	NOUN
cuesj-184	68	172	)	)	PUNCT
cuesj-184	68	173	5	5	NUM
cuesj-184	68	174	(	(	PUNCT
cuesj-184	68	175	25	25	NUM
cuesj-184	68	176	%	%	NOUN
cuesj-184	68	177	)	)	PUNCT
cuesj-184	68	178	20	20	NUM
cuesj-184	68	179	(	(	PUNCT
cuesj-184	68	180	100	100	NUM
cuesj-184	68	181	%	%	NOUN
cuesj-184	68	182	)	)	PUNCT
cuesj-184	68	183	0.00	0.00	NUM
cuesj-184	68	184	hbv	hbv	NOUN
cuesj-184	68	185	:	:	PUNCT
cuesj-184	68	186	hepatitis	hepatitis	PROPN
cuesj-184	68	187	b	b	PROPN
cuesj-184	68	188	virus	virus	PROPN
cuesj-184	68	189	,	,	PUNCT
cuesj-184	68	190	pcr	pcr	PROPN
cuesj-184	68	191	:	:	PUNCT
cuesj-184	68	192	polymerase	polymerase	NOUN
cuesj-184	68	193	chain	chain	NOUN
cuesj-184	68	194	reaction	reaction	NOUN
cuesj-184	68	195	,	,	PUNCT
cuesj-184	68	196	hbsag	hbsag	NOUN
cuesj-184	68	197	:	:	PUNCT
cuesj-184	68	198	hepatitis	hepatitis	PROPN
cuesj-184	68	199	b	b	PROPN
cuesj-184	68	200	surface	surface	NOUN
cuesj-184	68	201	antigen	antigen	PROPN
cuesj-184	68	202	khaleel	khaleel	NOUN
cuesj-184	68	203	,	,	PUNCT
cuesj-184	68	204	et	et	PROPN
cuesj-184	68	205	al	al	PROPN
cuesj-184	68	206	.	.	PUNCT
cuesj-184	68	207	:	:	PUNCT
cuesj-184	68	208	significance	significance	NOUN
cuesj-184	68	209	of	of	ADP
cuesj-184	68	210	hbv	hbv	NOUN
cuesj-184	68	211	diagnosis	diagnosis	NOUN
cuesj-184	68	212	by	by	ADP
cuesj-184	68	213	rt	rt	PROPN
cuesj-184	68	214	-	-	PUNCT
cuesj-184	68	215	pcr	pcr	ADJ
cuesj-184	68	216	55	55	NUM
cuesj-184	68	217	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-184	68	218	cuesj	cuesj	NOUN
cuesj-184	68	219	2020	2020	NUM
cuesj-184	68	220	,	,	PUNCT
cuesj-184	68	221	4	4	NUM
cuesj-184	68	222	(	(	PUNCT
cuesj-184	68	223	1	1	NUM
cuesj-184	68	224	):	):	PUNCT
cuesj-184	68	225	52	52	NUM
cuesj-184	68	226	-	-	SYM
cuesj-184	68	227	56	56	NUM
cuesj-184	68	228	disease	disease	NOUN
cuesj-184	68	229	progression.[4	progression.[4	ADV
cuesj-184	68	230	]	]	PUNCT
cuesj-184	68	231	martinot	martinot	ADV
cuesj-184	68	232	-	-	PUNCT
cuesj-184	68	233	peignoux	peignoux	VERB
cuesj-184	68	234	et	et	NOUN
cuesj-184	68	235	al.[39	al.[39	PROPN
cuesj-184	68	236	]	]	PUNCT
cuesj-184	68	237	referred	refer	VERB
cuesj-184	68	238	that	that	SCONJ
cuesj-184	68	239	hbv	hbv	PROPN
cuesj-184	68	240	dna	dna	PROPN
cuesj-184	68	241	diminished	diminish	VERB
cuesj-184	68	242	with	with	ADP
cuesj-184	68	243	time	time	NOUN
cuesj-184	68	244	from	from	ADP
cuesj-184	68	245	seroclearance	seroclearance	NOUN
cuesj-184	68	246	;	;	PUNCT
cuesj-184	68	247	however	however	ADV
cuesj-184	68	248	,	,	PUNCT
cuesj-184	68	249	covalently	covalently	ADV
cuesj-184	68	250	closed	close	VERB
cuesj-184	68	251	circular	circular	ADJ
cuesj-184	68	252	dna	dna	NOUN
cuesj-184	68	253	as	as	ADP
cuesj-184	68	254	integrated	integrate	VERB
cuesj-184	68	255	hbv	hbv	NOUN
cuesj-184	68	256	dna	dna	PROPN
cuesj-184	68	257	remained	remain	VERB
cuesj-184	68	258	detectable	detectable	ADJ
cuesj-184	68	259	in	in	ADP
cuesj-184	68	260	liver	liver	NOUN
cuesj-184	68	261	biopsies	biopsy	NOUN
cuesj-184	68	262	.	.	PUNCT
cuesj-184	69	1	it	it	PRON
cuesj-184	69	2	is	be	AUX
cuesj-184	69	3	thus	thus	ADV
cuesj-184	69	4	critical	critical	ADJ
cuesj-184	69	5	for	for	ADP
cuesj-184	69	6	clinicians	clinician	NOUN
cuesj-184	69	7	to	to	PART
cuesj-184	69	8	be	be	AUX
cuesj-184	69	9	aware	aware	ADJ
cuesj-184	69	10	of	of	ADP
cuesj-184	69	11	the	the	DET
cuesj-184	69	12	significance	significance	NOUN
cuesj-184	69	13	of	of	ADP
cuesj-184	69	14	hbv	hbv	NOUN
cuesj-184	69	15	dna	dna	PROPN
cuesj-184	69	16	serial	serial	ADJ
cuesj-184	69	17	measurement	measurement	NOUN
cuesj-184	69	18	and	and	CCONJ
cuesj-184	69	19	lifelong	lifelong	ADJ
cuesj-184	69	20	follow	follow	NOUN
cuesj-184	69	21	-	-	PUNCT
cuesj-184	69	22	up	up	NOUN
cuesj-184	69	23	to	to	PART
cuesj-184	69	24	establish	establish	VERB
cuesj-184	69	25	and	and	CCONJ
cuesj-184	69	26	confirm	confirm	VERB
cuesj-184	69	27	that	that	PRON
cuesj-184	69	28	inactive	inactive	ADJ
cuesj-184	69	29	carrier	carrier	NOUN
cuesj-184	69	30	condition	condition	NOUN
cuesj-184	69	31	is	be	AUX
cuesj-184	69	32	maintained.[4	maintained.[4	X
cuesj-184	69	33	]	]	PUNCT
cuesj-184	69	34	among	among	ADP
cuesj-184	69	35	major	major	ADJ
cuesj-184	69	36	guidelines	guideline	NOUN
cuesj-184	69	37	,	,	PUNCT
cuesj-184	69	38	if	if	SCONJ
cuesj-184	69	39	hbv	hbv	NOUN
cuesj-184	69	40	dna	dna	PROPN
cuesj-184	69	41	is	be	AUX
cuesj-184	69	42	undetectable	undetectable	ADJ
cuesj-184	69	43	,	,	PUNCT
cuesj-184	69	44	either	either	CCONJ
cuesj-184	69	45	prophylaxis	prophylaxis	ADJ
cuesj-184	69	46	with	with	ADP
cuesj-184	69	47	lamivudine	lamivudine	NOUN
cuesj-184	69	48	or	or	CCONJ
cuesj-184	69	49	strict	strict	ADJ
cuesj-184	69	50	follow	follow	NOUN
cuesj-184	69	51	-	-	PUNCT
cuesj-184	69	52	up	up	NOUN
cuesj-184	69	53	every	every	DET
cuesj-184	69	54	1–3	1–3	NUM
cuesj-184	69	55	months	month	NOUN
cuesj-184	69	56	for	for	ADP
cuesj-184	69	57	alt	alt	VERB
cuesj-184	69	58	and	and	CCONJ
cuesj-184	69	59	hbv	hbv	PROPN
cuesj-184	69	60	dna	dna	PROPN
cuesj-184	69	61	level	level	NOUN
cuesj-184	69	62	is	be	AUX
cuesj-184	69	63	indicated.[13	indicated.[13	NOUN
cuesj-184	69	64	]	]	PUNCT
cuesj-184	69	65	conclusion	conclusion	NOUN
cuesj-184	69	66	serology	serology	NOUN
cuesj-184	69	67	will	will	AUX
cuesj-184	69	68	undoubtedly	undoubtedly	ADV
cuesj-184	69	69	continue	continue	VERB
cuesj-184	69	70	to	to	PART
cuesj-184	69	71	be	be	AUX
cuesj-184	69	72	widely	widely	ADV
cuesj-184	69	73	used	use	VERB
cuesj-184	69	74	in	in	ADP
cuesj-184	69	75	the	the	DET
cuesj-184	69	76	detection	detection	NOUN
cuesj-184	69	77	of	of	ADP
cuesj-184	69	78	hbv	hbv	NOUN
cuesj-184	69	79	infection	infection	NOUN
cuesj-184	69	80	;	;	PUNCT
cuesj-184	69	81	however	however	ADV
cuesj-184	69	82	,	,	PUNCT
cuesj-184	69	83	hbv	hbv	PROPN
cuesj-184	69	84	dna	dna	PROPN
cuesj-184	69	85	assays	assay	NOUN
cuesj-184	69	86	can	can	AUX
cuesj-184	69	87	serve	serve	VERB
cuesj-184	69	88	as	as	ADP
cuesj-184	69	89	an	an	DET
cuesj-184	69	90	important	important	ADJ
cuesj-184	69	91	tool	tool	NOUN
cuesj-184	69	92	,	,	PUNCT
cuesj-184	69	93	especially	especially	ADV
cuesj-184	69	94	in	in	ADP
cuesj-184	69	95	detecting	detect	VERB
cuesj-184	69	96	low	low	ADJ
cuesj-184	69	97	levels	level	NOUN
cuesj-184	69	98	of	of	ADP
cuesj-184	69	99	hbv	hbv	NOUN
cuesj-184	69	100	dna	dna	PROPN
cuesj-184	69	101	and	and	CCONJ
cuesj-184	69	102	in	in	ADP
cuesj-184	69	103	patients	patient	NOUN
cuesj-184	69	104	with	with	ADP
cuesj-184	69	105	the	the	DET
cuesj-184	69	106	past	past	ADJ
cuesj-184	69	107	hbv	hbv	NOUN
cuesj-184	69	108	infection	infection	NOUN
cuesj-184	69	109	.	.	PUNCT
cuesj-184	70	1	data	datum	NOUN
cuesj-184	70	2	from	from	ADP
cuesj-184	70	3	the	the	DET
cuesj-184	70	4	present	present	ADJ
cuesj-184	70	5	study	study	NOUN
cuesj-184	70	6	also	also	ADV
cuesj-184	70	7	concluded	conclude	VERB
cuesj-184	70	8	that	that	SCONJ
cuesj-184	70	9	negative	negative	ADJ
cuesj-184	70	10	or	or	CCONJ
cuesj-184	70	11	undetectable	undetectable	ADJ
cuesj-184	70	12	quantitation	quantitation	NOUN
cuesj-184	70	13	of	of	ADP
cuesj-184	70	14	hbv	hbv	NOUN
cuesj-184	70	15	dna	dna	PROPN
cuesj-184	70	16	level	level	NOUN
cuesj-184	70	17	does	do	AUX
cuesj-184	70	18	not	not	PART
cuesj-184	70	19	exclude	exclude	VERB
cuesj-184	70	20	hbv	hbv	NOUN
cuesj-184	70	21	infection	infection	NOUN
cuesj-184	70	22	;	;	PUNCT
cuesj-184	70	23	as	as	SCONJ
cuesj-184	70	24	the	the	DET
cuesj-184	70	25	level	level	NOUN
cuesj-184	70	26	might	might	AUX
cuesj-184	70	27	fluctuate	fluctuate	VERB
cuesj-184	70	28	in	in	ADP
cuesj-184	70	29	different	different	ADJ
cuesj-184	70	30	phases	phase	NOUN
cuesj-184	70	31	of	of	ADP
cuesj-184	70	32	hbv	hbv	NOUN
cuesj-184	70	33	replication	replication	NOUN
cuesj-184	70	34	.	.	PUNCT
cuesj-184	71	1	this	this	PRON
cuesj-184	71	2	gives	give	VERB
cuesj-184	71	3	an	an	DET
cuesj-184	71	4	impression	impression	NOUN
cuesj-184	71	5	and	and	CCONJ
cuesj-184	71	6	raising	raise	VERB
cuesj-184	71	7	a	a	DET
cuesj-184	71	8	question	question	NOUN
cuesj-184	71	9	about	about	ADP
cuesj-184	71	10	significance	significance	NOUN
cuesj-184	71	11	of	of	ADP
cuesj-184	71	12	replacing	replace	VERB
cuesj-184	71	13	test	test	NOUN
cuesj-184	71	14	for	for	ADP
cuesj-184	71	15	hbsag	hbsag	NOUN
cuesj-184	71	16	with	with	ADP
cuesj-184	71	17	quantitation	quantitation	NOUN
cuesj-184	71	18	of	of	ADP
cuesj-184	71	19	hbv	hbv	PROPN
cuesj-184	71	20	dna	dna	PROPN
cuesj-184	71	21	pcr	pcr	PROPN
cuesj-184	71	22	assay	assay	VERB
cuesj-184	71	23	.	.	PUNCT
cuesj-184	72	1	thus	thus	ADV
cuesj-184	72	2	,	,	PUNCT
cuesj-184	72	3	the	the	DET
cuesj-184	72	4	study	study	NOUN
cuesj-184	72	5	refers	refer	VERB
cuesj-184	72	6	to	to	ADP
cuesj-184	72	7	a	a	DET
cuesj-184	72	8	special	special	ADJ
cuesj-184	72	9	hbv	hbv	NOUN
cuesj-184	72	10	profile	profile	NOUN
cuesj-184	72	11	outside	outside	ADP
cuesj-184	72	12	the	the	DET
cuesj-184	72	13	classical	classical	ADJ
cuesj-184	72	14	pattern	pattern	NOUN
cuesj-184	72	15	.	.	PUNCT
cuesj-184	73	1	references	reference	NOUN
cuesj-184	73	2	1	1	NUM
cuesj-184	73	3	.	.	PUNCT
cuesj-184	73	4	world	world	PROPN
cuesj-184	73	5	health	health	PROPN
cuesj-184	73	6	organization	organization	NOUN
cuesj-184	73	7	.	.	PUNCT
cuesj-184	74	1	“	"	PUNCT
cuesj-184	74	2	world	world	NOUN
cuesj-184	74	3	health	health	NOUN
cuesj-184	74	4	organization	organization	NOUN
cuesj-184	74	5	hepatitis	hepatitis	PROPN
cuesj-184	74	6	b	b	PROPN
cuesj-184	74	7	factsheet	factsheet	NOUN
cuesj-184	74	8	”	"	PUNCT
cuesj-184	74	9	.	.	PUNCT
cuesj-184	75	1	geneva	geneva	PROPN
cuesj-184	75	2	:	:	PUNCT
cuesj-184	75	3	world	world	PROPN
cuesj-184	75	4	health	health	PROPN
cuesj-184	75	5	organization	organization	NOUN
cuesj-184	75	6	,	,	PUNCT
cuesj-184	75	7	2017	2017	NUM
cuesj-184	75	8	.	.	PUNCT
cuesj-184	76	1	2	2	X
cuesj-184	76	2	.	.	PUNCT
cuesj-184	76	3	s.	s.	PROPN
cuesj-184	76	4	baig	baig	PROPN
cuesj-184	76	5	,	,	PUNCT
cuesj-184	76	6	a.	a.	NOUN
cuesj-184	76	7	a.	a.	NOUN
cuesj-184	76	8	siddiqui	siddiqui	PROPN
cuesj-184	76	9	,	,	PUNCT
cuesj-184	76	10	w.	w.	PROPN
cuesj-184	76	11	ahmed	ahmed	PROPN
cuesj-184	76	12	,	,	PUNCT
cuesj-184	76	13	h.	h.	PROPN
cuesj-184	76	14	qureshi	qureshi	PROPN
cuesj-184	76	15	and	and	CCONJ
cuesj-184	76	16	a.	a.	PROPN
cuesj-184	76	17	arif	arif	PROPN
cuesj-184	76	18	.	.	PUNCT
cuesj-184	77	1	“	"	PUNCT
cuesj-184	77	2	the	the	DET
cuesj-184	77	3	association	association	NOUN
cuesj-184	77	4	of	of	ADP
cuesj-184	77	5	complex	complex	ADJ
cuesj-184	77	6	liver	liver	NOUN
cuesj-184	77	7	disorders	disorder	NOUN
cuesj-184	77	8	with	with	ADP
cuesj-184	77	9	hbv	hbv	NOUN
cuesj-184	77	10	genotypes	genotype	NOUN
cuesj-184	77	11	prevalent	prevalent	ADJ
cuesj-184	77	12	in	in	ADP
cuesj-184	77	13	pakistan	pakistan	PROPN
cuesj-184	77	14	”	"	PUNCT
cuesj-184	77	15	.	.	PUNCT
cuesj-184	78	1	virology	virology	NOUN
cuesj-184	78	2	journal	journal	PROPN
cuesj-184	78	3	,	,	PUNCT
cuesj-184	78	4	vol	vol	NOUN
cuesj-184	78	5	.	.	PROPN
cuesj-184	78	6	4	4	NUM
cuesj-184	78	7	,	,	PUNCT
cuesj-184	78	8	no	no	INTJ
cuesj-184	78	9	.	.	NOUN
cuesj-184	78	10	1	1	NUM
cuesj-184	78	11	,	,	PUNCT
cuesj-184	78	12	p.	p.	NOUN
cuesj-184	78	13	128	128	NUM
cuesj-184	78	14	,	,	PUNCT
cuesj-184	78	15	2007	2007	NUM
cuesj-184	78	16	.	.	PUNCT
cuesj-184	79	1	3	3	X
cuesj-184	79	2	.	.	X
cuesj-184	79	3	g.	g.	PROPN
cuesj-184	79	4	fattovich	fattovich	PROPN
cuesj-184	79	5	.	.	PUNCT
cuesj-184	80	1	“	"	PUNCT
cuesj-184	80	2	natural	natural	ADJ
cuesj-184	80	3	history	history	NOUN
cuesj-184	80	4	of	of	ADP
cuesj-184	80	5	hepatitis	hepatitis	PROPN
cuesj-184	80	6	b	b	PROPN
cuesj-184	80	7	”	"	PUNCT
cuesj-184	80	8	.	.	PUNCT
cuesj-184	81	1	journal	journal	PROPN
cuesj-184	81	2	of	of	ADP
cuesj-184	81	3	hepatology	hepatology	NOUN
cuesj-184	81	4	,	,	PUNCT
cuesj-184	81	5	vol	vol	NOUN
cuesj-184	81	6	.	.	PROPN
cuesj-184	81	7	39	39	NUM
cuesj-184	81	8	,	,	PUNCT
cuesj-184	81	9	pp	pp	ADJ
cuesj-184	81	10	.	.	PUNCT
cuesj-184	82	1	50	50	NUM
cuesj-184	82	2	-	-	SYM
cuesj-184	82	3	58	58	NUM
cuesj-184	82	4	,	,	PUNCT
cuesj-184	82	5	2003	2003	NUM
cuesj-184	82	6	.	.	PUNCT
cuesj-184	83	1	4	4	X
cuesj-184	83	2	.	.	X
cuesj-184	83	3	i.	i.	PROPN
cuesj-184	83	4	pita	pita	PROPN
cuesj-184	83	5	,	,	PUNCT
cuesj-184	83	6	a.	a.	PROPN
cuesj-184	83	7	m.	m.	PROPN
cuesj-184	83	8	horta	horta	PROPN
cuesj-184	83	9	-	-	PUNCT
cuesj-184	83	10	vale	vale	NOUN
cuesj-184	83	11	,	,	PUNCT
cuesj-184	83	12	h.	h.	PROPN
cuesj-184	83	13	cardoso	cardoso	PROPN
cuesj-184	83	14	and	and	CCONJ
cuesj-184	83	15	g.	g.	PROPN
cuesj-184	83	16	macedo	macedo	PROPN
cuesj-184	83	17	.	.	PUNCT
cuesj-184	84	1	“	"	PUNCT
cuesj-184	84	2	hepatitis	hepatitis	NOUN
cuesj-184	84	3	b	b	NOUN
cuesj-184	84	4	inactive	inactive	ADJ
cuesj-184	84	5	carriers	carrier	NOUN
cuesj-184	84	6	:	:	PUNCT
cuesj-184	84	7	an	an	DET
cuesj-184	84	8	overlooked	overlook	VERB
cuesj-184	84	9	population	population	NOUN
cuesj-184	84	10	?	?	PUNCT
cuesj-184	84	11	”	"	PUNCT
cuesj-184	85	1	ge	ge	PROPN
cuesj-184	85	2	portuguese	portuguese	PROPN
cuesj-184	85	3	journal	journal	PROPN
cuesj-184	85	4	of	of	ADP
cuesj-184	85	5	gastroenterology	gastroenterology	NOUN
cuesj-184	85	6	,	,	PUNCT
cuesj-184	85	7	vol	vol	NOUN
cuesj-184	85	8	.	.	PROPN
cuesj-184	85	9	21	21	NUM
cuesj-184	85	10	,	,	PUNCT
cuesj-184	85	11	no	no	INTJ
cuesj-184	85	12	.	.	NOUN
cuesj-184	85	13	6	6	NUM
cuesj-184	85	14	,	,	PUNCT
cuesj-184	85	15	pp	pp	ADJ
cuesj-184	85	16	.	.	PUNCT
cuesj-184	86	1	241	241	NUM
cuesj-184	86	2	-	-	SYM
cuesj-184	86	3	249	249	NUM
cuesj-184	86	4	,	,	PUNCT
cuesj-184	86	5	2014	2014	NUM
cuesj-184	86	6	.	.	PUNCT
cuesj-184	87	1	5	5	NUM
cuesj-184	87	2	.	.	X
cuesj-184	87	3	l.	l.	PROPN
cuesj-184	87	4	m.	m.	PROPN
cuesj-184	87	5	villar	villar	PROPN
cuesj-184	87	6	,	,	PUNCT
cuesj-184	87	7	h.	h.	PROPN
cuesj-184	87	8	m.	m.	PROPN
cuesj-184	87	9	cruz	cruz	PROPN
cuesj-184	87	10	,	,	PUNCT
cuesj-184	87	11	j.	j.	PROPN
cuesj-184	87	12	r.	r.	PROPN
cuesj-184	87	13	barbosa	barbosa	PROPN
cuesj-184	87	14	,	,	PUNCT
cuesj-184	87	15	c.	c.	PROPN
cuesj-184	87	16	s.	s.	PROPN
cuesj-184	87	17	bezerra	bezerra	PROPN
cuesj-184	87	18	,	,	PUNCT
cuesj-184	87	19	m.	m.	NOUN
cuesj-184	87	20	m.	m.	PROPN
cuesj-184	87	21	portilho	portilho	PROPN
cuesj-184	87	22	and	and	CCONJ
cuesj-184	87	23	l.	l.	PROPN
cuesj-184	87	24	de	de	PROPN
cuesj-184	87	25	paula	paula	PROPN
cuesj-184	87	26	scalioni	scalioni	PROPN
cuesj-184	87	27	.	.	PUNCT
cuesj-184	88	1	“	"	PUNCT
cuesj-184	88	2	update	update	NOUN
cuesj-184	88	3	on	on	ADP
cuesj-184	88	4	hepatitis	hepatitis	PROPN
cuesj-184	88	5	b	b	PROPN
cuesj-184	88	6	and	and	CCONJ
cuesj-184	88	7	c	c	PROPN
cuesj-184	88	8	virus	virus	NOUN
cuesj-184	88	9	diagnosis	diagnosis	NOUN
cuesj-184	88	10	”	"	PUNCT
cuesj-184	88	11	.	.	PUNCT
cuesj-184	89	1	world	world	PROPN
cuesj-184	89	2	journal	journal	PROPN
cuesj-184	89	3	of	of	ADP
cuesj-184	89	4	virology	virology	NOUN
cuesj-184	89	5	,	,	PUNCT
cuesj-184	89	6	vol	vol	NOUN
cuesj-184	89	7	.	.	PROPN
cuesj-184	89	8	4	4	NUM
cuesj-184	89	9	,	,	PUNCT
cuesj-184	89	10	no	no	INTJ
cuesj-184	89	11	.	.	NOUN
cuesj-184	89	12	4	4	NUM
cuesj-184	89	13	,	,	PUNCT
cuesj-184	89	14	p.	p.	NOUN
cuesj-184	89	15	323	323	NUM
cuesj-184	89	16	,	,	PUNCT
cuesj-184	89	17	2015	2015	NUM
cuesj-184	89	18	.	.	PUNCT
cuesj-184	90	1	6	6	NUM
cuesj-184	90	2	.	.	PUNCT
cuesj-184	90	3	i.	i.	PROPN
cuesj-184	90	4	j.	j.	PROPN
cuesj-184	90	5	radii	radii	PROPN
cuesj-184	90	6	and	and	CCONJ
cuesj-184	90	7	a.	a.	NOUN
cuesj-184	90	8	m.	m.	NOUN
cuesj-184	90	9	saud	saud	PROPN
cuesj-184	90	10	.	.	PUNCT
cuesj-184	91	1	“	"	PUNCT
cuesj-184	91	2	comparative	comparative	ADJ
cuesj-184	91	3	assessment	assessment	NOUN
cuesj-184	91	4	between	between	ADP
cuesj-184	91	5	serological	serological	ADJ
cuesj-184	91	6	and	and	CCONJ
cuesj-184	91	7	molecular	molecular	ADJ
cuesj-184	91	8	diagnosis	diagnosis	NOUN
cuesj-184	91	9	for	for	ADP
cuesj-184	91	10	patients	patient	NOUN
cuesj-184	91	11	groups	group	NOUN
cuesj-184	91	12	with	with	ADP
cuesj-184	91	13	hepatitis	hepatitis	PROPN
cuesj-184	91	14	b	b	PROPN
cuesj-184	91	15	virus	virus	PROPN
cuesj-184	91	16	”	"	PUNCT
cuesj-184	91	17	.	.	PUNCT
cuesj-184	92	1	international	international	ADJ
cuesj-184	92	2	journal	journal	PROPN
cuesj-184	92	3	of	of	ADP
cuesj-184	92	4	current	current	ADJ
cuesj-184	92	5	microbiology	microbiology	NOUN
cuesj-184	92	6	and	and	CCONJ
cuesj-184	92	7	applied	apply	VERB
cuesj-184	92	8	science	science	NOUN
cuesj-184	92	9	,	,	PUNCT
cuesj-184	92	10	vol	vol	NOUN
cuesj-184	92	11	.	.	PROPN
cuesj-184	92	12	6	6	NUM
cuesj-184	92	13	,	,	PUNCT
cuesj-184	92	14	no	no	INTJ
cuesj-184	92	15	.	.	NOUN
cuesj-184	92	16	3	3	NUM
cuesj-184	92	17	,	,	PUNCT
cuesj-184	92	18	pp	pp	ADJ
cuesj-184	92	19	.	.	PUNCT
cuesj-184	93	1	742	742	NUM
cuesj-184	93	2	-	-	SYM
cuesj-184	93	3	748	748	NUM
cuesj-184	93	4	,	,	PUNCT
cuesj-184	93	5	2017	2017	NUM
cuesj-184	93	6	.	.	PUNCT
cuesj-184	94	1	7	7	X
cuesj-184	94	2	.	.	PUNCT
cuesj-184	94	3	t.	t.	PROPN
cuesj-184	94	4	c.	c.	PROPN
cuesj-184	94	5	tseng	tseng	PROPN
cuesj-184	94	6	,	,	PUNCT
cuesj-184	94	7	c.	c.	PROPN
cuesj-184	94	8	j.	j.	PROPN
cuesj-184	94	9	liu	liu	PROPN
cuesj-184	94	10	,	,	PUNCT
cuesj-184	94	11	h.	h.	PROPN
cuesj-184	94	12	c.	c.	PROPN
cuesj-184	94	13	yang	yang	PROPN
cuesj-184	94	14	,	,	PUNCT
cuesj-184	94	15	t.	t.	PROPN
cuesj-184	94	16	h.	h.	PROPN
cuesj-184	94	17	su	su	PROPN
cuesj-184	94	18	,	,	PUNCT
cuesj-184	94	19	c.	c.	PROPN
cuesj-184	94	20	c.	c.	PROPN
cuesj-184	94	21	wang	wang	PROPN
cuesj-184	94	22	,	,	PUNCT
cuesj-184	94	23	c.	c.	PROPN
cuesj-184	94	24	l.	l.	PROPN
cuesj-184	94	25	chen	chen	PROPN
cuesj-184	94	26	and	and	CCONJ
cuesj-184	94	27	j.	j.	PROPN
cuesj-184	94	28	h.	h.	PROPN
cuesj-184	94	29	kao	kao	PROPN
cuesj-184	94	30	.	.	PUNCT
cuesj-184	95	1	“	"	PUNCT
cuesj-184	95	2	high	high	ADJ
cuesj-184	95	3	levels	level	NOUN
cuesj-184	95	4	of	of	ADP
cuesj-184	95	5	hepatitis	hepatitis	PROPN
cuesj-184	95	6	b	b	PROPN
cuesj-184	95	7	surface	surface	NOUN
cuesj-184	95	8	antigen	antigen	NOUN
cuesj-184	95	9	increase	increase	VERB
cuesj-184	95	10	risk	risk	NOUN
cuesj-184	95	11	of	of	ADP
cuesj-184	95	12	hepatocellular	hepatocellular	ADJ
cuesj-184	95	13	carcinoma	carcinoma	NOUN
cuesj-184	95	14	in	in	ADP
cuesj-184	95	15	patients	patient	NOUN
cuesj-184	95	16	with	with	ADP
cuesj-184	95	17	low	low	ADJ
cuesj-184	95	18	hbv	hbv	NOUN
cuesj-184	95	19	load	load	NOUN
cuesj-184	95	20	”	"	PUNCT
cuesj-184	95	21	.	.	PUNCT
cuesj-184	96	1	gastroenterology	gastroenterology	NOUN
cuesj-184	96	2	,	,	PUNCT
cuesj-184	96	3	vol	vol	NOUN
cuesj-184	96	4	.	.	PROPN
cuesj-184	96	5	142	142	NUM
cuesj-184	96	6	,	,	PUNCT
cuesj-184	96	7	no	no	INTJ
cuesj-184	96	8	.	.	NOUN
cuesj-184	96	9	5	5	NUM
cuesj-184	96	10	,	,	PUNCT
cuesj-184	96	11	pp	pp	ADJ
cuesj-184	96	12	.	.	PUNCT
cuesj-184	97	1	1140	1140	NUM
cuesj-184	97	2	-	-	SYM
cuesj-184	97	3	1149	1149	NUM
cuesj-184	97	4	,	,	PUNCT
cuesj-184	97	5	2012	2012	NUM
cuesj-184	97	6	.	.	PUNCT
cuesj-184	98	1	8	8	X
cuesj-184	98	2	.	.	X
cuesj-184	98	3	m.	m.	PROPN
cuesj-184	98	4	kawanaka	kawanaka	PROPN
cuesj-184	98	5	,	,	PUNCT
cuesj-184	98	6	k.	k.	PROPN
cuesj-184	98	7	nishino	nishino	PROPN
cuesj-184	98	8	,	,	PUNCT
cuesj-184	98	9	j.	j.	PROPN
cuesj-184	98	10	nakamura	nakamura	PROPN
cuesj-184	98	11	,	,	PUNCT
cuesj-184	98	12	t.	t.	NOUN
cuesj-184	98	13	oka	oka	PROPN
cuesj-184	98	14	,	,	PUNCT
cuesj-184	98	15	n.	n.	PROPN
cuesj-184	98	16	urata	urata	PROPN
cuesj-184	98	17	,	,	PUNCT
cuesj-184	98	18	d.	d.	PROPN
cuesj-184	98	19	goto	goto	PROPN
cuesj-184	98	20	and	and	CCONJ
cuesj-184	98	21	g.	g.	PROPN
cuesj-184	98	22	yamada	yamada	PROPN
cuesj-184	98	23	.	.	PUNCT
cuesj-184	99	1	“	"	PUNCT
cuesj-184	99	2	quantitative	quantitative	ADJ
cuesj-184	99	3	levels	level	NOUN
cuesj-184	99	4	of	of	ADP
cuesj-184	99	5	hepatitis	hepatitis	PROPN
cuesj-184	99	6	b	b	PROPN
cuesj-184	99	7	virus	virus	NOUN
cuesj-184	99	8	dna	dna	NOUN
cuesj-184	99	9	and	and	CCONJ
cuesj-184	99	10	surface	surface	NOUN
cuesj-184	99	11	antigen	antigen	NOUN
cuesj-184	99	12	and	and	CCONJ
cuesj-184	99	13	the	the	DET
cuesj-184	99	14	risk	risk	NOUN
cuesj-184	99	15	of	of	ADP
cuesj-184	99	16	hepatocellular	hepatocellular	ADJ
cuesj-184	99	17	carcinoma	carcinoma	NOUN
cuesj-184	99	18	in	in	ADP
cuesj-184	99	19	patients	patient	NOUN
cuesj-184	99	20	with	with	ADP
cuesj-184	99	21	hepatitis	hepatitis	PROPN
cuesj-184	99	22	b	b	PROPN
cuesj-184	99	23	receiving	receive	VERB
cuesj-184	99	24	long	long	ADJ
cuesj-184	99	25	-	-	PUNCT
cuesj-184	99	26	term	term	NOUN
cuesj-184	99	27	nucleos	nucleo	NOUN
cuesj-184	99	28	(	(	PUNCT
cuesj-184	99	29	t	t	NOUN
cuesj-184	99	30	)	)	PUNCT
cuesj-184	99	31	ide	ide	NOUN
cuesj-184	99	32	analogue	analogue	NOUN
cuesj-184	99	33	therapy	therapy	NOUN
cuesj-184	99	34	”	"	PUNCT
cuesj-184	99	35	.	.	PUNCT
cuesj-184	100	1	liver	liver	NOUN
cuesj-184	100	2	cancer	cancer	NOUN
cuesj-184	100	3	,	,	PUNCT
cuesj-184	100	4	vol	vol	NOUN
cuesj-184	100	5	.	.	PROPN
cuesj-184	101	1	3	3	NUM
cuesj-184	101	2	,	,	PUNCT
cuesj-184	101	3	no	no	INTJ
cuesj-184	101	4	.	.	NOUN
cuesj-184	101	5	1	1	NUM
cuesj-184	101	6	,	,	PUNCT
cuesj-184	101	7	pp	pp	ADJ
cuesj-184	101	8	.	.	PUNCT
cuesj-184	102	1	41	41	NUM
cuesj-184	102	2	-	-	SYM
cuesj-184	102	3	52	52	NUM
cuesj-184	102	4	,	,	PUNCT
cuesj-184	102	5	2014	2014	NUM
cuesj-184	102	6	.	.	PUNCT
cuesj-184	103	1	9	9	NUM
cuesj-184	103	2	.	.	PUNCT
cuesj-184	103	3	t.	t.	PROPN
cuesj-184	103	4	c.	c.	PROPN
cuesj-184	103	5	tseng	tseng	PROPN
cuesj-184	103	6	,	,	PUNCT
cuesj-184	103	7	c.	c.	PROPN
cuesj-184	103	8	j.	j.	PROPN
cuesj-184	103	9	liu	liu	PROPN
cuesj-184	103	10	,	,	PUNCT
cuesj-184	103	11	t.	t.	PROPN
cuesj-184	103	12	h.	h.	PROPN
cuesj-184	103	13	su	su	PROPN
cuesj-184	103	14	,	,	PUNCT
cuesj-184	103	15	c.	c.	PROPN
cuesj-184	103	16	c.	c.	PROPN
cuesj-184	103	17	wang	wang	PROPN
cuesj-184	103	18	,	,	PUNCT
cuesj-184	103	19	c.	c.	PROPN
cuesj-184	103	20	l.	l.	PROPN
cuesj-184	103	21	chen	chen	PROPN
cuesj-184	103	22	,	,	PUNCT
cuesj-184	103	23	p.	p.	PROPN
cuesj-184	103	24	j.	j.	PROPN
cuesj-184	103	25	chen	chen	PROPN
cuesj-184	103	26	and	and	CCONJ
cuesj-184	103	27	j.	j.	PROPN
cuesj-184	103	28	h.	h.	PROPN
cuesj-184	103	29	kao	kao	PROPN
cuesj-184	103	30	.	.	PUNCT
cuesj-184	104	1	“	"	PUNCT
cuesj-184	104	2	serum	serum	VERB
cuesj-184	104	3	hepatitis	hepatitis	PROPN
cuesj-184	104	4	b	b	PROPN
cuesj-184	104	5	surface	surface	NOUN
cuesj-184	104	6	antigen	antigen	PROPN
cuesj-184	104	7	levels	level	NOUN
cuesj-184	104	8	predict	predict	VERB
cuesj-184	104	9	surface	surface	NOUN
cuesj-184	104	10	antigen	antigen	ADJ
cuesj-184	104	11	loss	loss	NOUN
cuesj-184	104	12	in	in	ADP
cuesj-184	104	13	hepatitis	hepatitis	PROPN
cuesj-184	104	14	b	b	PROPN
cuesj-184	105	1	e	e	PROPN
cuesj-184	105	2	antigen	antigen	PROPN
cuesj-184	105	3	seroconverts	seroconvert	NOUN
cuesj-184	105	4	”	"	PUNCT
cuesj-184	105	5	.	.	PUNCT
cuesj-184	106	1	gastroenterology	gastroenterology	NOUN
cuesj-184	106	2	,	,	PUNCT
cuesj-184	106	3	vol	vol	NOUN
cuesj-184	106	4	.	.	PROPN
cuesj-184	106	5	141	141	NUM
cuesj-184	106	6	,	,	PUNCT
cuesj-184	106	7	no	no	INTJ
cuesj-184	106	8	.	.	NOUN
cuesj-184	106	9	2	2	NUM
cuesj-184	106	10	,	,	PUNCT
cuesj-184	106	11	pp	pp	ADJ
cuesj-184	106	12	.	.	PUNCT
cuesj-184	107	1	517	517	NUM
cuesj-184	107	2	-	-	SYM
cuesj-184	107	3	525	525	NUM
cuesj-184	107	4	,	,	PUNCT
cuesj-184	107	5	2011	2011	NUM
cuesj-184	107	6	.	.	PUNCT
cuesj-184	108	1	10	10	NUM
cuesj-184	108	2	.	.	PUNCT
cuesj-184	109	1	k.	k.	PROPN
cuesj-184	109	2	m.	m.	PROPN
cuesj-184	109	3	weinberger	weinberger	PROPN
cuesj-184	109	4	,	,	PUNCT
cuesj-184	109	5	e.	e.	PROPN
cuesj-184	109	6	wiedenmann	wiedenmann	PROPN
cuesj-184	109	7	,	,	PUNCT
cuesj-184	109	8	s.	s.	PROPN
cuesj-184	109	9	böhm	böhm	PROPN
cuesj-184	109	10	and	and	CCONJ
cuesj-184	109	11	w.	w.	PROPN
cuesj-184	109	12	jilg	jilg	PROPN
cuesj-184	109	13	.	.	PUNCT
cuesj-184	110	1	“	"	PUNCT
cuesj-184	110	2	sensitive	sensitive	ADJ
cuesj-184	110	3	and	and	CCONJ
cuesj-184	110	4	accurate	accurate	ADJ
cuesj-184	110	5	quantitation	quantitation	NOUN
cuesj-184	110	6	of	of	ADP
cuesj-184	110	7	hepatitis	hepatitis	PROPN
cuesj-184	110	8	b	b	PROPN
cuesj-184	110	9	virus	virus	NOUN
cuesj-184	110	10	dna	dna	PROPN
cuesj-184	110	11	using	use	VERB
cuesj-184	110	12	a	a	DET
cuesj-184	110	13	kinetic	kinetic	ADJ
cuesj-184	110	14	fluorescence	fluorescence	NOUN
cuesj-184	110	15	detection	detection	NOUN
cuesj-184	110	16	system	system	NOUN
cuesj-184	110	17	(	(	PUNCT
cuesj-184	110	18	taqman	taqman	NOUN
cuesj-184	110	19	pcr	pcr	NOUN
cuesj-184	110	20	)	)	PUNCT
cuesj-184	110	21	”	"	PUNCT
cuesj-184	110	22	.	.	PUNCT
cuesj-184	111	1	journal	journal	PROPN
cuesj-184	111	2	of	of	ADP
cuesj-184	111	3	virological	virological	ADJ
cuesj-184	111	4	methods	method	NOUN
cuesj-184	111	5	,	,	PUNCT
cuesj-184	111	6	vol	vol	NOUN
cuesj-184	111	7	.	.	PROPN
cuesj-184	111	8	85	85	NUM
cuesj-184	111	9	,	,	PUNCT
cuesj-184	111	10	no	no	NOUN
cuesj-184	111	11	.	.	NOUN
cuesj-184	111	12	1	1	NUM
cuesj-184	111	13	-	-	SYM
cuesj-184	111	14	2	2	NUM
cuesj-184	111	15	,	,	PUNCT
cuesj-184	111	16	pp	pp	ADJ
cuesj-184	111	17	.	.	PUNCT
cuesj-184	112	1	75	75	NUM
cuesj-184	112	2	-	-	SYM
cuesj-184	112	3	82	82	NUM
cuesj-184	112	4	,	,	PUNCT
cuesj-184	112	5	2000	2000	NUM
cuesj-184	112	6	.	.	PUNCT
cuesj-184	113	1	11	11	NUM
cuesj-184	113	2	.	.	PUNCT
cuesj-184	114	1	h.	h.	PROPN
cuesj-184	114	2	j.	j.	PROPN
cuesj-184	114	3	lee	lee	PROPN
cuesj-184	114	4	,	,	PUNCT
cuesj-184	114	5	s.	s.	PROPN
cuesj-184	114	6	y.	y.	PROPN
cuesj-184	114	7	kim	kim	PROPN
cuesj-184	114	8	,	,	PUNCT
cuesj-184	114	9	s.	s.	PROPN
cuesj-184	114	10	m.	m.	PROPN
cuesj-184	114	11	lee	lee	PROPN
cuesj-184	114	12	,	,	PUNCT
cuesj-184	114	13	j.	j.	PROPN
cuesj-184	114	14	heo	heo	PROPN
cuesj-184	114	15	,	,	PUNCT
cuesj-184	114	16	h.	h.	PROPN
cuesj-184	114	17	h.	h.	PROPN
cuesj-184	114	18	kim	kim	PROPN
cuesj-184	114	19	,	,	PUNCT
cuesj-184	114	20	c.	c.	PROPN
cuesj-184	114	21	l.	l.	PROPN
cuesj-184	114	22	chang	chang	PROPN
cuesj-184	114	23	and	and	CCONJ
cuesj-184	114	24	h.	h.	PROPN
cuesj-184	114	25	c.	c.	PROPN
cuesj-184	114	26	son	son	PROPN
cuesj-184	114	27	.	.	PUNCT
cuesj-184	115	1	“	"	PUNCT
cuesj-184	115	2	elecsys	elecsys	VERB
cuesj-184	115	3	hepatitis	hepatitis	PROPN
cuesj-184	115	4	b	b	PROPN
cuesj-184	115	5	surface	surface	NOUN
cuesj-184	115	6	antigen	antigen	NOUN
cuesj-184	115	7	quantitative	quantitative	ADJ
cuesj-184	115	8	assay	assay	NOUN
cuesj-184	115	9	:	:	PUNCT
cuesj-184	115	10	performance	performance	NOUN
cuesj-184	115	11	evaluation	evaluation	NOUN
cuesj-184	115	12	and	and	CCONJ
cuesj-184	115	13	correlation	correlation	NOUN
cuesj-184	115	14	with	with	ADP
cuesj-184	115	15	hepatitis	hepatitis	PROPN
cuesj-184	115	16	b	b	PROPN
cuesj-184	115	17	virus	virus	NOUN
cuesj-184	115	18	dna	dna	NOUN
cuesj-184	115	19	during	during	ADP
cuesj-184	115	20	96	96	NUM
cuesj-184	115	21	weeks	week	NOUN
cuesj-184	115	22	of	of	ADP
cuesj-184	115	23	follow	follow	NOUN
cuesj-184	115	24	-	-	PUNCT
cuesj-184	115	25	up	up	NOUN
cuesj-184	115	26	in	in	ADP
cuesj-184	115	27	chronic	chronic	ADJ
cuesj-184	115	28	hepatitis	hepatitis	PROPN
cuesj-184	115	29	b	b	PROPN
cuesj-184	115	30	patients	patient	NOUN
cuesj-184	115	31	”	"	PUNCT
cuesj-184	115	32	.	.	PUNCT
cuesj-184	116	1	annals	annal	NOUN
cuesj-184	116	2	of	of	ADP
cuesj-184	116	3	laboratory	laboratory	NOUN
cuesj-184	116	4	medicine	medicine	NOUN
cuesj-184	116	5	,	,	PUNCT
cuesj-184	116	6	vol	vol	NOUN
cuesj-184	116	7	.	.	PROPN
cuesj-184	116	8	32	32	NUM
cuesj-184	116	9	,	,	PUNCT
cuesj-184	116	10	no	no	INTJ
cuesj-184	116	11	.	.	NOUN
cuesj-184	116	12	6	6	NUM
cuesj-184	116	13	,	,	PUNCT
cuesj-184	116	14	pp	pp	ADJ
cuesj-184	116	15	.	.	PUNCT
cuesj-184	117	1	420	420	NUM
cuesj-184	117	2	-	-	SYM
cuesj-184	117	3	425	425	NUM
cuesj-184	117	4	,	,	PUNCT
cuesj-184	117	5	2012	2012	NUM
cuesj-184	117	6	.	.	PUNCT
cuesj-184	118	1	12	12	NUM
cuesj-184	118	2	.	.	PUNCT
cuesj-184	118	3	a.	a.	PROPN
cuesj-184	118	4	s.	s.	PROPN
cuesj-184	118	5	lok	lok	PROPN
cuesj-184	118	6	and	and	CCONJ
cuesj-184	118	7	b.	b.	PROPN
cuesj-184	118	8	j.	j.	PROPN
cuesj-184	118	9	mcmahon	mcmahon	PROPN
cuesj-184	118	10	.	.	PUNCT
cuesj-184	119	1	“	"	PUNCT
cuesj-184	119	2	chronic	chronic	ADJ
cuesj-184	119	3	hepatitis	hepatitis	NOUN
cuesj-184	119	4	b	b	NOUN
cuesj-184	119	5	:	:	PUNCT
cuesj-184	119	6	update	update	NOUN
cuesj-184	119	7	2009	2009	NUM
cuesj-184	119	8	”	"	PUNCT
cuesj-184	119	9	.	.	PUNCT
cuesj-184	120	1	hepatology	hepatology	NOUN
cuesj-184	120	2	,	,	PUNCT
cuesj-184	120	3	vol	vol	NOUN
cuesj-184	120	4	.	.	PROPN
cuesj-184	120	5	50	50	NUM
cuesj-184	120	6	,	,	PUNCT
cuesj-184	120	7	no	no	INTJ
cuesj-184	120	8	.	.	NOUN
cuesj-184	120	9	3	3	NUM
cuesj-184	120	10	,	,	PUNCT
cuesj-184	120	11	pp	pp	ADJ
cuesj-184	120	12	.	.	PUNCT
cuesj-184	121	1	661	661	NUM
cuesj-184	121	2	-	-	SYM
cuesj-184	121	3	662	662	NUM
cuesj-184	121	4	,	,	PUNCT
cuesj-184	121	5	2009	2009	NUM
cuesj-184	121	6	.	.	PUNCT
cuesj-184	122	1	13	13	NUM
cuesj-184	122	2	.	.	PUNCT
cuesj-184	122	3	european	european	PROPN
cuesj-184	122	4	association	association	PROPN
cuesj-184	122	5	for	for	ADP
cuesj-184	122	6	the	the	DET
cuesj-184	122	7	study	study	NOUN
cuesj-184	122	8	of	of	ADP
cuesj-184	122	9	the	the	DET
cuesj-184	122	10	liver	liver	NOUN
cuesj-184	122	11	.	.	PUNCT
cuesj-184	123	1	“	"	PUNCT
cuesj-184	123	2	easl	easl	ADJ
cuesj-184	123	3	clinical	clinical	ADJ
cuesj-184	123	4	practice	practice	NOUN
cuesj-184	123	5	guidelines	guideline	NOUN
cuesj-184	123	6	:	:	PUNCT
cuesj-184	123	7	management	management	NOUN
cuesj-184	123	8	of	of	ADP
cuesj-184	123	9	chronic	chronic	ADJ
cuesj-184	123	10	hepatitis	hepatitis	PROPN
cuesj-184	123	11	b	b	PROPN
cuesj-184	123	12	virus	virus	NOUN
cuesj-184	123	13	infection	infection	NOUN
cuesj-184	123	14	”	"	PUNCT
cuesj-184	123	15	.	.	PUNCT
cuesj-184	124	1	journal	journal	PROPN
cuesj-184	124	2	of	of	ADP
cuesj-184	124	3	hepatology	hepatology	NOUN
cuesj-184	124	4	,	,	PUNCT
cuesj-184	124	5	vol	vol	NOUN
cuesj-184	124	6	.	.	PROPN
cuesj-184	124	7	57	57	NUM
cuesj-184	124	8	,	,	PUNCT
cuesj-184	124	9	no	no	INTJ
cuesj-184	124	10	.	.	NOUN
cuesj-184	124	11	1	1	NUM
cuesj-184	124	12	,	,	PUNCT
cuesj-184	124	13	pp	pp	ADJ
cuesj-184	124	14	.	.	PUNCT
cuesj-184	125	1	167	167	NUM
cuesj-184	125	2	-	-	SYM
cuesj-184	125	3	185	185	NUM
cuesj-184	125	4	,	,	PUNCT
cuesj-184	125	5	2012	2012	NUM
cuesj-184	125	6	.	.	PUNCT
cuesj-184	126	1	14	14	NUM
cuesj-184	126	2	.	.	PUNCT
cuesj-184	127	1	y.	y.	PROPN
cuesj-184	127	2	f.	f.	PROPN
cuesj-184	127	3	liaw	liaw	PROPN
cuesj-184	127	4	,	,	PUNCT
cuesj-184	127	5	j.	j.	PROPN
cuesj-184	127	6	h.	h.	PROPN
cuesj-184	127	7	kao	kao	PROPN
cuesj-184	127	8	,	,	PUNCT
cuesj-184	127	9	t.	t.	PROPN
cuesj-184	127	10	piratvisuth	piratvisuth	NOUN
cuesj-184	127	11	,	,	PUNCT
cuesj-184	127	12	h.	h.	PROPN
cuesj-184	127	13	l.	l.	PROPN
cuesj-184	127	14	y.	y.	PROPN
cuesj-184	127	15	chan	chan	PROPN
cuesj-184	127	16	,	,	PUNCT
cuesj-184	127	17	r.	r.	PROPN
cuesj-184	127	18	n.	n.	PROPN
cuesj-184	127	19	chien	chien	PROPN
cuesj-184	127	20	,	,	PUNCT
cuesj-184	127	21	c.	c.	PROPN
cuesj-184	127	22	j.	j.	PROPN
cuesj-184	127	23	liu	liu	PROPN
cuesj-184	127	24	and	and	CCONJ
cuesj-184	127	25	d.	d.	PROPN
cuesj-184	127	26	amarapurkar	amarapurkar	PROPN
cuesj-184	127	27	.	.	PUNCT
cuesj-184	128	1	“	"	PUNCT
cuesj-184	128	2	asian	asian	ADJ
cuesj-184	128	3	-	-	PUNCT
cuesj-184	128	4	pacific	pacific	ADJ
cuesj-184	128	5	consensus	consensus	NOUN
cuesj-184	128	6	statement	statement	NOUN
cuesj-184	128	7	on	on	ADP
cuesj-184	128	8	the	the	DET
cuesj-184	128	9	management	management	NOUN
cuesj-184	128	10	of	of	ADP
cuesj-184	128	11	chronic	chronic	ADJ
cuesj-184	128	12	hepatitis	hepatitis	PROPN
cuesj-184	128	13	b	b	PROPN
cuesj-184	128	14	:	:	PUNCT
cuesj-184	128	15	a	a	DET
cuesj-184	128	16	2012	2012	NUM
cuesj-184	128	17	update	update	NOUN
cuesj-184	128	18	”	"	PUNCT
cuesj-184	128	19	.	.	PUNCT
cuesj-184	129	1	hepatology	hepatology	PROPN
cuesj-184	129	2	international	international	PROPN
cuesj-184	129	3	,	,	PUNCT
cuesj-184	129	4	vol	vol	NOUN
cuesj-184	129	5	.	.	PROPN
cuesj-184	129	6	6	6	NUM
cuesj-184	129	7	,	,	PUNCT
cuesj-184	129	8	no	no	INTJ
cuesj-184	129	9	.	.	NOUN
cuesj-184	129	10	3	3	NUM
cuesj-184	129	11	,	,	PUNCT
cuesj-184	129	12	pp	pp	ADJ
cuesj-184	129	13	.	.	PUNCT
cuesj-184	130	1	531	531	NUM
cuesj-184	130	2	-	-	SYM
cuesj-184	130	3	561	561	NUM
cuesj-184	130	4	,	,	PUNCT
cuesj-184	130	5	2012	2012	NUM
cuesj-184	130	6	.	.	PUNCT
cuesj-184	131	1	15	15	NUM
cuesj-184	131	2	.	.	PUNCT
cuesj-184	132	1	h.	h.	PROPN
cuesj-184	132	2	lik	lik	PROPN
cuesj-184	132	3	-	-	PUNCT
cuesj-184	132	4	yuen	yuen	PROPN
cuesj-184	132	5	chan	chan	PROPN
cuesj-184	132	6	,	,	PUNCT
cuesj-184	132	7	g.	g.	PROPN
cuesj-184	132	8	lai	lai	PROPN
cuesj-184	132	9	-	-	PUNCT
cuesj-184	132	10	hung	hung	PROPN
cuesj-184	132	11	wong	wong	PROPN
cuesj-184	132	12	,	,	PUNCT
cuesj-184	132	13	c.	c.	PROPN
cuesj-184	132	14	h.	h.	PROPN
cuesj-184	132	15	tse	tse	PROPN
cuesj-184	132	16	,	,	PUNCT
cuesj-184	132	17	h.	h.	PROPN
cuesj-184	132	18	y.	y.	PROPN
cuesj-184	132	19	chan	chan	PROPN
cuesj-184	132	20	and	and	CCONJ
cuesj-184	132	21	v.	v.	ADP
cuesj-184	132	22	wai	wai	PROPN
cuesj-184	132	23	-	-	PUNCT
cuesj-184	132	24	sun	sun	PROPN
cuesj-184	132	25	wong	wong	PROPN
cuesj-184	132	26	.	.	PUNCT
cuesj-184	133	1	“	"	PUNCT
cuesj-184	133	2	viral	viral	ADJ
cuesj-184	133	3	determinants	determinant	NOUN
cuesj-184	133	4	of	of	ADP
cuesj-184	133	5	hepatitis	hepatitis	PROPN
cuesj-184	133	6	b	b	PROPN
cuesj-184	133	7	surface	surface	NOUN
cuesj-184	133	8	antigen	antigen	ADJ
cuesj-184	133	9	seroclearance	seroclearance	NOUN
cuesj-184	133	10	in	in	ADP
cuesj-184	133	11	hepatitis	hepatitis	PROPN
cuesj-184	133	12	b	b	PROPN
cuesj-184	133	13	e	e	ADP
cuesj-184	133	14	antigen	antigen	ADV
cuesj-184	133	15	-	-	PUNCT
cuesj-184	133	16	negative	negative	ADJ
cuesj-184	133	17	chronic	chronic	ADJ
cuesj-184	133	18	hepatitis	hepatitis	PROPN
cuesj-184	133	19	b	b	PROPN
cuesj-184	133	20	patients	patient	NOUN
cuesj-184	133	21	”	"	PUNCT
cuesj-184	133	22	.	.	PUNCT
cuesj-184	134	1	journal	journal	NOUN
cuesj-184	134	2	of	of	ADP
cuesj-184	134	3	infectious	infectious	ADJ
cuesj-184	134	4	diseases	disease	NOUN
cuesj-184	134	5	,	,	PUNCT
cuesj-184	134	6	vol	vol	NOUN
cuesj-184	134	7	.	.	PROPN
cuesj-184	134	8	204	204	NUM
cuesj-184	134	9	,	,	PUNCT
cuesj-184	134	10	no	no	INTJ
cuesj-184	134	11	.	.	NOUN
cuesj-184	134	12	3	3	NUM
cuesj-184	134	13	,	,	PUNCT
cuesj-184	134	14	pp	pp	ADJ
cuesj-184	134	15	.	.	PUNCT
cuesj-184	135	1	408	408	NUM
cuesj-184	135	2	-	-	SYM
cuesj-184	135	3	414	414	NUM
cuesj-184	135	4	,	,	PUNCT
cuesj-184	135	5	2011	2011	NUM
cuesj-184	135	6	.	.	PUNCT
cuesj-184	136	1	16	16	NUM
cuesj-184	136	2	.	.	PUNCT
cuesj-184	137	1	j.	j.	PROPN
cuesj-184	137	2	cheng	cheng	PROPN
cuesj-184	137	3	,	,	PUNCT
cuesj-184	137	4	c.	c.	PROPN
cuesj-184	137	5	sun	sun	PROPN
cuesj-184	137	6	,	,	PUNCT
cuesj-184	137	7	y.	y.	PROPN
cuesj-184	137	8	chen	chen	PROPN
cuesj-184	137	9	,	,	PUNCT
cuesj-184	137	10	y.	y.	PROPN
cuesj-184	137	11	dai	dai	PROPN
cuesj-184	137	12	,	,	PUNCT
cuesj-184	137	13	x.	x.	PROPN
cuesj-184	137	14	u.	u.	PROPN
cuesj-184	137	15	zhiliang	zhiliang	PROPN
cuesj-184	137	16	,	,	PUNCT
cuesj-184	137	17	g.	g.	PROPN
cuesj-184	137	18	sun	sun	PROPN
cuesj-184	137	19	and	and	CCONJ
cuesj-184	137	20	l.	l.	PROPN
cuesj-184	137	21	i.	i.	PROPN
cuesj-184	137	22	xiaojun	xiaojun	PROPN
cuesj-184	137	23	.	.	PUNCT
cuesj-184	138	1	“	"	PUNCT
cuesj-184	138	2	molecular	molecular	ADJ
cuesj-184	138	3	analysis	analysis	NOUN
cuesj-184	138	4	on	on	ADP
cuesj-184	138	5	chronic	chronic	ADJ
cuesj-184	138	6	hepatitis	hepatitis	PROPN
cuesj-184	138	7	b	b	PROPN
cuesj-184	138	8	patients	patient	NOUN
cuesj-184	138	9	with	with	ADP
cuesj-184	138	10	low	low	ADJ
cuesj-184	138	11	-	-	PUNCT
cuesj-184	138	12	level	level	NOUN
cuesj-184	138	13	hbsag	hbsag	NOUN
cuesj-184	138	14	”	"	PUNCT
cuesj-184	138	15	.	.	PUNCT
cuesj-184	139	1	chinese	chinese	ADJ
cuesj-184	139	2	journal	journal	PROPN
cuesj-184	139	3	of	of	ADP
cuesj-184	139	4	laboratory	laboratory	NOUN
cuesj-184	139	5	medicine	medicine	NOUN
cuesj-184	139	6	,	,	PUNCT
cuesj-184	139	7	vol	vol	NOUN
cuesj-184	139	8	.	.	PROPN
cuesj-184	139	9	32	32	NUM
cuesj-184	139	10	,	,	PUNCT
cuesj-184	139	11	no	no	INTJ
cuesj-184	139	12	.	.	NOUN
cuesj-184	139	13	10	10	NUM
cuesj-184	139	14	,	,	PUNCT
cuesj-184	139	15	pp	pp	ADJ
cuesj-184	139	16	.	.	PUNCT
cuesj-184	140	1	1128	1128	NUM
cuesj-184	140	2	-	-	SYM
cuesj-184	140	3	1132	1132	NUM
cuesj-184	140	4	,	,	PUNCT
cuesj-184	140	5	2009	2009	NUM
cuesj-184	140	6	.	.	PUNCT
cuesj-184	141	1	17	17	NUM
cuesj-184	141	2	.	.	PUNCT
cuesj-184	142	1	j.	j.	PROPN
cuesj-184	142	2	cheng	cheng	PROPN
cuesj-184	142	3	,	,	PUNCT
cuesj-184	142	4	c.	c.	PROPN
cuesj-184	142	5	sun	sun	PROPN
cuesj-184	142	6	,	,	PUNCT
cuesj-184	142	7	y.	y.	PROPN
cuesj-184	142	8	chen	chen	PROPN
cuesj-184	142	9	,	,	PUNCT
cuesj-184	142	10	z.	z.	PROPN
cuesj-184	142	11	xu	xu	PROPN
cuesj-184	142	12	,	,	PUNCT
cuesj-184	142	13	g.	g.	PROPN
cuesj-184	142	14	wang	wang	PROPN
cuesj-184	142	15	,	,	PUNCT
cuesj-184	142	16	g.	g.	PROPN
cuesj-184	142	17	sun	sun	PROPN
cuesj-184	142	18	and	and	CCONJ
cuesj-184	142	19	x.	x.	NOUN
cuesj-184	142	20	li	li	PROPN
cuesj-184	142	21	.	.	PUNCT
cuesj-184	143	1	“	"	PUNCT
cuesj-184	143	2	analysis	analysis	NOUN
cuesj-184	143	3	on	on	ADP
cuesj-184	143	4	clinical	clinical	ADJ
cuesj-184	143	5	features	feature	NOUN
cuesj-184	143	6	and	and	CCONJ
cuesj-184	143	7	immunity	immunity	NOUN
cuesj-184	143	8	in	in	ADP
cuesj-184	143	9	chronic	chronic	ADJ
cuesj-184	143	10	hepatitis	hepatitis	PROPN
cuesj-184	143	11	b	b	PROPN
cuesj-184	143	12	virus	virus	NOUN
cuesj-184	143	13	infected	infect	VERB
cuesj-184	143	14	patients	patient	NOUN
cuesj-184	143	15	with	with	ADP
cuesj-184	143	16	low	low	ADJ
cuesj-184	143	17	-	-	PUNCT
cuesj-184	143	18	level	level	NOUN
cuesj-184	143	19	hbsag	hbsag	NOUN
cuesj-184	143	20	”	"	PUNCT
cuesj-184	143	21	.	.	PUNCT
cuesj-184	144	1	african	african	ADJ
cuesj-184	144	2	journal	journal	PROPN
cuesj-184	144	3	of	of	ADP
cuesj-184	144	4	microbiology	microbiology	NOUN
cuesj-184	144	5	research	research	NOUN
cuesj-184	144	6	,	,	PUNCT
cuesj-184	144	7	vol	vol	NOUN
cuesj-184	144	8	.	.	PROPN
cuesj-184	144	9	4	4	NUM
cuesj-184	144	10	,	,	PUNCT
cuesj-184	144	11	no	no	INTJ
cuesj-184	144	12	.	.	NOUN
cuesj-184	144	13	7	7	NUM
cuesj-184	144	14	,	,	PUNCT
cuesj-184	144	15	pp	pp	ADJ
cuesj-184	144	16	.	.	PUNCT
cuesj-184	145	1	547	547	NUM
cuesj-184	145	2	-	-	SYM
cuesj-184	145	3	550	550	NUM
cuesj-184	145	4	,	,	PUNCT
cuesj-184	145	5	2010	2010	NUM
cuesj-184	145	6	.	.	PUNCT
cuesj-184	146	1	18	18	NUM
cuesj-184	146	2	.	.	PUNCT
cuesj-184	147	1	a.	a.	PROPN
cuesj-184	147	2	jeffery	jeffery	PROPN
cuesj-184	147	3	-	-	PUNCT
cuesj-184	147	4	smith	smith	PROPN
cuesj-184	147	5	,	,	PUNCT
cuesj-184	147	6	j.	j.	PROPN
cuesj-184	147	7	hubb	hubb	PROPN
cuesj-184	147	8	,	,	PUNCT
cuesj-184	147	9	a.	a.	PROPN
cuesj-184	147	10	oliver	oliver	PROPN
cuesj-184	147	11	and	and	CCONJ
cuesj-184	147	12	c.	c.	PROPN
cuesj-184	147	13	y.	y.	PROPN
cuesj-184	147	14	tong	tong	PROPN
cuesj-184	147	15	.	.	PUNCT
cuesj-184	148	1	“	"	PUNCT
cuesj-184	148	2	an	an	DET
cuesj-184	148	3	apparent	apparent	ADJ
cuesj-184	148	4	low	low	ADJ
cuesj-184	148	5	level	level	NOUN
cuesj-184	148	6	of	of	ADP
cuesj-184	148	7	hepatitis	hepatitis	PROPN
cuesj-184	148	8	b	b	PROPN
cuesj-184	148	9	surface	surface	NOUN
cuesj-184	148	10	antigen	antigen	NOUN
cuesj-184	148	11	(	(	PUNCT
cuesj-184	148	12	hbsag	hbsag	NOUN
cuesj-184	148	13	)	)	PUNCT
cuesj-184	148	14	in	in	ADP
cuesj-184	148	15	the	the	DET
cuesj-184	148	16	presence	presence	NOUN
cuesj-184	148	17	of	of	ADP
cuesj-184	148	18	significant	significant	ADJ
cuesj-184	148	19	viral	viral	ADJ
cuesj-184	148	20	replication	replication	NOUN
cuesj-184	148	21	”	"	PUNCT
cuesj-184	148	22	.	.	PUNCT
cuesj-184	149	1	journal	journal	NOUN
cuesj-184	149	2	of	of	ADP
cuesj-184	149	3	clinical	clinical	ADJ
cuesj-184	149	4	virology	virology	NOUN
cuesj-184	149	5	:	:	PUNCT
cuesj-184	149	6	the	the	DET
cuesj-184	149	7	official	official	ADJ
cuesj-184	149	8	publication	publication	NOUN
cuesj-184	149	9	of	of	ADP
cuesj-184	149	10	the	the	DET
cuesj-184	149	11	pan	pan	PROPN
cuesj-184	149	12	american	american	PROPN
cuesj-184	149	13	society	society	NOUN
cuesj-184	149	14	for	for	ADP
cuesj-184	149	15	clinical	clinical	ADJ
cuesj-184	149	16	virology	virology	NOUN
cuesj-184	149	17	,	,	PUNCT
cuesj-184	149	18	vol	vol	NOUN
cuesj-184	149	19	.	.	PROPN
cuesj-184	149	20	77	77	NUM
cuesj-184	149	21	,	,	PUNCT
cuesj-184	149	22	p.	p.	NOUN
cuesj-184	149	23	111	111	NUM
cuesj-184	149	24	,	,	PUNCT
cuesj-184	149	25	2016	2016	NUM
cuesj-184	149	26	.	.	PUNCT
cuesj-184	150	1	19	19	NUM
cuesj-184	150	2	.	.	PUNCT
cuesj-184	151	1	t.	t.	PROPN
cuesj-184	151	2	nguyen	nguyen	PROPN
cuesj-184	151	3	,	,	PUNCT
cuesj-184	151	4	a.	a.	PROPN
cuesj-184	151	5	j.	j.	PROPN
cuesj-184	151	6	thompson	thompson	PROPN
cuesj-184	151	7	,	,	PUNCT
cuesj-184	151	8	s.	s.	PROPN
cuesj-184	151	9	bowden	bowden	PROPN
cuesj-184	151	10	,	,	PUNCT
cuesj-184	151	11	c.	c.	PROPN
cuesj-184	151	12	croagh	croagh	PROPN
cuesj-184	151	13	,	,	PUNCT
cuesj-184	151	14	s.	s.	PROPN
cuesj-184	151	15	bell	bell	PROPN
cuesj-184	151	16	,	,	PUNCT
cuesj-184	151	17	p.	p.	PROPN
cuesj-184	151	18	v	v	NUM
cuesj-184	152	1	desmond	desmond	PROPN
cuesj-184	152	2	and	and	CCONJ
cuesj-184	152	3	s.	s.	PROPN
cuesj-184	152	4	a.	a.	PROPN
cuesj-184	152	5	locarnini	locarnini	PROPN
cuesj-184	152	6	.	.	PUNCT
cuesj-184	153	1	“	"	PUNCT
cuesj-184	153	2	hepatitis	hepatitis	NOUN
cuesj-184	153	3	b	b	PROPN
cuesj-184	153	4	surface	surface	NOUN
cuesj-184	153	5	antigen	antigen	ADJ
cuesj-184	153	6	levels	level	NOUN
cuesj-184	153	7	during	during	ADP
cuesj-184	153	8	the	the	DET
cuesj-184	153	9	natural	natural	ADJ
cuesj-184	153	10	history	history	NOUN
cuesj-184	153	11	of	of	ADP
cuesj-184	153	12	chronic	chronic	ADJ
cuesj-184	153	13	hepatitis	hepatitis	PROPN
cuesj-184	153	14	b	b	NOUN
cuesj-184	153	15	:	:	PUNCT
cuesj-184	153	16	a	a	DET
cuesj-184	153	17	perspective	perspective	NOUN
cuesj-184	153	18	on	on	ADP
cuesj-184	153	19	asia	asia	PROPN
cuesj-184	153	20	”	"	PUNCT
cuesj-184	153	21	.	.	PUNCT
cuesj-184	154	1	journal	journal	PROPN
cuesj-184	154	2	of	of	ADP
cuesj-184	154	3	hepatology	hepatology	NOUN
cuesj-184	154	4	,	,	PUNCT
cuesj-184	154	5	vol	vol	NOUN
cuesj-184	154	6	.	.	PROPN
cuesj-184	154	7	52	52	NUM
cuesj-184	154	8	,	,	PUNCT
cuesj-184	154	9	no	no	INTJ
cuesj-184	154	10	.	.	NOUN
cuesj-184	154	11	4	4	NUM
cuesj-184	154	12	,	,	PUNCT
cuesj-184	154	13	pp	pp	ADJ
cuesj-184	154	14	.	.	PUNCT
cuesj-184	155	1	508	508	NUM
cuesj-184	155	2	-	-	SYM
cuesj-184	155	3	513	513	NUM
cuesj-184	155	4	,	,	PUNCT
cuesj-184	155	5	2010	2010	NUM
cuesj-184	155	6	.	.	PUNCT
cuesj-184	156	1	20	20	NUM
cuesj-184	156	2	.	.	PUNCT
cuesj-184	157	1	s.	s.	PROPN
cuesj-184	157	2	t.	t.	PROPN
cuesj-184	157	3	balaky	balaky	PROPN
cuesj-184	157	4	,	,	PUNCT
cuesj-184	157	5	s.	s.	PROPN
cuesj-184	157	6	g.	g.	PROPN
cuesj-184	157	7	hussain	hussain	PROPN
cuesj-184	157	8	,	,	PUNCT
cuesj-184	157	9	a.	a.	PROPN
cuesj-184	157	10	a.	a.	PROPN
cuesj-184	157	11	khaleel	khaleel	PROPN
cuesj-184	157	12	,	,	PUNCT
cuesj-184	157	13	f.	f.	PROPN
cuesj-184	157	14	t.	t.	PROPN
cuesj-184	157	15	sabeer	sabeer	PROPN
cuesj-184	157	16	and	and	CCONJ
cuesj-184	157	17	a.	a.	PROPN
cuesj-184	157	18	h.	h.	PROPN
cuesj-184	157	19	mawlood	mawlood	PROPN
cuesj-184	157	20	.	.	PUNCT
cuesj-184	158	1	“	"	PUNCT
cuesj-184	158	2	molecular	molecular	ADJ
cuesj-184	158	3	diagnosis	diagnosis	NOUN
cuesj-184	158	4	in	in	ADP
cuesj-184	158	5	differentiating	differentiate	VERB
cuesj-184	158	6	active	active	ADJ
cuesj-184	158	7	and	and	CCONJ
cuesj-184	158	8	inactive	inactive	ADJ
cuesj-184	158	9	forms	form	NOUN
cuesj-184	158	10	of	of	ADP
cuesj-184	158	11	hepatitis	hepatitis	PROPN
cuesj-184	158	12	b	b	PROPN
cuesj-184	158	13	virus	virus	NOUN
cuesj-184	158	14	carriers	carrier	NOUN
cuesj-184	158	15	”	"	PUNCT
cuesj-184	158	16	.	.	PUNCT
cuesj-184	159	1	journal	journal	PROPN
cuesj-184	159	2	of	of	ADP
cuesj-184	159	3	university	university	PROPN
cuesj-184	159	4	of	of	ADP
cuesj-184	159	5	babylon	babylon	PROPN
cuesj-184	159	6	for	for	ADP
cuesj-184	159	7	pure	pure	ADJ
cuesj-184	159	8	and	and	CCONJ
cuesj-184	159	9	applied	applied	ADJ
cuesj-184	159	10	sciences	science	NOUN
cuesj-184	159	11	,	,	PUNCT
cuesj-184	159	12	vol	vol	NOUN
cuesj-184	159	13	.	.	PROPN
cuesj-184	159	14	26	26	NUM
cuesj-184	159	15	,	,	PUNCT
cuesj-184	159	16	no	no	INTJ
cuesj-184	159	17	.	.	NOUN
cuesj-184	159	18	10	10	NUM
cuesj-184	159	19	,	,	PUNCT
cuesj-184	159	20	pp	pp	ADJ
cuesj-184	159	21	.	.	PUNCT
cuesj-184	160	1	41	41	NUM
cuesj-184	160	2	-	-	SYM
cuesj-184	160	3	45	45	NUM
cuesj-184	160	4	,	,	PUNCT
cuesj-184	160	5	2018	2018	NUM
cuesj-184	160	6	.	.	PUNCT
cuesj-184	161	1	21	21	NUM
cuesj-184	161	2	.	.	PUNCT
cuesj-184	161	3	m.	m.	PROPN
cuesj-184	161	4	c.	c.	PROPN
cuesj-184	161	5	kuhns	kuhns	PROPN
cuesj-184	161	6	,	,	PUNCT
cuesj-184	161	7	s.	s.	PROPN
cuesj-184	161	8	h.	h.	PROPN
cuesj-184	161	9	kleinman	kleinman	PROPN
cuesj-184	161	10	,	,	PUNCT
cuesj-184	161	11	a.	a.	PROPN
cuesj-184	161	12	l.	l.	PROPN
cuesj-184	161	13	mcnamara	mcnamara	PROPN
cuesj-184	161	14	,	,	PUNCT
cuesj-184	161	15	b.	b.	PROPN
cuesj-184	161	16	rawal	rawal	PROPN
cuesj-184	161	17	,	,	PUNCT
cuesj-184	161	18	s.	s.	PROPN
cuesj-184	161	19	glynn	glynn	PROPN
cuesj-184	161	20	and	and	CCONJ
cuesj-184	161	21	m.	m.	PROPN
cuesj-184	161	22	p.	p.	PROPN
cuesj-184	161	23	busch	busch	PROPN
cuesj-184	161	24	.	.	PUNCT
cuesj-184	162	1	“	"	PUNCT
cuesj-184	162	2	lack	lack	NOUN
cuesj-184	162	3	of	of	ADP
cuesj-184	162	4	correlation	correlation	NOUN
cuesj-184	162	5	between	between	ADP
cuesj-184	162	6	hbsag	hbsag	NOUN
cuesj-184	162	7	and	and	CCONJ
cuesj-184	162	8	hbv	hbv	NOUN
cuesj-184	162	9	dna	dna	PROPN
cuesj-184	162	10	levels	level	NOUN
cuesj-184	162	11	in	in	ADP
cuesj-184	162	12	blood	blood	NOUN
cuesj-184	162	13	donors	donor	NOUN
cuesj-184	162	14	who	who	PRON
cuesj-184	162	15	test	test	VERB
cuesj-184	162	16	positive	positive	ADJ
cuesj-184	162	17	for	for	ADP
cuesj-184	162	18	hbsag	hbsag	NOUN
cuesj-184	162	19	and	and	CCONJ
cuesj-184	162	20	anti	anti	ADJ
cuesj-184	162	21	-	-	NOUN
cuesj-184	162	22	hbc	hbc	ADJ
cuesj-184	162	23	:	:	PUNCT
cuesj-184	162	24	implications	implication	NOUN
cuesj-184	162	25	for	for	ADP
cuesj-184	162	26	future	future	ADJ
cuesj-184	162	27	hbv	hbv	NOUN
cuesj-184	162	28	screening	screen	VERB
cuesj-184	162	29	policy	policy	NOUN
cuesj-184	162	30	”	"	PUNCT
cuesj-184	162	31	.	.	PUNCT
cuesj-184	163	1	transfusion	transfusion	NOUN
cuesj-184	163	2	,	,	PUNCT
cuesj-184	163	3	vol	vol	NOUN
cuesj-184	163	4	.	.	PROPN
cuesj-184	163	5	44	44	NUM
cuesj-184	163	6	,	,	PUNCT
cuesj-184	163	7	no	no	INTJ
cuesj-184	163	8	.	.	NOUN
cuesj-184	163	9	9	9	NUM
cuesj-184	163	10	,	,	PUNCT
cuesj-184	163	11	pp	pp	ADJ
cuesj-184	163	12	.	.	PUNCT
cuesj-184	163	13	1332	1332	NUM
cuesj-184	163	14	-	-	SYM
cuesj-184	163	15	1339	1339	NUM
cuesj-184	163	16	,	,	PUNCT
cuesj-184	163	17	2004	2004	NUM
cuesj-184	163	18	.	.	PUNCT
cuesj-184	164	1	22	22	NUM
cuesj-184	164	2	.	.	PUNCT
cuesj-184	164	3	a.	a.	PROPN
cuesj-184	164	4	s.	s.	PROPN
cuesj-184	164	5	k.	k.	PROPN
cuesj-184	165	1	al	al	PROPN
cuesj-184	165	2	-	-	PROPN
cuesj-184	165	3	suraifi	suraifi	PROPN
cuesj-184	165	4	,	,	PUNCT
cuesj-184	165	5	a.	a.	PROPN
cuesj-184	165	6	d.	d.	PROPN
cuesj-184	165	7	j.	j.	PROPN
cuesj-184	165	8	al	al	PROPN
cuesj-184	165	9	-	-	PROPN
cuesj-184	165	10	rubaie	rubaie	PROPN
cuesj-184	165	11	,	,	PUNCT
cuesj-184	165	12	s.	s.	PROPN
cuesj-184	165	13	m.	m.	PROPN
cuesj-184	165	14	g.	g.	PROPN
cuesj-184	165	15	al	al	PROPN
cuesj-184	165	16	-	-	PUNCT
cuesj-184	165	17	mayahie	mayahie	PROPN
cuesj-184	165	18	and	and	CCONJ
cuesj-184	165	19	n.	n.	PROPN
cuesj-184	165	20	m.	m.	PROPN
cuesj-184	165	21	m.	m.	PROPN
cuesj-184	165	22	al	al	PROPN
cuesj-184	165	23	-	-	PUNCT
cuesj-184	165	24	abedy	abedy	NOUN
cuesj-184	165	25	.	.	PUNCT
cuesj-184	166	1	“	"	PUNCT
cuesj-184	166	2	unusual	unusual	ADJ
cuesj-184	166	3	hbv	hbv	NOUN
cuesj-184	166	4	mixed	mix	VERB
cuesj-184	166	5	genotype	genotype	NOUN
cuesj-184	166	6	infections	infection	NOUN
cuesj-184	166	7	among	among	ADP
cuesj-184	166	8	hepatitis	hepatitis	NOUN
cuesj-184	166	9	type	type	NOUN
cuesj-184	166	10	b	b	PROPN
cuesj-184	166	11	iraqi	iraqi	ADJ
cuesj-184	166	12	patients	patient	NOUN
cuesj-184	166	13	in	in	ADP
cuesj-184	166	14	wasit	wasit	PROPN
cuesj-184	166	15	province	province	PROPN
cuesj-184	166	16	/	/	SYM
cuesj-184	166	17	iraq	iraq	PROPN
cuesj-184	166	18	”	"	PUNCT
cuesj-184	166	19	.	.	PUNCT
cuesj-184	167	1	international	international	ADJ
cuesj-184	167	2	journal	journal	PROPN
cuesj-184	167	3	of	of	ADP
cuesj-184	167	4	biomedical	biomedical	ADJ
cuesj-184	167	5	engineering	engineering	NOUN
cuesj-184	167	6	and	and	CCONJ
cuesj-184	167	7	clinical	clinical	ADJ
cuesj-184	167	8	science	science	NOUN
cuesj-184	167	9	,	,	PUNCT
cuesj-184	167	10	vol	vol	NOUN
cuesj-184	167	11	.	.	PROPN
cuesj-184	168	1	2	2	NUM
cuesj-184	168	2	,	,	PUNCT
cuesj-184	168	3	no	no	INTJ
cuesj-184	168	4	.	.	NOUN
cuesj-184	168	5	1	1	NUM
cuesj-184	168	6	,	,	PUNCT
cuesj-184	168	7	pp	pp	ADJ
cuesj-184	168	8	.	.	PUNCT
cuesj-184	169	1	1	1	NUM
cuesj-184	169	2	-	-	SYM
cuesj-184	169	3	7	7	NUM
cuesj-184	169	4	,	,	PUNCT
cuesj-184	169	5	2016	2016	NUM
cuesj-184	169	6	.	.	PUNCT
cuesj-184	170	1	23	23	NUM
cuesj-184	170	2	.	.	PUNCT
cuesj-184	170	3	i.	i.	PROPN
cuesj-184	170	4	a.	a.	PROPN
cuesj-184	170	5	a.	a.	PROPN
cuesj-184	170	6	khaled	khaled	PROPN
cuesj-184	170	7	,	,	PUNCT
cuesj-184	170	8	o.	o.	PROPN
cuesj-184	170	9	m.	m.	PROPN
cuesj-184	170	10	mahmoud	mahmoud	PROPN
cuesj-184	170	11	,	,	PUNCT
cuesj-184	170	12	a.	a.	PROPN
cuesj-184	170	13	f.	f.	PROPN
cuesj-184	170	14	saleh	saleh	PROPN
cuesj-184	170	15	and	and	CCONJ
cuesj-184	170	16	e.	e.	PROPN
cuesj-184	170	17	a.	a.	PROPN
cuesj-184	170	18	baioumi	baioumi	PROPN
cuesj-184	170	19	.	.	PUNCT
cuesj-184	171	1	“	"	PUNCT
cuesj-184	171	2	prevalence	prevalence	NOUN
cuesj-184	171	3	of	of	ADP
cuesj-184	171	4	hbv	hbv	NOUN
cuesj-184	171	5	genotypes	genotype	NOUN
cuesj-184	171	6	in	in	ADP
cuesj-184	171	7	egypt	egypt	PROPN
cuesj-184	171	8	among	among	ADP
cuesj-184	171	9	hepatitis	hepatitis	NOUN
cuesj-184	171	10	patients	patient	NOUN
cuesj-184	171	11	”	"	PUNCT
cuesj-184	171	12	.	.	PUNCT
cuesj-184	172	1	journal	journal	PROPN
cuesj-184	172	2	of	of	ADP
cuesj-184	172	3	american	american	PROPN
cuesj-184	172	4	science	science	PROPN
cuesj-184	172	5	,	,	PUNCT
cuesj-184	172	6	vol	vol	NOUN
cuesj-184	172	7	.	.	PROPN
cuesj-184	172	8	6	6	NUM
cuesj-184	172	9	,	,	PUNCT
cuesj-184	172	10	no	no	INTJ
cuesj-184	172	11	.	.	NOUN
cuesj-184	172	12	11	11	NUM
cuesj-184	172	13	,	,	PUNCT
cuesj-184	172	14	pp	pp	ADJ
cuesj-184	172	15	.	.	PUNCT
cuesj-184	173	1	185	185	NUM
cuesj-184	173	2	-	-	SYM
cuesj-184	173	3	190	190	NUM
cuesj-184	173	4	,	,	PUNCT
cuesj-184	173	5	2010	2010	NUM
cuesj-184	173	6	.	.	PUNCT
cuesj-184	174	1	24	24	NUM
cuesj-184	174	2	.	.	PUNCT
cuesj-184	174	3	w.	w.	PROPN
cuesj-184	174	4	k.	k.	PROPN
cuesj-184	174	5	roth	roth	PROPN
cuesj-184	174	6	,	,	PUNCT
cuesj-184	174	7	m.	m.	PROPN
cuesj-184	174	8	weber	weber	PROPN
cuesj-184	174	9	,	,	PUNCT
cuesj-184	174	10	d.	d.	PROPN
cuesj-184	174	11	petersen	petersen	PROPN
cuesj-184	174	12	,	,	PUNCT
cuesj-184	174	13	c.	c.	PROPN
cuesj-184	174	14	drosten	drosten	PROPN
cuesj-184	174	15	,	,	PUNCT
cuesj-184	174	16	s.	s.	PROPN
cuesj-184	174	17	buhr	buhr	PROPN
cuesj-184	174	18	,	,	PUNCT
cuesj-184	174	19	w.	w.	PROPN
cuesj-184	174	20	sireis	sireis	PROPN
cuesj-184	174	21	and	and	CCONJ
cuesj-184	174	22	e.	e.	PROPN
cuesj-184	174	23	seifried	seifried	PROPN
cuesj-184	174	24	.	.	PUNCT
cuesj-184	175	1	“	"	PUNCT
cuesj-184	175	2	nat	nat	NOUN
cuesj-184	175	3	for	for	ADP
cuesj-184	175	4	hbv	hbv	NOUN
cuesj-184	175	5	and	and	CCONJ
cuesj-184	175	6	anti	anti	ADJ
cuesj-184	175	7	-	-	ADJ
cuesj-184	175	8	hbc	hbc	ADJ
cuesj-184	175	9	testing	testing	NOUN
cuesj-184	175	10	increase	increase	VERB
cuesj-184	175	11	blood	blood	NOUN
cuesj-184	175	12	safety	safety	NOUN
cuesj-184	175	13	”	"	PUNCT
cuesj-184	175	14	.	.	PUNCT
cuesj-184	176	1	transfusion	transfusion	NOUN
cuesj-184	176	2	,	,	PUNCT
cuesj-184	176	3	vol	vol	NOUN
cuesj-184	176	4	.	.	PROPN
cuesj-184	176	5	42	42	NUM
cuesj-184	176	6	,	,	PUNCT
cuesj-184	176	7	no	no	INTJ
cuesj-184	176	8	.	.	NOUN
cuesj-184	176	9	7	7	NUM
cuesj-184	176	10	,	,	PUNCT
cuesj-184	176	11	pp	pp	ADJ
cuesj-184	176	12	.	.	PUNCT
cuesj-184	176	13	869	869	NUM
cuesj-184	176	14	-	-	SYM
cuesj-184	176	15	875	875	NUM
cuesj-184	176	16	,	,	PUNCT
cuesj-184	176	17	2002	2002	NUM
cuesj-184	176	18	.	.	PUNCT
cuesj-184	177	1	25	25	NUM
cuesj-184	177	2	.	.	PUNCT
cuesj-184	178	1	s.	s.	PROPN
cuesj-184	178	2	sato	sato	PROPN
cuesj-184	178	3	,	,	PUNCT
cuesj-184	178	4	w.	w.	PROPN
cuesj-184	178	5	ohhashi	ohhashi	PROPN
cuesj-184	178	6	,	,	PUNCT
cuesj-184	178	7	h.	h.	PROPN
cuesj-184	178	8	ihara	ihara	PROPN
cuesj-184	178	9	,	,	PUNCT
cuesj-184	178	10	s.	s.	PROPN
cuesj-184	178	11	sakaya	sakaya	PROPN
cuesj-184	178	12	,	,	PUNCT
cuesj-184	178	13	t.	t.	PROPN
cuesj-184	178	14	kato	kato	PROPN
cuesj-184	178	15	and	and	CCONJ
cuesj-184	178	16	h.	h.	PROPN
cuesj-184	178	17	ikeda	ikeda	PROPN
cuesj-184	178	18	.	.	PUNCT
cuesj-184	179	1	“	"	PUNCT
cuesj-184	179	2	comparison	comparison	NOUN
cuesj-184	179	3	of	of	ADP
cuesj-184	179	4	the	the	DET
cuesj-184	179	5	sensitivity	sensitivity	NOUN
cuesj-184	179	6	of	of	ADP
cuesj-184	179	7	nat	nat	NOUN
cuesj-184	179	8	using	use	VERB
cuesj-184	179	9	pooled	pool	VERB
cuesj-184	179	10	donor	donor	NOUN
cuesj-184	179	11	samples	sample	NOUN
cuesj-184	179	12	for	for	ADP
cuesj-184	179	13	hbv	hbv	NOUN
cuesj-184	179	14	and	and	CCONJ
cuesj-184	179	15	that	that	PRON
cuesj-184	179	16	of	of	ADP
cuesj-184	179	17	a	a	DET
cuesj-184	179	18	serologic	serologic	ADJ
cuesj-184	179	19	hbsag	hbsag	NOUN
cuesj-184	179	20	assay	assay	NOUN
cuesj-184	179	21	”	"	PUNCT
cuesj-184	179	22	.	.	PUNCT
cuesj-184	180	1	transfusion	transfusion	NOUN
cuesj-184	180	2	,	,	PUNCT
cuesj-184	180	3	vol	vol	NOUN
cuesj-184	180	4	.	.	PROPN
cuesj-184	180	5	41	41	NUM
cuesj-184	180	6	,	,	PUNCT
cuesj-184	180	7	no	no	INTJ
cuesj-184	180	8	.	.	NOUN
cuesj-184	180	9	9	9	NUM
cuesj-184	180	10	,	,	PUNCT
cuesj-184	180	11	pp	pp	ADJ
cuesj-184	180	12	.	.	PUNCT
cuesj-184	181	1	1107	1107	NUM
cuesj-184	181	2	-	-	SYM
cuesj-184	181	3	1113	1113	NUM
cuesj-184	181	4	,	,	PUNCT
cuesj-184	181	5	2001	2001	NUM
cuesj-184	181	6	.	.	PUNCT
cuesj-184	182	1	26	26	NUM
cuesj-184	182	2	.	.	PUNCT
cuesj-184	183	1	h.	h.	PROPN
cuesj-184	183	2	hennig	hennig	PROPN
cuesj-184	183	3	,	,	PUNCT
cuesj-184	183	4	i.	i.	PROPN
cuesj-184	183	5	puchta	puchta	PROPN
cuesj-184	183	6	,	,	PUNCT
cuesj-184	183	7	j.	j.	PROPN
cuesj-184	183	8	luhm	luhm	PROPN
cuesj-184	183	9	,	,	PUNCT
cuesj-184	183	10	p.	p.	PROPN
cuesj-184	183	11	schlenke	schlenke	NOUN
cuesj-184	183	12	,	,	PUNCT
cuesj-184	183	13	s.	s.	PROPN
cuesj-184	183	14	goerg	goerg	PROPN
cuesj-184	183	15	and	and	CCONJ
cuesj-184	183	16	h.	h.	PROPN
cuesj-184	183	17	kirchner	kirchner	PROPN
cuesj-184	183	18	.	.	PUNCT
cuesj-184	184	1	“	"	PUNCT
cuesj-184	184	2	frequency	frequency	NOUN
cuesj-184	184	3	and	and	CCONJ
cuesj-184	184	4	load	load	NOUN
cuesj-184	184	5	of	of	ADP
cuesj-184	184	6	hepatitis	hepatitis	PROPN
cuesj-184	184	7	b	b	PROPN
cuesj-184	184	8	virus	virus	NOUN
cuesj-184	184	9	dna	dna	PROPN
cuesj-184	184	10	in	in	ADP
cuesj-184	184	11	firsttime	firsttime	ADJ
cuesj-184	184	12	blood	blood	NOUN
cuesj-184	184	13	donors	donor	NOUN
cuesj-184	184	14	with	with	ADP
cuesj-184	184	15	antibodies	antibody	NOUN
cuesj-184	184	16	to	to	ADP
cuesj-184	184	17	hepatitis	hepatitis	PROPN
cuesj-184	184	18	b	b	PROPN
cuesj-184	184	19	core	core	NOUN
cuesj-184	184	20	antigen	antigen	PROPN
cuesj-184	184	21	”	"	PUNCT
cuesj-184	184	22	.	.	PUNCT
cuesj-184	185	1	blood	blood	NOUN
cuesj-184	185	2	,	,	PUNCT
cuesj-184	185	3	vol	vol	NOUN
cuesj-184	185	4	.	.	PROPN
cuesj-184	185	5	100	100	NUM
cuesj-184	185	6	,	,	PUNCT
cuesj-184	185	7	no	no	INTJ
cuesj-184	185	8	.	.	NOUN
cuesj-184	185	9	7	7	NUM
cuesj-184	185	10	,	,	PUNCT
cuesj-184	185	11	pp	pp	ADJ
cuesj-184	185	12	.	.	PUNCT
cuesj-184	186	1	2637	2637	NUM
cuesj-184	186	2	-	-	SYM
cuesj-184	186	3	2641	2641	NUM
cuesj-184	186	4	,	,	PUNCT
cuesj-184	186	5	2002	2002	NUM
cuesj-184	186	6	.	.	PUNCT
cuesj-184	187	1	27	27	NUM
cuesj-184	187	2	.	.	PUNCT
cuesj-184	187	3	m.	m.	PROPN
cuesj-184	187	4	c.	c.	PROPN
cuesj-184	187	5	kuhns	kuhns	PROPN
cuesj-184	187	6	,	,	PUNCT
cuesj-184	187	7	a.	a.	PROPN
cuesj-184	187	8	l.	l.	PROPN
cuesj-184	187	9	mcnamara	mcnamara	PROPN
cuesj-184	187	10	and	and	CCONJ
cuesj-184	187	11	r.	r.	PROPN
cuesj-184	187	12	perrillo	perrillo	PROPN
cuesj-184	187	13	.	.	PUNCT
cuesj-184	188	1	“	"	PUNCT
cuesj-184	188	2	intermittent	intermittent	ADJ
cuesj-184	188	3	pcr	pcr	NOUN
cuesj-184	188	4	positivity	positivity	NOUN
cuesj-184	188	5	for	for	ADP
cuesj-184	188	6	hepatitis	hepatitis	PROPN
cuesj-184	188	7	b	b	PROPN
cuesj-184	188	8	viral	viral	ADJ
cuesj-184	188	9	dna	dna	NOUN
cuesj-184	188	10	in	in	ADP
cuesj-184	188	11	surface	surface	NOUN
cuesj-184	188	12	antigen	antigen	ADP
cuesj-184	188	13	negative	negative	ADJ
cuesj-184	188	14	anti	anti	ADJ
cuesj-184	188	15	-	-	ADJ
cuesj-184	188	16	core	core	ADJ
cuesj-184	188	17	positive	positive	ADJ
cuesj-184	188	18	individuals	individual	NOUN
cuesj-184	188	19	”	"	PUNCT
cuesj-184	188	20	.	.	PUNCT
cuesj-184	189	1	transfusion	transfusion	NOUN
cuesj-184	189	2	,	,	PUNCT
cuesj-184	189	3	vol	vol	NOUN
cuesj-184	189	4	.	.	PROPN
cuesj-184	189	5	39	39	NUM
cuesj-184	189	6	,	,	PUNCT
cuesj-184	189	7	no	no	INTJ
cuesj-184	189	8	.	.	NOUN
cuesj-184	189	9	10	10	NUM
cuesj-184	189	10	,	,	PUNCT
cuesj-184	189	11	pp	pp	ADJ
cuesj-184	189	12	.	.	PUNCT
cuesj-184	190	1	95s-95s	95s-95s	NUM
cuesj-184	190	2	,	,	PUNCT
cuesj-184	190	3	1999	1999	NUM
cuesj-184	190	4	.	.	PUNCT
cuesj-184	191	1	28	28	NUM
cuesj-184	191	2	.	.	PUNCT
cuesj-184	192	1	y.	y.	PROPN
cuesj-184	192	2	j.	j.	PROPN
cuesj-184	192	3	kim	kim	PROPN
cuesj-184	192	4	,	,	PUNCT
cuesj-184	192	5	h.	h.	PROPN
cuesj-184	192	6	c.	c.	PROPN
cuesj-184	192	7	cho	cho	PROPN
cuesj-184	192	8	,	,	PUNCT
cuesj-184	192	9	m.	m.	NOUN
cuesj-184	192	10	s.	s.	PROPN
cuesj-184	192	11	choi	choi	PROPN
cuesj-184	192	12	,	,	PUNCT
cuesj-184	192	13	j.	j.	PROPN
cuesj-184	192	14	h.	h.	PROPN
cuesj-184	192	15	lee	lee	PROPN
cuesj-184	192	16	,	,	PUNCT
cuesj-184	192	17	k.	k.	PROPN
cuesj-184	192	18	c.	c.	PROPN
cuesj-184	192	19	koh	koh	PROPN
cuesj-184	192	20	,	,	PUNCT
cuesj-184	192	21	b.	b.	PROPN
cuesj-184	192	22	c.	c.	PROPN
cuesj-184	192	23	yoo	yoo	PROPN
cuesj-184	192	24	and	and	CCONJ
cuesj-184	192	25	s.	s.	PROPN
cuesj-184	192	26	w.	w.	PROPN
cuesj-184	192	27	paik	paik	PROPN
cuesj-184	192	28	.	.	PUNCT
cuesj-184	193	1	“	"	PUNCT
cuesj-184	193	2	the	the	DET
cuesj-184	193	3	change	change	NOUN
cuesj-184	193	4	of	of	ADP
cuesj-184	193	5	the	the	DET
cuesj-184	193	6	quantitative	quantitative	ADJ
cuesj-184	193	7	hbsag	hbsag	ADJ
cuesj-184	193	8	level	level	NOUN
cuesj-184	193	9	during	during	ADP
cuesj-184	193	10	khaleel	khaleel	NOUN
cuesj-184	193	11	,	,	PUNCT
cuesj-184	193	12	et	et	PROPN
cuesj-184	193	13	al	al	PROPN
cuesj-184	193	14	.	.	PUNCT
cuesj-184	193	15	:	:	PUNCT
cuesj-184	194	1	significance	significance	NOUN
cuesj-184	194	2	of	of	ADP
cuesj-184	194	3	hbv	hbv	NOUN
cuesj-184	194	4	diagnosis	diagnosis	NOUN
cuesj-184	194	5	by	by	ADP
cuesj-184	194	6	rt	rt	PROPN
cuesj-184	194	7	-	-	PUNCT
cuesj-184	194	8	pcr	pcr	ADJ
cuesj-184	194	9	56	56	NUM
cuesj-184	194	10	http://journals.cihanuniversity.edu.iq/index.php/cuesj	http://journals.cihanuniversity.edu.iq/index.php/cuesj	ADJ
cuesj-184	194	11	cuesj	cuesj	NOUN
cuesj-184	194	12	2020	2020	NUM
cuesj-184	194	13	,	,	PUNCT
cuesj-184	194	14	4	4	NUM
cuesj-184	194	15	(	(	PUNCT
cuesj-184	194	16	1	1	NUM
cuesj-184	194	17	):	):	PUNCT
cuesj-184	194	18	52	52	NUM
cuesj-184	194	19	-	-	SYM
cuesj-184	194	20	56	56	NUM
cuesj-184	194	21	the	the	DET
cuesj-184	194	22	natural	natural	ADJ
cuesj-184	194	23	course	course	NOUN
cuesj-184	194	24	of	of	ADP
cuesj-184	194	25	chronic	chronic	ADJ
cuesj-184	194	26	hepatitis	hepatitis	NOUN
cuesj-184	194	27	b	b	NOUN
cuesj-184	194	28	”	"	PUNCT
cuesj-184	194	29	.	.	PUNCT
cuesj-184	195	1	liver	liver	PROPN
cuesj-184	195	2	international	international	ADJ
cuesj-184	195	3	,	,	PUNCT
cuesj-184	195	4	vol	vol	NOUN
cuesj-184	195	5	.	.	PROPN
cuesj-184	196	1	31	31	NUM
cuesj-184	196	2	,	,	PUNCT
cuesj-184	196	3	no	no	INTJ
cuesj-184	196	4	.	.	NOUN
cuesj-184	196	5	6	6	NUM
cuesj-184	196	6	,	,	PUNCT
cuesj-184	196	7	pp	pp	ADJ
cuesj-184	196	8	.	.	PUNCT
cuesj-184	197	1	817	817	NUM
cuesj-184	197	2	-	-	SYM
cuesj-184	197	3	823	823	NUM
cuesj-184	197	4	,	,	PUNCT
cuesj-184	197	5	2011	2011	NUM
cuesj-184	197	6	.	.	PUNCT
cuesj-184	198	1	29	29	NUM
cuesj-184	198	2	.	.	PUNCT
cuesj-184	199	1	j.	j.	PROPN
cuesj-184	199	2	jaroszewicz	jaroszewicz	PROPN
cuesj-184	199	3	,	,	PUNCT
cuesj-184	199	4	b.	b.	PROPN
cuesj-184	199	5	c.	c.	PROPN
cuesj-184	199	6	serrano	serrano	PROPN
cuesj-184	199	7	,	,	PUNCT
cuesj-184	199	8	k.	k.	PROPN
cuesj-184	199	9	wursthorn	wursthorn	PROPN
cuesj-184	199	10	,	,	PUNCT
cuesj-184	199	11	k.	k.	PROPN
cuesj-184	200	1	deterding	deterding	PROPN
cuesj-184	200	2	,	,	PUNCT
cuesj-184	200	3	j.	j.	PROPN
cuesj-184	200	4	schlue	schlue	PROPN
cuesj-184	200	5	,	,	PUNCT
cuesj-184	200	6	r.	r.	PROPN
cuesj-184	200	7	raupach	raupach	PROPN
cuesj-184	200	8	and	and	CCONJ
cuesj-184	200	9	m.	m.	NOUN
cuesj-184	200	10	cornberg	cornberg	PROPN
cuesj-184	200	11	.	.	PUNCT
cuesj-184	201	1	“	"	PUNCT
cuesj-184	201	2	hepatitis	hepatitis	NOUN
cuesj-184	201	3	b	b	PROPN
cuesj-184	201	4	surface	surface	NOUN
cuesj-184	201	5	antigen	antigen	NOUN
cuesj-184	201	6	(	(	PUNCT
cuesj-184	201	7	hbsag	hbsag	NOUN
cuesj-184	201	8	)	)	PUNCT
cuesj-184	201	9	levels	level	NOUN
cuesj-184	201	10	in	in	ADP
cuesj-184	201	11	the	the	DET
cuesj-184	201	12	natural	natural	ADJ
cuesj-184	201	13	history	history	NOUN
cuesj-184	201	14	of	of	ADP
cuesj-184	201	15	hepatitis	hepatitis	PROPN
cuesj-184	201	16	b	b	PROPN
cuesj-184	201	17	virus	virus	NOUN
cuesj-184	201	18	(	(	PUNCT
cuesj-184	201	19	hbv)-infection	hbv)-infection	NOUN
cuesj-184	201	20	:	:	PUNCT
cuesj-184	201	21	a	a	DET
cuesj-184	201	22	european	european	PROPN
cuesj-184	201	23	perspective	perspective	NOUN
cuesj-184	201	24	”	"	PUNCT
cuesj-184	201	25	.	.	PUNCT
cuesj-184	202	1	journal	journal	PROPN
cuesj-184	202	2	of	of	ADP
cuesj-184	202	3	hepatology	hepatology	NOUN
cuesj-184	202	4	,	,	PUNCT
cuesj-184	202	5	vol	vol	NOUN
cuesj-184	202	6	.	.	PROPN
cuesj-184	202	7	52	52	NUM
cuesj-184	202	8	,	,	PUNCT
cuesj-184	202	9	no	no	INTJ
cuesj-184	202	10	.	.	NOUN
cuesj-184	202	11	4	4	NUM
cuesj-184	202	12	,	,	PUNCT
cuesj-184	202	13	pp	pp	ADJ
cuesj-184	202	14	.	.	PUNCT
cuesj-184	203	1	514	514	NUM
cuesj-184	203	2	-	-	SYM
cuesj-184	203	3	522	522	NUM
cuesj-184	203	4	,	,	PUNCT
cuesj-184	203	5	2010	2010	NUM
cuesj-184	203	6	.	.	PUNCT
cuesj-184	204	1	30	30	NUM
cuesj-184	204	2	.	.	PUNCT
cuesj-184	204	3	a.	a.	NOUN
cuesj-184	204	4	alghamdi	alghamdi	PROPN
cuesj-184	204	5	,	,	PUNCT
cuesj-184	204	6	n.	n.	PROPN
cuesj-184	204	7	aref	aref	PROPN
cuesj-184	204	8	,	,	PUNCT
cuesj-184	204	9	m.	m.	NOUN
cuesj-184	204	10	el	el	PROPN
cuesj-184	204	11	-	-	PROPN
cuesj-184	204	12	hazmi	hazmi	NOUN
cuesj-184	204	13	,	,	PUNCT
cuesj-184	204	14	w.	w.	PROPN
cuesj-184	204	15	al	al	PROPN
cuesj-184	204	16	-	-	PUNCT
cuesj-184	204	17	hamoudi	hamoudi	PROPN
cuesj-184	204	18	,	,	PUNCT
cuesj-184	204	19	k.	k.	PROPN
cuesj-184	204	20	alswat	alswat	PROPN
cuesj-184	204	21	,	,	PUNCT
cuesj-184	204	22	a.	a.	NOUN
cuesj-184	204	23	helmy	helmy	NOUN
cuesj-184	204	24	and	and	CCONJ
cuesj-184	204	25	a.	a.	NOUN
cuesj-184	204	26	a.	a.	NOUN
cuesj-184	204	27	abdo	abdo	PROPN
cuesj-184	204	28	.	.	PUNCT
cuesj-184	205	1	“	"	PUNCT
cuesj-184	205	2	correlation	correlation	NOUN
cuesj-184	205	3	between	between	ADP
cuesj-184	205	4	hepatitis	hepatitis	PROPN
cuesj-184	205	5	b	b	PROPN
cuesj-184	205	6	surface	surface	NOUN
cuesj-184	205	7	antigen	antigen	NOUN
cuesj-184	205	8	titers	titer	NOUN
cuesj-184	205	9	and	and	CCONJ
cuesj-184	205	10	hbv	hbv	PROPN
cuesj-184	205	11	dna	dna	PROPN
cuesj-184	205	12	levels	level	NOUN
cuesj-184	205	13	”	"	PUNCT
cuesj-184	205	14	.	.	PUNCT
cuesj-184	206	1	saudi	saudi	ADJ
cuesj-184	206	2	journal	journal	PROPN
cuesj-184	206	3	of	of	ADP
cuesj-184	206	4	gastroenterology	gastroenterology	NOUN
cuesj-184	206	5	:	:	PUNCT
cuesj-184	206	6	official	official	ADJ
cuesj-184	206	7	journal	journal	NOUN
cuesj-184	206	8	of	of	ADP
cuesj-184	206	9	the	the	DET
cuesj-184	206	10	saudi	saudi	ADJ
cuesj-184	206	11	gastroenterology	gastroenterology	NOUN
cuesj-184	206	12	association	association	PROPN
cuesj-184	206	13	,	,	PUNCT
cuesj-184	206	14	vol	vol	NOUN
cuesj-184	206	15	.	.	PROPN
cuesj-184	206	16	19	19	NUM
cuesj-184	206	17	,	,	PUNCT
cuesj-184	206	18	no	no	INTJ
cuesj-184	206	19	.	.	NOUN
cuesj-184	206	20	6	6	NUM
cuesj-184	206	21	,	,	PUNCT
cuesj-184	206	22	p.	p.	NOUN
cuesj-184	206	23	252	252	NUM
cuesj-184	206	24	,	,	PUNCT
cuesj-184	206	25	2013	2013	NUM
cuesj-184	206	26	.	.	PUNCT
cuesj-184	207	1	31	31	NUM
cuesj-184	207	2	.	.	PUNCT
cuesj-184	208	1	p.	p.	NOUN
cuesj-184	208	2	p.	p.	NOUN
cuesj-184	209	1	primadharsini	primadharsini	PROPN
cuesj-184	209	2	and	and	CCONJ
cuesj-184	209	3	i.	i.	PROPN
cuesj-184	209	4	wibawa	wibawa	PROPN
cuesj-184	209	5	.	.	PUNCT
cuesj-184	210	1	“	"	PUNCT
cuesj-184	210	2	correlation	correlation	NOUN
cuesj-184	210	3	between	between	ADP
cuesj-184	210	4	quantitative	quantitative	ADJ
cuesj-184	210	5	hbsag	hbsag	NOUN
cuesj-184	210	6	and	and	CCONJ
cuesj-184	210	7	hbv	hbv	NOUN
cuesj-184	210	8	-	-	PUNCT
cuesj-184	210	9	dna	dna	NOUN
cuesj-184	210	10	in	in	ADP
cuesj-184	210	11	chronic	chronic	ADJ
cuesj-184	210	12	hepatitis	hepatitis	PROPN
cuesj-184	210	13	b	b	NOUN
cuesj-184	210	14	infection	infection	NOUN
cuesj-184	210	15	”	"	PUNCT
cuesj-184	210	16	.	.	PUNCT
cuesj-184	211	1	indonesian	indonesian	ADJ
cuesj-184	211	2	journal	journal	PROPN
cuesj-184	211	3	of	of	ADP
cuesj-184	211	4	gastroenterology	gastroenterology	NOUN
cuesj-184	211	5	,	,	PUNCT
cuesj-184	211	6	hepatology	hepatology	NOUN
cuesj-184	211	7	,	,	PUNCT
cuesj-184	211	8	and	and	CCONJ
cuesj-184	211	9	digestive	digestive	ADJ
cuesj-184	211	10	endoscopy	endoscopy	NOUN
cuesj-184	211	11	,	,	PUNCT
cuesj-184	211	12	vol	vol	NOUN
cuesj-184	211	13	.	.	PROPN
cuesj-184	211	14	14	14	NUM
cuesj-184	211	15	,	,	PUNCT
cuesj-184	211	16	no	no	INTJ
cuesj-184	211	17	.	.	NOUN
cuesj-184	211	18	1	1	NUM
cuesj-184	211	19	,	,	PUNCT
cuesj-184	211	20	pp	pp	ADJ
cuesj-184	211	21	.	.	PUNCT
cuesj-184	212	1	9	9	NUM
cuesj-184	212	2	-	-	SYM
cuesj-184	212	3	12	12	NUM
cuesj-184	212	4	,	,	PUNCT
cuesj-184	212	5	2013	2013	NUM
cuesj-184	212	6	.	.	PUNCT
cuesj-184	213	1	32	32	NUM
cuesj-184	213	2	.	.	PUNCT
cuesj-184	214	1	m.	m.	NOUN
cuesj-184	214	2	z.	z.	PROPN
cuesj-184	214	3	hong	hong	PROPN
cuesj-184	214	4	,	,	PUNCT
cuesj-184	214	5	w.	w.	PROPN
cuesj-184	214	6	q.	q.	PROPN
cuesj-184	214	7	huang	huang	PROPN
cuesj-184	214	8	,	,	PUNCT
cuesj-184	214	9	f.	f.	PROPN
cuesj-184	214	10	min	min	PROPN
cuesj-184	214	11	,	,	PUNCT
cuesj-184	214	12	j.	j.	PROPN
cuesj-184	214	13	c.	c.	PROPN
cuesj-184	214	14	xu	xu	PROPN
cuesj-184	214	15	,	,	PUNCT
cuesj-184	214	16	z.	z.	PROPN
cuesj-184	214	17	lin	lin	PROPN
cuesj-184	214	18	,	,	PUNCT
cuesj-184	214	19	k.	k.	PROPN
cuesj-184	214	20	n.	n.	PROPN
cuesj-184	214	21	fang	fang	PROPN
cuesj-184	214	22	and	and	CCONJ
cuesj-184	214	23	j.	j.	PROPN
cuesj-184	214	24	s.	s.	PROPN
cuesj-184	214	25	pan	pan	PROPN
cuesj-184	214	26	.	.	PUNCT
cuesj-184	215	1	“	"	PUNCT
cuesj-184	215	2	enhanced	enhance	VERB
cuesj-184	215	3	hbsag	hbsag	ADJ
cuesj-184	215	4	synthesis	synthesis	NOUN
cuesj-184	215	5	correlates	correlate	VERB
cuesj-184	215	6	with	with	ADP
cuesj-184	215	7	increased	increase	VERB
cuesj-184	215	8	severity	severity	NOUN
cuesj-184	215	9	of	of	ADP
cuesj-184	215	10	fibrosis	fibrosis	NOUN
cuesj-184	215	11	in	in	ADP
cuesj-184	215	12	chronic	chronic	ADJ
cuesj-184	215	13	hepatitis	hepatitis	PROPN
cuesj-184	215	14	b	b	PROPN
cuesj-184	215	15	patients	patient	NOUN
cuesj-184	215	16	”	"	PUNCT
cuesj-184	215	17	.	.	PUNCT
cuesj-184	216	1	plos	plos	PROPN
cuesj-184	216	2	one	one	NUM
cuesj-184	216	3	,	,	PUNCT
cuesj-184	216	4	vol	vol	NOUN
cuesj-184	216	5	.	.	NOUN
cuesj-184	216	6	9	9	NUM
cuesj-184	216	7	,	,	PUNCT
cuesj-184	216	8	no	no	INTJ
cuesj-184	216	9	.	.	NOUN
cuesj-184	216	10	1	1	NUM
cuesj-184	216	11	,	,	PUNCT
cuesj-184	216	12	p.	p.	NOUN
cuesj-184	216	13	e87344	e87344	NOUN
cuesj-184	216	14	,	,	PUNCT
cuesj-184	216	15	2014	2014	NUM
cuesj-184	216	16	.	.	PUNCT
cuesj-184	217	1	33	33	NUM
cuesj-184	217	2	.	.	PUNCT
cuesj-184	218	1	o.	o.	PROPN
cuesj-184	218	2	günal	günal	PROPN
cuesj-184	218	3	,	,	PUNCT
cuesj-184	218	4	s.	s.	PROPN
cuesj-184	218	5	barut	barut	PROPN
cuesj-184	218	6	,	,	PUNCT
cuesj-184	218	7	i.	i.	PROPN
cuesj-184	218	8	etikan	etikan	PROPN
cuesj-184	218	9	,	,	PUNCT
cuesj-184	218	10	f.	f.	PROPN
cuesj-184	218	11	duygu	duygu	PROPN
cuesj-184	218	12	,	,	PUNCT
cuesj-184	218	13	u.	u.	PROPN
cuesj-184	218	14	tuncel	tuncel	PROPN
cuesj-184	218	15	and	and	CCONJ
cuesj-184	218	16	m.	m.	NOUN
cuesj-184	218	17	sünbül	sünbül	PROPN
cuesj-184	218	18	.	.	PUNCT
cuesj-184	219	1	“	"	PUNCT
cuesj-184	219	2	relation	relation	NOUN
cuesj-184	219	3	between	between	ADP
cuesj-184	219	4	serum	serum	PROPN
cuesj-184	219	5	quantitative	quantitative	ADJ
cuesj-184	219	6	hbsag	hbsag	NOUN
cuesj-184	219	7	,	,	PUNCT
cuesj-184	219	8	alt	alt	VERB
cuesj-184	219	9	and	and	CCONJ
cuesj-184	219	10	hbv	hbv	PROPN
cuesj-184	219	11	dna	dna	PROPN
cuesj-184	219	12	levels	level	NOUN
cuesj-184	219	13	in	in	ADP
cuesj-184	219	14	hbeag	hbeag	ADJ
cuesj-184	219	15	negative	negative	ADJ
cuesj-184	219	16	chronic	chronic	ADJ
cuesj-184	219	17	hbv	hbv	NOUN
cuesj-184	219	18	infection	infection	NOUN
cuesj-184	219	19	”	"	PUNCT
cuesj-184	219	20	.	.	PUNCT
cuesj-184	220	1	turkish	turkish	ADJ
cuesj-184	220	2	journal	journal	NOUN
cuesj-184	220	3	of	of	ADP
cuesj-184	220	4	gastroenterology	gastroenterology	NOUN
cuesj-184	220	5	,	,	PUNCT
cuesj-184	220	6	vol	vol	NOUN
cuesj-184	220	7	.	.	PROPN
cuesj-184	220	8	25	25	NUM
cuesj-184	220	9	,	,	PUNCT
cuesj-184	220	10	no	no	INTJ
cuesj-184	220	11	.	.	NOUN
cuesj-184	220	12	1	1	NUM
cuesj-184	220	13	,	,	PUNCT
cuesj-184	220	14	pp	pp	ADJ
cuesj-184	220	15	.	.	PUNCT
cuesj-184	221	1	142	142	NUM
cuesj-184	221	2	-	-	SYM
cuesj-184	221	3	146	146	NUM
cuesj-184	221	4	,	,	PUNCT
cuesj-184	221	5	2014	2014	NUM
cuesj-184	221	6	.	.	PUNCT
cuesj-184	222	1	34	34	NUM
cuesj-184	222	2	.	.	PUNCT
cuesj-184	223	1	g.	g.	PROPN
cuesj-184	223	2	li	li	PROPN
cuesj-184	223	3	,	,	PUNCT
cuesj-184	223	4	j.	j.	PROPN
cuesj-184	223	5	wang	wang	PROPN
cuesj-184	223	6	,	,	PUNCT
cuesj-184	223	7	y.	y.	PROPN
cuesj-184	223	8	bao	bao	PROPN
cuesj-184	223	9	,	,	PUNCT
cuesj-184	223	10	l.	l.	PROPN
cuesj-184	223	11	zheng	zheng	PROPN
cuesj-184	223	12	,	,	PUNCT
cuesj-184	223	13	k.	k.	PROPN
cuesj-184	223	14	ge	ge	PROPN
cuesj-184	223	15	,	,	PUNCT
cuesj-184	223	16	x.	x.	PROPN
cuesj-184	223	17	zhou	zhou	PROPN
cuesj-184	223	18	and	and	CCONJ
cuesj-184	223	19	g.	g.	PROPN
cuesj-184	223	20	chen	chen	PROPN
cuesj-184	223	21	.	.	PUNCT
cuesj-184	224	1	“	"	PUNCT
cuesj-184	224	2	clinical	clinical	ADJ
cuesj-184	224	3	significance	significance	NOUN
cuesj-184	224	4	of	of	ADP
cuesj-184	224	5	serum	serum	PROPN
cuesj-184	224	6	hbsag	hbsag	NOUN
cuesj-184	224	7	levels	level	NOUN
cuesj-184	224	8	,	,	PUNCT
cuesj-184	224	9	hbsag	hbsag	ADJ
cuesj-184	224	10	/	/	SYM
cuesj-184	224	11	hbv	hbv	PROPN
cuesj-184	224	12	dna	dna	PROPN
cuesj-184	224	13	ratio	ratio	NOUN
cuesj-184	224	14	,	,	PUNCT
cuesj-184	224	15	and	and	CCONJ
cuesj-184	224	16	association	association	NOUN
cuesj-184	224	17	with	with	ADP
cuesj-184	224	18	liver	liver	NOUN
cuesj-184	224	19	inflammation	inflammation	NOUN
cuesj-184	224	20	activity	activity	NOUN
cuesj-184	224	21	in	in	ADP
cuesj-184	224	22	hbeag	hbeag	ADV
cuesj-184	224	23	-	-	PUNCT
cuesj-184	224	24	positive	positive	ADJ
cuesj-184	224	25	chronic	chronic	ADJ
cuesj-184	224	26	hepatitis	hepatitis	NOUN
cuesj-184	224	27	b	b	NOUN
cuesj-184	224	28	”	"	PUNCT
cuesj-184	224	29	.	.	PUNCT
cuesj-184	225	1	zhonghua	zhonghua	PROPN
cuesj-184	225	2	gan	gan	PROPN
cuesj-184	225	3	zang	zang	PROPN
cuesj-184	225	4	bing	bing	PROPN
cuesj-184	225	5	za	za	PROPN
cuesj-184	225	6	zhi	zhi	PROPN
cuesj-184	226	1	=	=	PROPN
cuesj-184	226	2	zhonghua	zhonghua	PROPN
cuesj-184	226	3	ganzangbing	ganzangbe	VERB
cuesj-184	226	4	zazhi	zazhi	PROPN
cuesj-184	226	5	=	=	PROPN
cuesj-184	226	6	chinese	chinese	PROPN
cuesj-184	226	7	journal	journal	PROPN
cuesj-184	226	8	of	of	ADP
cuesj-184	226	9	hepatology	hepatology	NOUN
cuesj-184	226	10	,	,	PUNCT
cuesj-184	226	11	vol	vol	NOUN
cuesj-184	226	12	.	.	PROPN
cuesj-184	226	13	23	23	NUM
cuesj-184	226	14	,	,	PUNCT
cuesj-184	226	15	no	no	INTJ
cuesj-184	226	16	.	.	NOUN
cuesj-184	226	17	1	1	NUM
cuesj-184	226	18	,	,	PUNCT
cuesj-184	226	19	pp	pp	ADJ
cuesj-184	226	20	.	.	PUNCT
cuesj-184	226	21	40	40	NUM
cuesj-184	226	22	-	-	SYM
cuesj-184	226	23	45	45	NUM
cuesj-184	226	24	,	,	PUNCT
cuesj-184	226	25	2015	2015	NUM
cuesj-184	226	26	.	.	PUNCT
cuesj-184	226	27	35	35	NUM
cuesj-184	226	28	.	.	PUNCT
cuesj-184	226	29	a.	a.	NOUN
cuesj-184	226	30	ganji	ganji	PROPN
cuesj-184	226	31	,	,	PUNCT
cuesj-184	226	32	a.	a.	NOUN
cuesj-184	226	33	esmaeilzadeh	esmaeilzadeh	PROPN
cuesj-184	226	34	,	,	PUNCT
cuesj-184	226	35	k.	k.	PROPN
cuesj-184	226	36	ghafarzadegan	ghafarzadegan	PROPN
cuesj-184	226	37	,	,	PUNCT
cuesj-184	226	38	h.	h.	PROPN
cuesj-184	226	39	helalat	helalat	PROPN
cuesj-184	226	40	,	,	PUNCT
cuesj-184	226	41	h.	h.	PROPN
cuesj-184	226	42	rafatpanah	rafatpanah	PROPN
cuesj-184	226	43	and	and	CCONJ
cuesj-184	226	44	a.	a.	NOUN
cuesj-184	226	45	mokhtarifar	mokhtarifar	PROPN
cuesj-184	226	46	.	.	PUNCT
cuesj-184	227	1	“	"	PUNCT
cuesj-184	227	2	correlation	correlation	NOUN
cuesj-184	227	3	between	between	ADP
cuesj-184	227	4	hbsag	hbsag	NOUN
cuesj-184	227	5	quantitative	quantitative	ADJ
cuesj-184	227	6	assay	assay	NOUN
cuesj-184	227	7	results	result	NOUN
cuesj-184	227	8	and	and	CCONJ
cuesj-184	227	9	hbv	hbv	NOUN
cuesj-184	227	10	dna	dna	PROPN
cuesj-184	227	11	levels	level	NOUN
cuesj-184	227	12	in	in	ADP
cuesj-184	227	13	chronic	chronic	ADJ
cuesj-184	227	14	hbv	hbv	NOUN
cuesj-184	227	15	”	"	PUNCT
cuesj-184	227	16	.	.	PUNCT
cuesj-184	228	1	hepatitis	hepatitis	PROPN
cuesj-184	228	2	monthly	monthly	ADJ
cuesj-184	228	3	,	,	PUNCT
cuesj-184	228	4	vol	vol	NOUN
cuesj-184	228	5	.	.	PROPN
cuesj-184	228	6	11	11	NUM
cuesj-184	228	7	,	,	PUNCT
cuesj-184	228	8	no	no	INTJ
cuesj-184	228	9	.	.	NOUN
cuesj-184	228	10	5	5	NUM
cuesj-184	228	11	,	,	PUNCT
cuesj-184	228	12	p.	p.	NOUN
cuesj-184	228	13	342	342	NUM
cuesj-184	228	14	,	,	PUNCT
cuesj-184	228	15	2011	2011	NUM
cuesj-184	228	16	.	.	PUNCT
cuesj-184	229	1	36	36	NUM
cuesj-184	229	2	.	.	PUNCT
cuesj-184	229	3	r.	r.	PROPN
cuesj-184	229	4	m.	m.	PROPN
cuesj-184	229	5	mukherjee	mukherjee	PROPN
cuesj-184	229	6	,	,	PUNCT
cuesj-184	229	7	j.	j.	PROPN
cuesj-184	229	8	arava	arava	PROPN
cuesj-184	229	9	,	,	PUNCT
cuesj-184	229	10	p.	p.	PROPN
cuesj-184	229	11	b.	b.	PROPN
cuesj-184	229	12	reddy	reddy	PROPN
cuesj-184	229	13	,	,	PUNCT
cuesj-184	229	14	p.	p.	PROPN
cuesj-184	229	15	n.	n.	PROPN
cuesj-184	229	16	rao	rao	PROPN
cuesj-184	229	17	,	,	PUNCT
cuesj-184	229	18	r.	r.	PROPN
cuesj-184	229	19	gupta	gupta	PROPN
cuesj-184	229	20	and	and	CCONJ
cuesj-184	229	21	d.	d.	PROPN
cuesj-184	229	22	n.	n.	PROPN
cuesj-184	229	23	reddy	reddy	PROPN
cuesj-184	229	24	.	.	PUNCT
cuesj-184	230	1	“	"	PUNCT
cuesj-184	230	2	role	role	NOUN
cuesj-184	230	3	of	of	ADP
cuesj-184	230	4	hepatitis	hepatitis	PROPN
cuesj-184	230	5	b	b	PROPN
cuesj-184	230	6	virus	virus	NOUN
cuesj-184	230	7	surface	surface	VERB
cuesj-184	230	8	antigen	antigen	ADJ
cuesj-184	230	9	quantification	quantification	NOUN
cuesj-184	230	10	in	in	ADP
cuesj-184	230	11	e	e	NOUN
cuesj-184	230	12	antigen	antigen	ADP
cuesj-184	230	13	negative	negative	ADJ
cuesj-184	230	14	chronic	chronic	ADJ
cuesj-184	230	15	hepatitis	hepatitis	NOUN
cuesj-184	230	16	b	b	NOUN
cuesj-184	230	17	infection	infection	NOUN
cuesj-184	230	18	”	"	PUNCT
cuesj-184	230	19	.	.	PUNCT
cuesj-184	231	1	global	global	ADJ
cuesj-184	231	2	journal	journal	PROPN
cuesj-184	231	3	of	of	ADP
cuesj-184	231	4	science	science	PROPN
cuesj-184	231	5	frontier	frontier	NOUN
cuesj-184	231	6	research	research	NOUN
cuesj-184	231	7	,	,	PUNCT
cuesj-184	231	8	vol	vol	NOUN
cuesj-184	231	9	.	.	PROPN
cuesj-184	231	10	13	13	NUM
cuesj-184	231	11	,	,	PUNCT
cuesj-184	231	12	no	no	INTJ
cuesj-184	231	13	.	.	NOUN
cuesj-184	231	14	1	1	NUM
cuesj-184	231	15	,	,	PUNCT
cuesj-184	231	16	pp	pp	ADJ
cuesj-184	231	17	.	.	PUNCT
cuesj-184	232	1	1	1	NUM
cuesj-184	232	2	-	-	SYM
cuesj-184	232	3	5	5	NUM
cuesj-184	232	4	,	,	PUNCT
cuesj-184	232	5	2013	2013	NUM
cuesj-184	232	6	.	.	PUNCT
cuesj-184	233	1	37	37	NUM
cuesj-184	233	2	.	.	PUNCT
cuesj-184	234	1	h.	h.	PROPN
cuesj-184	234	2	park	park	PROPN
cuesj-184	234	3	,	,	PUNCT
cuesj-184	234	4	j.	j.	PROPN
cuesj-184	234	5	m.	m.	PROPN
cuesj-184	234	6	lee	lee	PROPN
cuesj-184	234	7	,	,	PUNCT
cuesj-184	234	8	j.	j.	PROPN
cuesj-184	234	9	h.	h.	PROPN
cuesj-184	234	10	seo	seo	PROPN
cuesj-184	234	11	,	,	PUNCT
cuesj-184	234	12	h.	h.	PROPN
cuesj-184	234	13	s.	s.	PROPN
cuesj-184	234	14	kim	kim	PROPN
cuesj-184	234	15	,	,	PUNCT
cuesj-184	234	16	s.	s.	PROPN
cuesj-184	234	17	h.	h.	PROPN
cuesj-184	234	18	ahn	ahn	PROPN
cuesj-184	234	19	,	,	PUNCT
cuesj-184	234	20	d.	d.	PROPN
cuesj-184	234	21	y.	y.	PROPN
cuesj-184	234	22	kim	kim	PROPN
cuesj-184	234	23	and	and	CCONJ
cuesj-184	234	24	j.	j.	PROPN
cuesj-184	234	25	y.	y.	PROPN
cuesj-184	234	26	park	park	PROPN
cuesj-184	234	27	.	.	PUNCT
cuesj-184	235	1	“	"	PUNCT
cuesj-184	235	2	predictive	predictive	ADJ
cuesj-184	235	3	value	value	NOUN
cuesj-184	235	4	of	of	ADP
cuesj-184	235	5	hbsag	hbsag	ADJ
cuesj-184	235	6	quantification	quantification	NOUN
cuesj-184	235	7	for	for	ADP
cuesj-184	235	8	determining	determine	VERB
cuesj-184	235	9	the	the	DET
cuesj-184	235	10	clinical	clinical	ADJ
cuesj-184	235	11	course	course	NOUN
cuesj-184	235	12	of	of	ADP
cuesj-184	235	13	genotype	genotype	NOUN
cuesj-184	235	14	c	c	NOUN
cuesj-184	235	15	hbeag	hbeag	ADV
cuesj-184	235	16	-	-	PUNCT
cuesj-184	235	17	negative	negative	ADJ
cuesj-184	235	18	carriers	carrier	NOUN
cuesj-184	235	19	”	"	PUNCT
cuesj-184	235	20	.	.	PUNCT
cuesj-184	236	1	liver	liver	PROPN
cuesj-184	236	2	international	international	ADJ
cuesj-184	236	3	,	,	PUNCT
cuesj-184	236	4	vol	vol	NOUN
cuesj-184	236	5	.	.	PROPN
cuesj-184	237	1	32	32	NUM
cuesj-184	237	2	,	,	PUNCT
cuesj-184	237	3	no	no	INTJ
cuesj-184	237	4	.	.	NOUN
cuesj-184	237	5	5	5	NUM
cuesj-184	237	6	,	,	PUNCT
cuesj-184	237	7	pp	pp	ADJ
cuesj-184	237	8	.	.	PUNCT
cuesj-184	238	1	796	796	NUM
cuesj-184	238	2	-	-	SYM
cuesj-184	238	3	802	802	NUM
cuesj-184	238	4	,	,	PUNCT
cuesj-184	238	5	2012	2012	NUM
cuesj-184	238	6	.	.	PUNCT
cuesj-184	239	1	38	38	NUM
cuesj-184	239	2	.	.	PUNCT
cuesj-184	239	3	a.	a.	PROPN
cuesj-184	239	4	j.	j.	PROPN
cuesj-184	239	5	thompson	thompson	PROPN
cuesj-184	239	6	,	,	PUNCT
cuesj-184	239	7	t.	t.	NOUN
cuesj-184	239	8	nguyen	nguyen	PROPN
cuesj-184	239	9	,	,	PUNCT
cuesj-184	239	10	d.	d.	PROPN
cuesj-184	239	11	iser	iser	PROPN
cuesj-184	239	12	,	,	PUNCT
cuesj-184	239	13	a.	a.	PROPN
cuesj-184	239	14	ayres	ayres	PROPN
cuesj-184	239	15	,	,	PUNCT
cuesj-184	239	16	k.	k.	PROPN
cuesj-184	239	17	jackson	jackson	PROPN
cuesj-184	239	18	,	,	PUNCT
cuesj-184	239	19	m.	m.	PROPN
cuesj-184	239	20	littlejohn	littlejohn	PROPN
cuesj-184	239	21	and	and	CCONJ
cuesj-184	239	22	g.	g.	PROPN
cuesj-184	239	23	k.	k.	PROPN
cuesj-184	239	24	lau	lau	PROPN
cuesj-184	239	25	.	.	PUNCT
cuesj-184	240	1	“	"	PUNCT
cuesj-184	240	2	serum	serum	VERB
cuesj-184	240	3	hepatitis	hepatitis	PROPN
cuesj-184	240	4	b	b	PROPN
cuesj-184	240	5	surface	surface	NOUN
cuesj-184	240	6	antigen	antigen	NOUN
cuesj-184	240	7	and	and	CCONJ
cuesj-184	240	8	hepatitis	hepatitis	PROPN
cuesj-184	240	9	b	b	PROPN
cuesj-184	240	10	e	e	NOUN
cuesj-184	240	11	antigen	antigen	NOUN
cuesj-184	240	12	titers	titer	NOUN
cuesj-184	240	13	:	:	PUNCT
cuesj-184	240	14	disease	disease	NOUN
cuesj-184	240	15	phase	phase	NOUN
cuesj-184	240	16	influences	influence	VERB
cuesj-184	240	17	correlation	correlation	NOUN
cuesj-184	240	18	with	with	ADP
cuesj-184	240	19	viral	viral	ADJ
cuesj-184	240	20	load	load	NOUN
cuesj-184	240	21	and	and	CCONJ
cuesj-184	240	22	intrahepatic	intrahepatic	ADJ
cuesj-184	240	23	hepatitis	hepatitis	PROPN
cuesj-184	240	24	b	b	PROPN
cuesj-184	240	25	virus	virus	NOUN
cuesj-184	240	26	markers	marker	NOUN
cuesj-184	240	27	”	"	PUNCT
cuesj-184	240	28	.	.	PUNCT
cuesj-184	241	1	hepatology	hepatology	NOUN
cuesj-184	241	2	,	,	PUNCT
cuesj-184	241	3	vol	vol	NOUN
cuesj-184	241	4	.	.	PROPN
cuesj-184	241	5	51	51	NUM
cuesj-184	241	6	,	,	PUNCT
cuesj-184	241	7	no	no	INTJ
cuesj-184	241	8	.	.	NOUN
cuesj-184	241	9	6	6	NUM
cuesj-184	241	10	,	,	PUNCT
cuesj-184	241	11	pp	pp	ADJ
cuesj-184	241	12	.	.	PUNCT
cuesj-184	241	13	1933	1933	NUM
cuesj-184	241	14	-	-	SYM
cuesj-184	241	15	1944	1944	NUM
cuesj-184	241	16	,	,	PUNCT
cuesj-184	241	17	2010	2010	NUM
cuesj-184	241	18	.	.	PUNCT
cuesj-184	241	19	39	39	NUM
cuesj-184	241	20	.	.	PUNCT
cuesj-184	242	1	m.	m.	NOUN
cuesj-184	242	2	martinot	martinot	ADV
cuesj-184	242	3	-	-	PUNCT
cuesj-184	242	4	peignoux	peignoux	ADJ
cuesj-184	242	5	,	,	PUNCT
cuesj-184	242	6	m.	m.	NOUN
cuesj-184	242	7	lapalus	lapalus	NOUN
cuesj-184	242	8	,	,	PUNCT
cuesj-184	242	9	c.	c.	PROPN
cuesj-184	242	10	laouénan	laouénan	PROPN
cuesj-184	242	11	,	,	PUNCT
cuesj-184	242	12	o.	o.	PROPN
cuesj-184	242	13	lada	lada	PROPN
cuesj-184	242	14	,	,	PUNCT
cuesj-184	242	15	a.	a.	PROPN
cuesj-184	242	16	c.	c.	PROPN
cuesj-184	242	17	f.	f.	PROPN
cuesj-184	242	18	netto	netto	PROPN
cuesj-184	242	19	-	-	PUNCT
cuesj-184	242	20	cardoso	cardoso	PROPN
cuesj-184	242	21	,	,	PUNCT
cuesj-184	242	22	n.	n.	PROPN
cuesj-184	242	23	boyer	boyer	PROPN
cuesj-184	242	24	and	and	CCONJ
cuesj-184	242	25	p.	p.	PROPN
cuesj-184	242	26	marcellin	marcellin	PROPN
cuesj-184	242	27	.	.	PUNCT
cuesj-184	243	1	“	"	PUNCT
cuesj-184	243	2	prediction	prediction	NOUN
cuesj-184	243	3	of	of	ADP
cuesj-184	243	4	disease	disease	NOUN
cuesj-184	243	5	reactivation	reactivation	NOUN
cuesj-184	243	6	in	in	ADP
cuesj-184	243	7	asymptomatic	asymptomatic	ADJ
cuesj-184	243	8	hepatitis	hepatitis	PROPN
cuesj-184	243	9	b	b	PROPN
cuesj-184	243	10	e	e	ADP
cuesj-184	243	11	antigennegative	antigennegative	ADJ
cuesj-184	243	12	chronic	chronic	ADJ
cuesj-184	243	13	hepatitis	hepatitis	PROPN
cuesj-184	243	14	b	b	PROPN
cuesj-184	243	15	patients	patient	NOUN
cuesj-184	243	16	using	use	VERB
cuesj-184	243	17	baseline	baseline	NOUN
cuesj-184	243	18	serum	serum	NOUN
cuesj-184	243	19	measurements	measurement	NOUN
cuesj-184	243	20	of	of	ADP
cuesj-184	243	21	hbsag	hbsag	NOUN
cuesj-184	243	22	and	and	CCONJ
cuesj-184	243	23	hbv	hbv	NOUN
cuesj-184	243	24	-	-	PUNCT
cuesj-184	243	25	dna	dna	NOUN
cuesj-184	243	26	”	"	PUNCT
cuesj-184	243	27	.	.	PUNCT
cuesj-184	244	1	journal	journal	PROPN
cuesj-184	244	2	of	of	ADP
cuesj-184	244	3	clinical	clinical	ADJ
cuesj-184	244	4	virology	virology	NOUN
cuesj-184	244	5	,	,	PUNCT
cuesj-184	244	6	vol	vol	NOUN
cuesj-184	244	7	.	.	PROPN
cuesj-184	245	1	58	58	NUM
cuesj-184	245	2	,	,	PUNCT
cuesj-184	245	3	no	no	INTJ
cuesj-184	245	4	.	.	NOUN
cuesj-184	245	5	2	2	NUM
cuesj-184	245	6	,	,	PUNCT
cuesj-184	245	7	pp	pp	ADJ
cuesj-184	245	8	.	.	PUNCT
cuesj-184	246	1	401	401	NUM
cuesj-184	246	2	-	-	SYM
cuesj-184	246	3	407	407	NUM
cuesj-184	246	4	,	,	PUNCT
cuesj-184	246	5	2013	2013	NUM
cuesj-184	246	6	.	.	PUNCT